CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tert-butyl hydroperoxide
Accession: CHEBI:64090
browse the term
Definition: An alkyl hydroperoxide in which the alkyl group is tert-butyl. It is widely used in a variety of oxidation processes.
Synonyms: related_synonym: 1,1-Dimethylethyl hydroperoxide; 2-Hydroperoxy-2-methylpropane; Dimethylethyl hydroperoxide; Formula=C4H10O2; Hydroperoxyde de butyle tertiaire; InChI=1S/C4H10O2/c1-4(2,3)6-5/h5H,1-3H3; InChIKey=CIHOLLKRGTVIJN-UHFFFAOYSA-N; SMILES=CC(C)(C)OO; TBHP; Tertiary-butyl hydroperoxide; t-Butylhydroperoxide; t-butyl hydroperoxide; tert-Butylhydroperoxide
xref: CAS:75-91-2
xref_mesh: MESH:D020122
xref: PMID:21418283; PMID:22037478; PMID:22039964; PMID:22326806; PMID:22337620; PMID:22369679; Reaxys:1098280; Wikipedia:Tert-Butyl_hydroperoxide
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA
CTD
PMID:15336504
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions affects localization decreases expression
EXP ISO
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein tert-Butylhydroperoxide results in decreased expression of ABCB11 mRNA
CTD
PMID:16452108 PMID:24306262 PMID:34767876
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCB1A mRNA
CTD
PMID:14729362
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression multiple interactions affects localization
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ABCC2 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein
CTD
PMID:22956110 PMID:24306262 PMID:34303734
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcd1
ATP binding cassette subfamily D member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCD1 mRNA
CTD
PMID:15003993
NCBI chr X:151,428,334...151,450,115
Ensembl chr X:151,428,578...151,450,115
G
Abhd17a
abhydrolase domain containing 17A, depalmitoylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABHD17A mRNA
CTD
PMID:15336504
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
G
Ablim1
actin-binding LIM protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABLIM1 mRNA
CTD
PMID:15336504
NCBI chr 1:256,083,747...256,372,075
Ensembl chr 1:256,084,297...256,371,969
G
Abr
ABR activator of RhoGEF and GTPase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABR mRNA
CTD
PMID:15003993
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
G
Acads
acyl-CoA dehydrogenase short chain
increases expression decreases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of ACADS mRNA tert-Butylhydroperoxide results in decreased expression of ACADS mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein
CTD
PMID:15003993 PMID:26989860
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
G
Ache
acetylcholinesterase
multiple interactions increases expression increases secretion
EXP
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of ACHE protein] tert-Butylhydroperoxide results in increased expression of ACHE mRNA alternative form
CTD
PMID:16903848
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACKR3 mRNA
CTD
PMID:15336504
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
Aco1
aconitase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACO1 mRNA
CTD
PMID:15336504
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
G
Acot1
acyl-CoA thioesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT1 mRNA
CTD
PMID:14729362
NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163
G
Acot7
acyl-CoA thioesterase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT7 mRNA
CTD
PMID:15003993
NCBI chr 5:162,686,562...162,779,309
Ensembl chr 5:162,684,645...162,779,309
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA
CTD
PMID:15336504
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
G
Actb
actin, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTB mRNA
CTD
PMID:12419474
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg2
actin gamma 2, smooth muscle
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA
CTD
PMID:15336504
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
G
Actn1
actinin, alpha 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTN1 mRNA
CTD
PMID:15336504
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Actr3
actin related protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTR3 mRNA
CTD
PMID:15336504
NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
G
Actr3b
actin related protein 3B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTR3B mRNA
CTD
PMID:15336504
NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
G
Acy3
aminoacylase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACY3 mRNA
CTD
PMID:15003993
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
G
Acyp1
acylphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACYP1 mRNA
CTD
PMID:15336504
NCBI chr 6:104,919,162...104,932,348
Ensembl chr 6:104,919,162...104,932,387
G
Adam19
ADAM metallopeptidase domain 19
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM19 mRNA
CTD
PMID:15336504
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
G
Adam8
ADAM metallopeptidase domain 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM8 mRNA
CTD
PMID:15003993
NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801
G
Adam9
ADAM metallopeptidase domain 9
multiple interactions increases expression affects expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] tert-Butylhydroperoxide affects the expression of ADAM9 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
G
Adar
adenosine deaminase, RNA-specific
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAR mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
G
Adat1
adenosine deaminase, tRNA-specific 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADAT1 mRNA
CTD
PMID:15963989
NCBI chr19:39,918,083...39,956,886
Ensembl chr19:39,918,227...39,956,883
G
Adcy3
adenylate cyclase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY3 mRNA
CTD
PMID:12414654
NCBI chr 6:27,100,089...27,203,686
Ensembl chr 6:27,124,828...27,203,686
G
Adcy9
adenylate cyclase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA
CTD
PMID:15336504
NCBI chr10:11,138,966...11,262,067
Ensembl chr10:11,139,446...11,262,066
G
Add2
adducin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADD2 mRNA
CTD
PMID:15336504
NCBI chr 4:118,444,594...118,538,505
Ensembl chr 4:118,497,416...118,538,505
G
Add3
adducin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA
CTD
PMID:15336504
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgrg6
adhesion G protein-coupled receptor G6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA
CTD
PMID:15336504
NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADH7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adipor2
adiponectin receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA
CTD
PMID:15336504
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
G
Adm
adrenomedullin
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:20847119 PMID:29432895
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adora1
adenosine A1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA
CTD
PMID:12419474
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2b
adenosine A2B receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA
CTD
PMID:15336504
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Agk
acylglycerol kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AGK mRNA
CTD
PMID:15336504
NCBI chr 4:69,114,850...69,193,989
Ensembl chr 4:69,114,269...69,193,934
G
Ago2
argonaute RISC catalytic component 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA
CTD
PMID:15003993
NCBI chr20:4,135,955...4,144,880
Ensembl chr20:4,135,957...4,145,278
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AHSA1 mRNA
CTD
PMID:15336504
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions increases expression
ISO
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein]
CTD
PMID:25522270
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Aip
aryl-hydrocarbon receptor-interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AIP mRNA
CTD
PMID:15336504
NCBI chr 1:201,408,002...201,419,220
Ensembl chr 1:201,407,288...201,419,122
G
Ajuba
ajuba LIM protein
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA]
CTD
PMID:20847119
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
G
Ak2
adenylate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AK2 mRNA
CTD
PMID:15336504
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
G
Ak4
adenylate kinase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AK4 mRNA
CTD
PMID:15003993
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akap12
A-kinase anchoring protein 12
affects expression
ISO
tert-Butylhydroperoxide affects the expression of AKAP12 mRNA
CTD
PMID:23410634
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akap9
A-kinase anchoring protein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA
CTD
PMID:15336504
NCBI chr 4:30,056,738...30,192,716
Ensembl chr 4:30,056,738...30,192,606
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA
CTD
PMID:23410634 PMID:34767876
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C1 mRNA
CTD
PMID:15336504
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA
CTD
PMID:12414654 PMID:15336504 PMID:23410634
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]
CTD
PMID:29128606 PMID:35690295
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA tert-Butylhydroperoxide results in increased methylation of AKT2 gene
CTD
PMID:27509014
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alad
aminolevulinate dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAD mRNA
CTD
PMID:15336504
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAS1 protein
CTD
PMID:21659532
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH1A1 mRNA tert-Butylhydroperoxide affects the expression of ALDH1A1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA
CTD
PMID:15336504
NCBI chr 1:119,982,272...120,017,416
Ensembl chr 1:119,982,277...120,017,436
G
Aldh2
aldehyde dehydrogenase 2 family member
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of ALDH2 mRNA ALDH2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH3A2 mRNA
CTD
PMID:15336504
NCBI chr10:45,928,313...45,949,366
Ensembl chr10:45,908,524...45,949,281
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH4A1 mRNA
CTD
PMID:15336504
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH6A1 mRNA
CTD
PMID:15336504
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH7A1 mRNA
CTD
PMID:15336504
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDOA mRNA
CTD
PMID:15003993
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alox5
arachidonate 5-lipoxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA
CTD
PMID:15336504
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Amd1
adenosylmethionine decarboxylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMD1 mRNA
CTD
PMID:27509014
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMIGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
G
Amotl2
angiomotin like 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA]
CTD
PMID:20847119
NCBI chr 8:103,303,368...103,319,161
Ensembl chr 8:103,302,992...103,318,910
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMPD3 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Amph
amphiphysin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AMPH mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA
CTD
PMID:15336504
NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
G
Angptl2
angiopoietin-like 2
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]
CTD
PMID:15003993 PMID:20847119
NCBI chr 3:16,517,185...16,547,024
Ensembl chr 3:16,517,420...16,548,178
G
Angptl7
angiopoietin like 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANGPTL7 mRNA
CTD
PMID:15336504
NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:158,932,794...158,937,324
G
Ankmy2
ankyrin repeat and MYND domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA
CTD
PMID:15336504
NCBI chr 6:52,888,959...52,930,343
Ensembl chr 6:52,888,963...52,930,394
G
Ankra2
ankyrin repeat family A member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA
CTD
PMID:23410634
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd10
ankyrin repeat domain 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA
CTD
PMID:15336504
NCBI chr16:77,866,489...77,889,745
Ensembl chr16:77,864,261...77,889,745
G
Ankrd2
ankyrin repeat domain 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA
CTD
PMID:15336504
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
G
Ankrd37
ankyrin repeat domain 37
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Ankrd6
ankyrin repeat domain 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA
CTD
PMID:15336504
NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA
CTD
PMID:15336504
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
G
Anpep
alanyl aminopeptidase, membrane
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANPEP mRNA
CTD
PMID:15336504
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Anxa4
annexin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA
CTD
PMID:15336504
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Anxa8
annexin A8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
G
Aox1
aldehyde oxidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AOX1 mRNA
CTD
PMID:15336504
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3B1 mRNA
CTD
PMID:15336504
NCBI chr 2:25,600,069...25,800,937
Ensembl chr 2:25,600,040...25,800,935
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3D1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,970,249...9,005,651
Ensembl chr 7:8,970,291...9,005,643
G
Apaf1
apoptotic peptidase activating factor 1
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of APAF1 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein] [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]
CTD
PMID:15877105 PMID:17419000 PMID:35690295
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Aplp2
amyloid beta precursor like protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APLP2 mRNA
CTD
PMID:15336504
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
G
Apoa5
apolipoprotein A5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of APOA5 mRNA
CTD
PMID:23410634
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
G
Apoe
apolipoprotein E
increases expression affects localization
ISO EXP
tert-Butylhydroperoxide results in increased expression of APOE mRNA tert-Butylhydroperoxide affects the localization of APOE protein
CTD
PMID:15336504 PMID:19720132
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Apold1
apolipoprotein L domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA
CTD
PMID:15336504
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
G
App
amyloid beta precursor protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APP mRNA
CTD
PMID:12419474
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL1 mRNA
CTD
PMID:15336504
NCBI chr16:2,118,503...2,166,741
Ensembl chr16:2,121,255...2,166,692
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL2 mRNA
CTD
PMID:15336504
NCBI chr 7:20,135,248...20,184,757
Ensembl chr 7:20,135,375...20,184,754
G
Aqp1
aquaporin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA
CTD
PMID:15336504
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Aqp4
aquaporin 4
multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of and affects the localization of AQP4 protein
CTD
PMID:20648640
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
Aqr
aquarius intron-binding spliceosomal factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQR mRNA
CTD
PMID:15336504
NCBI chr 3:100,874,987...100,945,026
Ensembl chr 3:100,874,987...100,945,044
G
Areg
amphiregulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AREG mRNA
CTD
PMID:12414654
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arf6
ARF GTPase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ARF6 mRNA
CTD
PMID:15336504
NCBI chr 6:87,853,742...87,854,890
Ensembl chr 6:87,840,142...87,874,114
G
Arg2
arginase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARG2 mRNA
CTD
PMID:23410634
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA
CTD
PMID:12419474
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arhgef10
Rho guanine nucleotide exchange factor 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF10 mRNA
CTD
PMID:15336504
NCBI chr16:74,647,147...74,738,784
Ensembl chr16:74,647,153...74,738,173
G
Arhgef7
Rho guanine nucleotide exchange factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF7 mRNA
CTD
PMID:15336504
NCBI chr16:77,671,021...77,782,593
Ensembl chr16:77,671,023...77,782,697
G
Arid3a
AT-rich interaction domain 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARID3A mRNA
CTD
PMID:23410634
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP1 mRNA
CTD
PMID:15336504
NCBI chr 1:172,430,475...172,439,990
Ensembl chr 1:172,430,489...172,439,994
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA
CTD
PMID:15336504
NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]
CTD
PMID:35690295
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARPC1A mRNA
CTD
PMID:15336504
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ASF1A mRNA
CTD
PMID:23410634
NCBI chr20:32,893,962...32,908,808
Ensembl chr20:32,893,573...32,908,808
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA
CTD
PMID:15336504
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Asph
aspartate-beta-hydroxylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPH mRNA
CTD
PMID:15336504
NCBI chr 5:22,601,581...22,814,107
Ensembl chr 5:22,603,486...22,813,876
G
Aspscr1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPSCR1 mRNA
CTD
PMID:15336504
NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904
G
Ass1
argininosuccinate synthase 1
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ASS1 mRNA; tert-Butylhydroperoxide results in decreased expression of ASS1 protein
CTD
PMID:15336504 PMID:24394546
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASXL1 mRNA
CTD
PMID:15336504
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
G
Atad2
ATPase family, AAA domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA
CTD
PMID:15336504
NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA
CTD
PMID:12414654 PMID:20196124 PMID:20847119
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atg4b
autophagy related 4B, cysteine peptidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG4B mRNA
CTD
PMID:15336504
NCBI chr 9:94,282,417...94,314,109
Ensembl chr 9:94,282,509...94,314,103
G
Atg5
autophagy related 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA
CTD
PMID:15336504
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atp13a3
ATPase 13A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP13A3 mRNA
CTD
PMID:15336504
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA
CTD
PMID:15336504
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA
CTD
PMID:15336504
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Atp6v1a
ATPase H+ transporting V1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA
CTD
PMID:15336504
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP6V1C1 mRNA
CTD
PMID:15336504
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
G
Atr
ATR serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATR mRNA
CTD
PMID:12419474
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Atxn1
ataxin 1
affects localization multiple interactions decreases expression
ISO
tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]; Buthionine Sulfoximine promotes the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form] tert-Butylhydroperoxide results in decreased expression of ATXN1 mRNA
CTD
PMID:12893416 PMID:15336504
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
G
Atxn3
ataxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATXN3 mRNA
CTD
PMID:15336504
NCBI chr 6:121,072,228...121,107,902
Ensembl chr 6:121,074,448...121,107,902
G
Aurka
aurora kinase A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AURKA mRNA
CTD
PMID:15003993
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AURKB mRNA tert-Butylhydroperoxide results in increased expression of AURKB mRNA
CTD
PMID:12414654 PMID:29432895
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
G
Auts2
activator of transcription and developmental regulator AUTS2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AUTS2 mRNA
CTD
PMID:15336504
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
G
Azin1
antizyme inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA
CTD
PMID:15336504
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
G
Babam1
BRISC and BRCA1 A complex member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BABAM1 mRNA
CTD
PMID:15336504
NCBI chr16:18,068,830...18,074,938
Ensembl chr16:18,068,884...18,074,923
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BABAM2 mRNA
CTD
PMID:15003993
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
G
Bace2
beta-secretase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA
CTD
PMID:15336504
NCBI chr11:36,707,447...36,789,550
Ensembl chr11:36,707,458...36,789,546
G
Bad
BCL2-associated agonist of cell death
decreases expression increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in decreased expression of BAD mRNA tert-Butylhydroperoxide results in increased expression of BAD protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA
CTD
PMID:12419474
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAMBI mRNA tert-Butylhydroperoxide affects the expression of BAMBI mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions decreases expression increases expression affects localization
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] tert-Butylhydroperoxide results in decreased expression of BAX mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000 PMID:18552516 PMID:20510348 PMID:23994092 PMID:25522270 PMID:26989860 PMID:28063877 PMID:29111459 PMID:35690295 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA
CTD
PMID:15336504
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
G
Bbln
bublin coiled coil protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BBLN mRNA
CTD
PMID:15336504
NCBI chr 3:15,674,577...15,677,322
Ensembl chr 3:15,674,580...15,677,374
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression affects localization
EXP ISO
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA; Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]
CTD
PMID:12782109 PMID:15288519 PMID:15569404 PMID:17419000 PMID:19772912 PMID:20510348 PMID:22659508 PMID:23994092 PMID:25522270 PMID:26989860 PMID:27050144 PMID:29111459 PMID:29128606 PMID:35690295 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
EXP ISO
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein
CTD
PMID:12419474 PMID:15569404 PMID:26102008 PMID:27050144
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l13
Bcl2-like 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BCL2L13 mRNA
CTD
PMID:15336504
NCBI chr 4:154,056,116...154,112,890
Ensembl chr 4:154,056,127...154,108,985
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BDH1 mRNA
CTD
PMID:29432895
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BDNF mRNA
CTD
PMID:15336504
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bex2
brain expressed X-linked 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX1 mRNA
CTD
PMID:15336504
NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503
G
Bex4
brain expressed, X-linked 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX4 mRNA
CTD
PMID:15336504
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bhmt
betaine-homocysteine S-methyltransferase
increases methylation decreases expression
ISO
tert-Butylhydroperoxide results in increased methylation of BHMT gene tert-Butylhydroperoxide results in decreased expression of BHMT mRNA
CTD
PMID:27509014
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Bicd1
BICD cargo adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BICD1 mRNA
CTD
PMID:15336504
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
G
Bik
BCL2-interacting killer
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIK mRNA
CTD
PMID:23410634
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA
CTD
PMID:15003993
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Bles03
basophilic leukemia expressed protein BLES03
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of C11ORF68 mRNA
CTD
PMID:15336504
NCBI chr 1:202,734,555...202,736,809
Ensembl chr 1:202,734,555...202,736,804
G
Blnk
B-cell linker
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BLNK mRNA
CTD
PMID:14729362
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bmal2
basic helix-loop-helix ARNT like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMAL2 mRNA
CTD
PMID:15336504
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
G
Bmerb1
bMERB domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA
CTD
PMID:15336504
NCBI chr10:1,779,834...1,946,586
Ensembl chr10:1,779,835...1,946,575
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP1 mRNA
CTD
PMID:12419474
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP4 mRNA
CTD
PMID:12419474
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
G
Bnip3
BCL2 interacting protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BORA mRNA
CTD
PMID:15336504
NCBI chr15:75,797,624...75,835,599
Ensembl chr15:75,797,891...75,821,322
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA
CTD
PMID:12419474
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Brd3
bromodomain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3 mRNA
CTD
PMID:15336504
NCBI chr 3:10,773,163...10,829,675
Ensembl chr 3:10,775,272...10,829,577
G
Brd3os
BRD3 opposite strand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3OS mRNA
CTD
PMID:15336504
NCBI chr 3:10,770,229...10,771,860
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Bst1
bone marrow stromal cell antigen 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST1 mRNA
CTD
PMID:15336504
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST2 mRNA
CTD
PMID:15336504
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Btbd2
BTB domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTBD2 mRNA
CTD
PMID:15336504
NCBI chr 7:9,058,609...9,075,341
Ensembl chr 7:9,060,788...9,075,344
G
Btd
biotinidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTD mRNA
CTD
PMID:15336504
NCBI chr16:6,863,068...6,894,345
Ensembl chr16:6,862,407...6,940,945
G
Btf3
basic transcription factor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTF3 mRNA
CTD
PMID:15336504
NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:29,659,231...29,666,879
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTG1 mRNA
CTD
PMID:15003993
NCBI chr 7:31,341,391...31,343,649
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTG2 mRNA
CTD
PMID:12414654 PMID:21382384
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of BUB1 mRNA
CTD
PMID:23410634
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bud23
BUD23, rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BUD23 mRNA
CTD
PMID:15336504
NCBI chr12:21,629,551...21,640,758
Ensembl chr12:21,629,536...21,640,751
G
Bzw1
basic leucine zipper and W2 domains 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C17ORF100 mRNA
CTD
PMID:23410634
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C13h1orf115
similar to human chromosome 1 open reading frame 115
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA
CTD
PMID:15336504
NCBI chr13:96,422,308...96,432,044
Ensembl chr13:96,422,302...96,432,068
G
C17h6orf62
similar to human chromosome 6 open reading frame 62
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C6ORF62 mRNA
CTD
PMID:23410634
NCBI chr17:40,256,211...40,267,851
Ensembl chr17:40,256,211...40,276,020
G
C1r
complement C1r
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1R mRNA
CTD
PMID:15336504
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C2CD2 mRNA
CTD
PMID:15336504
NCBI chr11:37,225,321...37,289,741
Ensembl chr11:37,227,415...37,289,739
G
C5
complement C5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C5 mRNA
CTD
PMID:15336504
NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994
G
C7h8orf76
similar to human chromosome 8 open reading frame 76
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C8ORF76 mRNA
CTD
PMID:23410634
NCBI chr 7:89,558,890...89,569,810
Ensembl chr 7:89,558,909...89,569,810
G
Cadm1
cell adhesion molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CADM1 mRNA
CTD
PMID:15336504
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
G
Cadm4
cell adhesion molecule 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA
CTD
PMID:15336504
NCBI chr 1:80,075,163...80,097,423
Ensembl chr 1:80,075,202...80,097,423
G
Calhm2
calcium homeostasis modulator family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALHM2 mRNA
CTD
PMID:15336504
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
G
Calm1
calmodulin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM1 mRNA
CTD
PMID:15336504
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calm3
calmodulin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM3 mRNA
CTD
PMID:15003993
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
G
Calml4
calmodulin-like 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALML4 mRNA
CTD
PMID:15003993
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
G
Calr
calreticulin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALR mRNA
CTD
PMID:15336504
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALU mRNA
CTD
PMID:15336504
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA
CTD
PMID:15336504
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Camlg
calcium modulating ligand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAML mRNA
CTD
PMID:14729362
NCBI chr17:8,992,697...9,003,576
Ensembl chr17:8,992,696...9,003,552
G
Camp
cathelicidin antimicrobial peptide
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAMP mRNA
CTD
PMID:22659508
NCBI chr 8:109,841,729...109,843,543
Ensembl chr 8:109,841,729...109,843,543
G
Cand1
cullin-associated and neddylation-dissociated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAND1 mRNA
CTD
PMID:15336504
NCBI chr 7:54,681,114...54,719,002
Ensembl chr 7:54,680,900...54,718,993
G
Capn1
calpain 1
increases response to substance increases expression
ISO
CAPN1 protein results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CAPN1 mRNA
CTD
PMID:12842444 PMID:15003993
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN2 mRNA tert-Butylhydroperoxide affects the expression of CAPN2 mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Capn5
calpain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAPN5 mRNA
CTD
PMID:15003993
NCBI chr 1:152,416,252...152,472,923
Ensembl chr 1:152,416,252...152,472,923
G
Capn7
calpain 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA
CTD
PMID:15336504
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
G
Capns1
calpain, small subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPNS1 mRNA
CTD
PMID:12419474
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
G
Caprin2
caprin family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPRIN2 mRNA
CTD
PMID:15336504
NCBI chr 4:181,806,105...181,860,754
Ensembl chr 4:181,806,575...181,860,830
G
Car8
carbonic anhydrase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CA8 mRNA
CTD
PMID:15336504
NCBI chr 5:21,302,940...21,402,395
Ensembl chr 5:21,305,383...21,402,374
G
Cars2
cysteinyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CARS2 mRNA
CTD
PMID:15336504
NCBI chr16:77,945,468...77,987,163
Ensembl chr16:77,950,008...77,987,772
G
Cask
calcium/calmodulin dependent serine protein kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CASK mRNA
CTD
PMID:12419474
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp3
caspase 3
multiple interactions increases activity increases expression increases cleavage decreases expression decreases activity
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] tert-Butylhydroperoxide results in increased expression of CASP3 protein; tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; caffeoylquinic acid analog inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; tert-Butylhydroperoxide results in increased expression of and results in increased cleavage of CASP3 protein acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] tert-butylhydroperoxide decreases activity of Casp3 protein in hepatocyte cytosol
CTD RGD
PMID:12406338 PMID:15496407 PMID:15569404 PMID:15611089 PMID:15877105 PMID:16753784 PMID:17419000 PMID:19647727 PMID:19772912 PMID:20510348 PMID:20847119 PMID:26102008 PMID:26989860 PMID:27511913 PMID:28025122 PMID:28063877 PMID:28733231 PMID:35690295 PMID:38053484 PMID:18316105 More...
RGD:2311460
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CASP6 mRNA
CTD
PMID:15003993
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
multiple interactions increases cleavage decreases activity
ISO EXP
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein] tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol
CTD RGD
PMID:27050144 PMID:18316105
RGD:2311460
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]
CTD
PMID:35690295
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage increases expression multiple interactions decreases activity
EXP ISO
tert-Butylhydroperoxide results in increased cleavage of CASP9 protein tert-Butylhydroperoxide results in increased expression of CASP9 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] Tert-butylhydroperoxide decreases activity of Casp9 protein in hepatocyte cytosol
CTD RGD
PMID:15877105 PMID:17003459 PMID:19772912 PMID:20510348 PMID:27050144 PMID:18316105 More...
RGD:2311460
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAST mRNA
CTD
PMID:15336504
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
affects response to substance decreases response to substance multiple interactions decreases activity decreases expression increases expression increases activity
ISO EXP
CAT protein affects the susceptibility to tert-Butylhydroperoxide CAT protein results in decreased susceptibility to tert-Butylhydroperoxide [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CAT mRNA; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CAT protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CAT protein] tert-Butylhydroperoxide results in decreased activity of CAT protein tert-Butylhydroperoxide results in decreased expression of CAT mRNA; tert-Butylhydroperoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of CAT protein] tert-Butylhydroperoxide results in increased expression of CAT mRNA CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol]
CTD
PMID:10754530 PMID:11178967 PMID:12423650 PMID:12628296 PMID:12646410 PMID:14729362 PMID:15003993 PMID:15105052 PMID:15207383 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16753784 PMID:16928893 PMID:17003459 PMID:20100471 PMID:34303734 PMID:35690295 More...
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAV1 mRNA
CTD
PMID:15963989
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Cav2
caveolin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA
CTD
PMID:15336504
NCBI chr 4:45,616,766...45,624,144
Ensembl chr 4:45,616,712...45,624,244
G
Cavin2
caveolae associated protein 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CAVIN2 mRNA
CTD
PMID:23410634
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Cbfb
core-binding factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CBFB mRNA
CTD
PMID:15336504
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
G
Cbr3
carbonyl reductase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CBR3 mRNA
CTD
PMID:21382384
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
G
Cbs
cystathionine beta synthase
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of CBS mRNA tert-Butylhydroperoxide results in increased methylation of CBS gene
CTD
PMID:15336504 PMID:27509014
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccdc25
coiled-coil domain containing 25
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCDC25 mRNA
CTD
PMID:15336504
NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758
G
Ccdc86
coiled-coil domain containing 86
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC86 mRNA
CTD
PMID:15336504
NCBI chr 1:207,590,167...207,596,547
Ensembl chr 1:207,590,168...207,596,544
G
Ccdc93
coiled-coil domain containing 93
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA
CTD
PMID:15336504
NCBI chr13:32,607,618...32,675,993
Ensembl chr13:32,607,587...32,676,023
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA]
CTD
PMID:20847119
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
multiple interactions decreases expression affects expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] tert-Butylhydroperoxide affects the expression of CCN2 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCN3 mRNA
CTD
PMID:15336504
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
G
Ccna2
cyclin A2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNA2 mRNA tert-Butylhydroperoxide affects the expression of CCNA2 mRNA
CTD
PMID:12414654 PMID:12419474 PMID:15336504 PMID:23410634
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb2
cyclin B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA
CTD
PMID:15003993
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
multiple interactions
ISO
ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CCNE1 protein]
CTD
PMID:15606011
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNE2 mRNA
CTD
PMID:15336504
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccnf
cyclin F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNF mRNA
CTD
PMID:15003993
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
G
Ccng2
cyclin G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:15336504
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnj
cyclin J
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNJ mRNA
CTD
PMID:15336504
NCBI chr 1:239,659,588...239,677,367
G
Ccnk
cyclin K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNK mRNA
CTD
PMID:12419474
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCS mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
G
Cd24
CD24 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD24 mRNA
CTD
PMID:15336504
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd320
CD320 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD320 mRNA
CTD
PMID:15336504
NCBI chr 7:14,626,171...14,631,976
Ensembl chr 7:14,609,146...14,631,976
G
Cd46
CD46 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD46 mRNA
CTD
PMID:15336504
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
Cd47
Cd47 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD47 mRNA
CTD
PMID:12419474
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD55 mRNA
CTD
PMID:15336504
NCBI chr13:41,857,242...41,885,966
Ensembl chr13:41,857,395...41,885,831
G
Cd68
Cd68 molecule
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of CD68 mRNA CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
G
Cd82
Cd82 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD82 mRNA
CTD
PMID:15336504
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
G
Cd9
CD9 molecule
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD9 mRNA tert-Butylhydroperoxide affects the expression of CD9 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cd99
CD99 molecule (Xg blood group)
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD99 mRNA
CTD
PMID:15336504
NCBI chr20:54,418,239...54,422,882
G
Cdc16
cell division cycle 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA
CTD
PMID:15336504
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25B mRNA
CTD
PMID:15336504
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdc25c
cell division cycle 25C
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25C mRNA tert-Butylhydroperoxide results in increased expression of CDC25C mRNA
CTD
PMID:12419474 PMID:14729362 PMID:15003993
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdc27
cell division cycle 27
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC27 mRNA
CTD
PMID:15336504
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc37l1
cell division cycle 37-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC37L1 mRNA
CTD
PMID:15963989
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
G
Cdc42
cell division cycle 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42 mRNA
CTD
PMID:15336504
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdc42ep2
CDC42 effector protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP2 mRNA
CTD
PMID:15336504
NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897
G
Cdc42ep3
CDC42 effector protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA
CTD
PMID:15336504
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
G
Cdc42ep4
CDC42 effector protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CDC42EP4 mRNA
CTD
PMID:23410634
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
G
Cdc42se1
CDC42 small effector 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42SE1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,805,691...182,813,520
Ensembl chr 2:182,804,925...182,814,028
G
Cdc5l
cell division cycle 5-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC5L mRNA
CTD
PMID:15336504
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDCA3 mRNA
CTD
PMID:15336504
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
G
Cdcp1
CUB domain containing protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA
CTD
PMID:15336504
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
G
Cdh11
cadherin 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH11 mRNA
CTD
PMID:12419474
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdh3
cadherin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH3 mRNA
CTD
PMID:12419474
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdh5
cadherin 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDH5 mRNA
CTD
PMID:22659508
NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDK1 mRNA
CTD
PMID:15003993
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA
CTD
PMID:12419474
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk2
cyclin dependent kinase 2
decreases activity multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in decreased activity of CDK2 protein ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDK2 protein] tert-Butylhydroperoxide results in decreased expression of CDK2 mRNA
CTD
PMID:12766906 PMID:15336504 PMID:15606011
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA; tert-Butylhydroperoxide results in increased expression of CDKN1A protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA; ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]
CTD
PMID:12414654 PMID:12766906 PMID:12782109 PMID:15336504 PMID:15606011 PMID:18619952 PMID:22563892 PMID:35690295 More...
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA
CTD
PMID:35690295
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA] tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:12419474 PMID:20847119
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA
CTD
PMID:12419474 PMID:14729362
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:15336504
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA
CTD
PMID:15003993 PMID:27509014
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
G
Cebpa
CCAAT/enhancer binding protein alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CEBPA mRNA
CTD
PMID:23410634
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEBPB mRNA
CTD
PMID:15336504
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
G
Celf2
CUGBP, Elav-like family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELF2 mRNA
CTD
PMID:15336504
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
G
Celsr2
cadherin, EGF LAG seven-pass G-type receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELSR2 mRNA
CTD
PMID:15336504
NCBI chr 2:196,029,206...196,053,848
Ensembl chr 2:196,029,434...196,053,845
G
Cenpa
centromere protein A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPA mRNA
CTD
PMID:12414654
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cenpm
centromere protein M
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPM mRNA
CTD
PMID:15336504
NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
G
Cep170
centrosomal protein 170
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170 mRNA
CTD
PMID:15336504
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Cep170b
centrosomal protein 170B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170B mRNA
CTD
PMID:15336504
NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658
G
Cep192
centrosomal protein 192
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP192 mRNA
CTD
PMID:15336504
NCBI chr18:61,373,937...61,458,405
Ensembl chr18:61,332,158...61,458,379
G
Cep43
centrosomal protein 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP43 mRNA
CTD
PMID:15336504
NCBI chr 1:52,533,418...52,564,025
Ensembl chr 1:52,533,428...52,563,923
G
Cep57
centrosomal protein 57
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA
CTD
PMID:15336504
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
G
Cep89
centrosomal protein 89
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP89 mRNA
CTD
PMID:15003993
NCBI chr 1:88,058,211...88,100,114
Ensembl chr 1:88,058,227...88,100,112
G
Cfb
complement factor B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFB mRNA
CTD
PMID:15336504
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfi
complement factor I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFI mRNA
CTD
PMID:15336504
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Chaf1a
chromatin assembly factor 1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHAF1A mRNA
CTD
PMID:15336504
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
G
Chdh
choline dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHDH mRNA
CTD
PMID:27509014
NCBI chr16:5,194,269...5,225,541
Ensembl chr16:5,194,269...5,225,537
G
Chek1
checkpoint kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA
CTD
PMID:12414654
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chka
choline kinase alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHKA mRNA
CTD
PMID:23410634
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
G
Chmp2a
charged multivesicular body protein 2A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA
CTD
PMID:15336504
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA
CTD
PMID:15336504
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
G
Chrdl1
chordin-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA
CTD
PMID:15336504
NCBI chr X:106,889,125...106,992,937
Ensembl chr X:106,889,125...106,992,921
G
Chst15
carbohydrate sulfotransferase 15
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHST15 mRNA
CTD
PMID:23410634
NCBI chr 1:187,028,860...187,107,908
Ensembl chr 1:187,028,970...187,107,707
G
Chst2
carbohydrate sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHST2 mRNA
CTD
PMID:15336504
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
G
Clasp1
cytoplasmic linker associated protein 1
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of CLASP1 intron tert-Butylhydroperoxide results in decreased expression of CLASP1 mRNA
CTD
PMID:29432895
NCBI chr13:29,493,554...29,715,151
Ensembl chr13:29,493,596...29,715,146
G
Clcn3
chloride voltage-gated channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLCN3 mRNA
CTD
PMID:15003993
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
G
Clic3
chloride intracellular channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLIC3 mRNA
CTD
PMID:15336504
NCBI chr 3:8,271,416...8,274,023
Ensembl chr 3:8,272,097...8,274,018
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLN3 mRNA
CTD
PMID:15336504
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
G
Cln6
CLN6, transmembrane ER protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLN6 mRNA
CTD
PMID:15003993
NCBI chr 8:63,303,356...63,318,360
Ensembl chr 8:63,303,029...63,318,360
G
Clstn1
calsyntenin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA
CTD
PMID:15336504
NCBI chr 5:160,031,235...160,094,585
Ensembl chr 5:160,031,308...160,094,583
G
Clu
clusterin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLU mRNA
CTD
PMID:15963989
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmtm1
CKLF-like MARVEL transmembrane domain containing 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of CMTM1 gene
CTD
PMID:29432895
NCBI chr19:651,641...661,184
Ensembl chr19:651,644...661,184
G
Cndp2
carnosine dipeptidase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA
CTD
PMID:15003993
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
G
Cnnm3
cyclin and CBS domain divalent metal cation transport mediator 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNNM3 mRNA
CTD
PMID:15336504
NCBI chr 9:38,755,374...38,770,740
Ensembl chr 9:38,755,390...38,770,740
G
Cnot8
CCR4-NOT transcription complex, subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA
CTD
PMID:15336504
NCBI chr10:42,281,614...42,294,740
Ensembl chr10:42,281,722...42,294,730
G
Cog5
component of oligomeric golgi complex 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COG5 mRNA
CTD
PMID:15336504
NCBI chr 6:48,242,470...48,545,185
Ensembl chr 6:48,242,482...48,529,009
G
Cog8
component of oligomeric golgi complex 8
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA]
CTD
PMID:20847119
NCBI chr19:34,951,625...34,962,377
Ensembl chr19:34,951,627...34,962,397
G
Col13a1
collagen type XIII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA
CTD
PMID:15336504
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:15336504
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:15336504
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A1 mRNA
CTD
PMID:15336504
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA
CTD
PMID:15336504
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Col5a1
collagen type V alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA
CTD
PMID:15336504
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A2 mRNA
CTD
PMID:15336504
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a1
collagen type VI alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA
CTD
PMID:15336504
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA
CTD
PMID:15336504
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Col7a1
collagen type VII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL7A1 mRNA
CTD
PMID:15336504
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Col8a2
collagen type VIII alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA
CTD
PMID:15336504
NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850
G
Comt
catechol-O-methyltransferase
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of COMT mRNA tert-Butylhydroperoxide results in decreased expression of COMT protein
CTD
PMID:12419474 PMID:24394546
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Copa
COPI coat complex subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPA mRNA
CTD
PMID:15336504
NCBI chr13:84,546,483...84,586,879
Ensembl chr13:84,545,943...84,586,874
G
Copb1
COPI coat complex subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COPB1 mRNA
CTD
PMID:15336504
NCBI chr 1:168,404,334...168,438,589
Ensembl chr 1:168,404,335...168,438,416
G
Cope
COPI coat complex subunit epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPE mRNA
CTD
PMID:15336504
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
G
Cops6
COP9 signalosome subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS6 mRNA
CTD
PMID:15336504
NCBI chr12:17,038,979...17,041,818
Ensembl chr12:17,038,979...17,046,371
G
Cops8
COP9 signalosome subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS8 mRNA
CTD
PMID:15336504
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
G
Cox7a1
cytochrome c oxidase subunit 7A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COX7A1 mRNA
CTD
PMID:15003993
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
G
Cp
ceruloplasmin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CP mRNA
CTD
PMID:14729362
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpe
carboxypeptidase E
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPE mRNA tert-Butylhydroperoxide results in increased expression of CPE mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cpm
carboxypeptidase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPM mRNA
CTD
PMID:15336504
NCBI chr 7:53,225,647...53,286,220
Ensembl chr 7:53,225,696...53,286,220
G
Cpne1
copine 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPNE1 mRNA
CTD
PMID:15336504
NCBI chr 3:144,587,531...144,629,911
Ensembl chr 3:144,588,995...144,598,636
G
Cpq
carboxypeptidase Q
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPQ mRNA
CTD
PMID:15336504
NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546
G
Crat
carnitine O-acetyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CRAT mRNA
CTD
PMID:15336504
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
G
Creb1
cAMP responsive element binding protein 1
decreases expression multiple interactions increases phosphorylation
ISO
tert-Butylhydroperoxide results in decreased expression of CREB1 mRNA U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein]
CTD
PMID:12419474 PMID:17003459
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crip1
cysteine rich protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRIP1 mRNA
CTD
PMID:15003993
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRISPLD2 mRNA
CTD
PMID:15336504
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
G
Cryab
crystallin, alpha B
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Cryz
crystallin zeta
decreases response to substance increases expression
ISO
CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CRYZ mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Csf1
colony stimulating factor 1
decreases response to substance
ISO
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16446085
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA
CTD
PMID:15336504
NCBI chr10:106,221,992...106,256,620
Ensembl chr10:106,221,992...106,256,614
G
Cspg4
chondroitin sulfate proteoglycan 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CSPG4 mRNA
CTD
PMID:15336504
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
Ctdspl
CTD small phosphatase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA
CTD
PMID:15336504
NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117
G
Cth
cystathionine gamma-lyase
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of CTH protein
CTD
PMID:18184479
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna1
catenin alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTNNA1 mRNA
CTD
PMID:12419474
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]
CTD
PMID:20847119
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSB mRNA
CTD
PMID:15336504
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsl
cathepsin L
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSL mRNA tert-Butylhydroperoxide results in decreased expression of CTSL mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cttn
cortactin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTTN mRNA
CTD
PMID:12419474
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cul3
cullin 3
multiple interactions increases expression
ISO
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 protein] tert-Butylhydroperoxide results in increased expression of CUL3 mRNA; tert-Butylhydroperoxide results in increased expression of CUL3 protein
CTD
PMID:38272317
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cul4a
cullin 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUL4A mRNA
CTD
PMID:15336504
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
G
Cux1
cut-like homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUX1 mRNA
CTD
PMID:12419474
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXADR mRNA
CTD
PMID:15336504
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA
CTD
PMID:15003993
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA
CTD
PMID:15336504
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]
CTD
PMID:20847119
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cxxc5
CXXC finger protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA
CTD
PMID:29432895
NCBI chr18:27,427,591...27,458,579
Ensembl chr18:27,427,230...27,458,673
G
Cyb561
cytochrome b-561
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYB561 mRNA
CTD
PMID:15336504
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
G
Cyb5d2
cytochrome b5 domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYB5D2 mRNA
CTD
PMID:23410634
NCBI chr10:57,394,268...57,413,336
Ensembl chr10:57,396,765...57,413,715
G
Cyb5r2
cytochrome b5 reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYB5R2 mRNA
CTD
PMID:15336504
NCBI chr 1:161,655,862...161,664,359
Ensembl chr 1:161,655,864...161,664,097
G
Cybc1
cytochrome b-245 chaperone 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYBC1 mRNA
CTD
PMID:15336504
NCBI chr10:106,498,730...106,505,549
Ensembl chr10:106,498,725...106,505,596
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
ISO
tert-Butylhydroperoxide affects the localization of CYCS protein hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein]
CTD
PMID:18552516
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cygb
cytoglobin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYGB mRNA
CTD
PMID:27509014
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA
CTD
PMID:12414654
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYP24A1 mRNA
CTD
PMID:23410634
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
G
Cyria
CYFIP related Rac1 interactor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYRIA mRNA
CTD
PMID:15336504
NCBI chr 6:35,045,208...35,150,669
Ensembl chr 6:35,045,208...35,150,668
G
Dap3
death associated protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DAP3 mRNA
CTD
PMID:14729362
NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:174,318,983...174,346,461
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dars1
aspartyl-tRNA synthetase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DARS1 mRNA
CTD
PMID:15336504
NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
G
Dazap2
DAZ associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAZAP2 mRNA
CTD
PMID:15336504
NCBI chr 7:131,714,749...131,720,266
Ensembl chr 7:131,714,745...131,720,265
G
Dbi
diazepam binding inhibitor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DBI mRNA
CTD
PMID:15336504
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA
CTD
PMID:15336504
NCBI chr10:90,974,095...90,996,275
Ensembl chr10:90,974,095...90,996,275
G
Dctn5
dynactin subunit 5
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene
CTD
PMID:29432895
NCBI chr 1:176,689,176...176,705,907
Ensembl chr 1:176,689,156...176,705,906
G
Ddb2
damage specific DNA binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA
CTD
PMID:15336504
NCBI chr 3:77,185,114...77,207,650
Ensembl chr 3:77,185,109...77,207,631
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of DDIT3 mRNA; tert-Butylhydroperoxide results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]
CTD
PMID:12414654 PMID:22659508 PMID:24394546
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DDIT4 mRNA
CTD
PMID:23410634
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddr1
discoidin domain receptor tyrosine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDR1 mRNA
CTD
PMID:15336504
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Ddx11
DEAD/H-box helicase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX11 mRNA
CTD
PMID:15336504
NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550
G
Ddx21
DExD-box helicase 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX21 mRNA
CTD
PMID:15336504
NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
G
Ddx42
DEAD-box helicase 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX42 mRNA
CTD
PMID:12414654
NCBI chr10:91,148,926...91,180,940
Ensembl chr10:91,148,254...91,180,939
G
Ddx43
DEAD-box helicase 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX43 mRNA
CTD
PMID:15336504
NCBI chr 8:79,255,001...79,284,468
Ensembl chr 8:79,255,655...79,284,453
G
Ddx50
DExD-box helicase 50
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX50 mRNA
CTD
PMID:15003993
NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152
G
Ddx52
DExD-box helicase 52
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX52 mRNA
CTD
PMID:15336504
NCBI chr10:68,824,594...68,847,400
Ensembl chr10:68,824,645...68,848,266
G
Ddx56
DEAD-box helicase 56
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX56 mRNA
CTD
PMID:15336504
NCBI chr14:81,112,008...81,122,331
Ensembl chr14:81,112,012...81,122,333
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX6 mRNA
CTD
PMID:15003993
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dennd3
DENN domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DENND3 mRNA
CTD
PMID:15336504
NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592
G
Depp1
DEPP autophagy regulator 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]
CTD
PMID:20847119
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Derl1
derlin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DERL1 mRNA
CTD
PMID:15003993
NCBI chr 7:89,404,413...89,427,095
Ensembl chr 7:89,404,417...89,427,145
G
Dffb
DNA fragmentation factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DFFB mRNA
CTD
PMID:12419474
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dgat2
diacylglycerol O-acyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DGAT2 mRNA
CTD
PMID:23410634
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dhps
deoxyhypusine synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHPS mRNA
CTD
PMID:15336504
NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA
CTD
PMID:15336504
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
G
Dimt1
DIM1 rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIMT1 mRNA
CTD
PMID:15336504
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
G
Dip2c
disco-interacting protein 2 homolog C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIP2C mRNA
CTD
PMID:15336504
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DKK1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202
G
Dlg1
discs large MAGUK scaffold protein 1
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DLG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
G
Dlg3
discs large MAGUK scaffold protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DLG3 mRNA
CTD
PMID:15336504
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
G
Dlgap4
DLG associated protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA
CTD
PMID:15336504
NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
G
Dlgap5
DLG associated protein 5
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dlx2
distal-less homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA
CTD
PMID:14729362 PMID:29432895
NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597
G
Dmpk
DM1 protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DMPK mRNA
CTD
PMID:15003993
NCBI chr 1:78,730,255...78,740,585
Ensembl chr 1:78,730,275...78,740,593
G
Dnaaf2
dynein, axonemal, assembly factor 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr 6:87,661,101...87,670,267
Ensembl chr 6:87,660,821...87,670,199
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA
CTD
PMID:15336504
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB11 mRNA
CTD
PMID:15003993
NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA
CTD
PMID:15336504
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DNAJB7 intron
CTD
PMID:29432895
NCBI chr 7:112,932,736...112,934,050
Ensembl chr 7:112,932,616...112,945,537
G
Dnase2
deoxyribonuclease 2, lysosomal
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNASE2 mRNA
CTD
PMID:15336504
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnm2
dynamin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNM2 mRNA
CTD
PMID:15336504
NCBI chr 8:19,978,313...20,060,162
Ensembl chr 8:19,978,400...20,060,157
G
Dnmbp
dynamin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DNMBP mRNA
CTD
PMID:15336504
NCBI chr 1:242,736,189...242,829,431
Ensembl chr 1:242,736,189...242,802,604
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNPH1 mRNA
CTD
PMID:12419474
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dock2
dedicator of cytokinesis 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DOCK2 mRNA
CTD
PMID:15336504
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA
CTD
PMID:15336504
NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
G
Dpp4
dipeptidylpeptidase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPP4 mRNA
CTD
PMID:15336504
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpy19l1
dpy-19 like C-mannosyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA
CTD
PMID:15336504
NCBI chr 8:22,933,163...23,021,461
Ensembl chr 8:22,933,163...23,021,751
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPYSL3 mRNA
CTD
PMID:15336504
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Drap1
Dr1 associated protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DRAP1 mRNA
CTD
PMID:15003993
NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425
G
Dsc3
desmocollin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DSC3 mRNA
CTD
PMID:15336504
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dst
dystonin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DST mRNA
CTD
PMID:12419474
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Dusp1
dual specificity phosphatase 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP1 mRNA
CTD
PMID:23410634
NCBI chr10:16,680,478...16,683,275
G
Dusp10
dual specificity phosphatase 10
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]
CTD
PMID:15336504 PMID:20847119
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA
CTD
PMID:15336504
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp6
dual specificity phosphatase 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUSP6 mRNA tert-Butylhydroperoxide results in increased expression of DUSP6 mRNA
CTD
PMID:15336504 PMID:17003459
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Dusp9
dual specificity phosphatase 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP9 mRNA
CTD
PMID:23410634
NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821
G
Dut
deoxyuridine triphosphatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUT mRNA
CTD
PMID:15336504
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
G
Dvl3
dishevelled segment polarity protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DVL3 mRNA
CTD
PMID:29432895
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA
CTD
PMID:12419474
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Dynlrb1
dynein light chain roadblock-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLRB1 mRNA
CTD
PMID:15336504
NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
G
E2f1
E2F transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of E2F1 mRNA
CTD
PMID:12419474
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Ech1
enoyl-CoA hydratase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ECH1 mRNA
CTD
PMID:15003993
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECHDC2 mRNA
CTD
PMID:15336504
NCBI chr 5:122,915,874...122,934,860
Ensembl chr 5:122,916,134...122,934,859
G
Echs1
enoyl-CoA hydratase, short chain 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECHS1 protein
CTD
PMID:24394546
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECI1 mRNA
CTD
PMID:15336504
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
G
Ecsit
ECSIT signaling integrator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECSIT mRNA
CTD
PMID:15336504
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
G
Edil3
EGF like repeats and discoidin domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EDIL3 mRNA
CTD
PMID:15336504
NCBI chr 2:19,890,396...20,405,028
Ensembl chr 2:19,890,373...20,405,008
G
Edn1
endothelin 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EDN1 mRNA tert-Butylhydroperoxide affects the expression of EDN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EEF2 protein
CTD
PMID:16469450
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFEMP1 mRNA
CTD
PMID:15336504
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Efhd1
EF-hand domain family, member D1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFHD1 mRNA
CTD
PMID:15336504
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
G
Efna4
ephrin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFNA4 mRNA
CTD
PMID:12419474
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
G
Efs
embryonal Fyn-associated substrate
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EFS mRNA
CTD
PMID:15336504
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]
CTD
PMID:35690295
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EGR1 mRNA tert-Butylhydroperoxide affects the expression of EGR1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2AK2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b4
eukaryotic translation initiation factor 2B subunit delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA
CTD
PMID:15336504
NCBI chr 6:25,183,177...25,188,832
Ensembl chr 6:25,183,186...25,188,829
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF3M mRNA
CTD
PMID:15336504
NCBI chr 3:91,424,754...91,442,358
Ensembl chr 3:91,416,325...91,442,392
G
Eif5
eukaryotic translation initiation factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5 mRNA
CTD
PMID:15336504
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
G
Eif5b
eukaryotic translation initiation factor 5B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5B mRNA
CTD
PMID:15336504
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
G
Elavl1
ELAV like RNA binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELAVL1 mRNA
CTD
PMID:15336504
NCBI chr12:2,640,936...2,684,787
Ensembl chr12:2,645,061...2,684,784
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELF1 mRNA
CTD
PMID:15336504
NCBI chr15:54,890,644...54,986,721
Ensembl chr15:54,865,616...54,986,699
G
Elf5
E74 like ETS transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ELF5 mRNA
CTD
PMID:15003993
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
G
Elob
elongin B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELOB mRNA
CTD
PMID:15336504
NCBI chr10:12,848,830...12,853,897
Ensembl chr10:12,848,827...12,853,635
G
Eme1
essential meiotic structure-specific endonuclease 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EME1 mRNA
CTD
PMID:27509014
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Emilin1
elastin microfibril interfacer 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of EMILIN1 mRNA
CTD
PMID:23410634
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
G
Eml1
EMAP like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EML1 mRNA
CTD
PMID:15336504
NCBI chr 6:127,283,968...127,457,246
Ensembl chr 6:127,284,029...127,457,246
G
Eml4
EMAP like 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EML4 mRNA
CTD
PMID:15336504
NCBI chr 6:11,219,545...11,334,824
Ensembl chr 6:11,219,566...11,334,879
G
Emp3
epithelial membrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EMP3 mRNA
CTD
PMID:15003993
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Eng
endoglin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ENG mRNA
CTD
PMID:15336504
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPB41L2 mRNA
CTD
PMID:15336504
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
G
Epb42
erythrocyte membrane protein band 4.2
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of EPB42 protein
CTD
PMID:15040847
NCBI chr 3:107,979,709...107,997,932
Ensembl chr 3:107,979,713...107,997,932
G
Ephb2
Eph receptor B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA
CTD
PMID:15336504
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
G
Ephb4
EPH receptor B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPHB4 mRNA
CTD
PMID:15336504
NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA
CTD
PMID:14729362
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB2 mRNA
CTD
PMID:15336504
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB4 mRNA
CTD
PMID:12419474
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Erbin
erbb2 interacting protein
multiple interactions increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
G
Ercc5
ERCC excision repair 5, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA
CTD
PMID:12419474
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Erp29
endoplasmic reticulum protein 29
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERP29 mRNA
CTD
PMID:15336504
NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
G
Esm1
endothelial cell-specific molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESM1 mRNA
CTD
PMID:15336504
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Ess2
ess-2 splicing factor homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESS2 mRNA
CTD
PMID:15336504
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
G
Etf1
eukaryotic translation termination factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETF1 mRNA
CTD
PMID:15336504
NCBI chr18:26,502,413...26,530,753
Ensembl chr18:26,504,080...26,530,810
G
Etfa
electron transfer flavoprotein subunit alpha
multiple interactions increases expression decreases expression
ISO EXP
ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; pyrazolanthrone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ETFA protein] tert-Butylhydroperoxide results in decreased expression of ETFA protein
CTD
PMID:24394546
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Etfb
electron transfer flavoprotein subunit beta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of ETFB mRNA tert-Butylhydroperoxide results in increased methylation of ETFB gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:93,851,908...93,866,072
Ensembl chr 1:93,851,858...93,866,068
G
Ets1
ETS proto-oncogene 1, transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS1 mRNA
CTD
PMID:12419474
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA tert-Butylhydroperoxide results in increased expression of ETS2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETV3 mRNA
CTD
PMID:12419474
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
G
Etv4
ETS variant transcription factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV4 mRNA
CTD
PMID:15003993
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Etv5
ETS variant transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV5 mRNA
CTD
PMID:15336504
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
G
Exo1
exonuclease 1
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]
CTD
PMID:35690295
NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
G
Exoc7
exocyst complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EXOC7 mRNA
CTD
PMID:15336504
NCBI chr10:101,521,630...101,540,425
Ensembl chr10:101,520,927...101,540,561
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA
CTD
PMID:15336504
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
G
Ezr
ezrin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZR mRNA
CTD
PMID:12419474
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F2rl1
F2R like trypsin receptor 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of F2RL1 mRNA
CTD
PMID:23410634
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Fah
fumarylacetoacetate hydrolase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FAH protein
CTD
PMID:24394546
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fam110b
family with sequence similarity 110, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAM110B mRNA
CTD
PMID:29432895
NCBI chr 5:18,789,362...18,929,647
Ensembl chr 5:18,789,389...18,929,828
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM111A mRNA
CTD
PMID:15336504
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
G
Fam13b
family with sequence similarity 13, member B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM13B mRNA
CTD
PMID:15003993
NCBI chr18:26,040,285...26,107,112
Ensembl chr18:26,040,285...26,106,587
G
Fam171a1
family with sequence similarity 171, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA
CTD
PMID:29432895
NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255
G
Fam210a
family with sequence similarity 210, member A
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]
CTD
PMID:20847119
NCBI chr18:61,846,447...61,886,123
Ensembl chr18:61,852,907...61,886,171
G
Fanci
FA complementation group I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FANCI mRNA
CTD
PMID:15336504
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
G
Farp1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA
CTD
PMID:15336504
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
G
Fas
Fas cell surface death receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAS mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fastk
Fas-activated serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
G
Fbln1
fibulin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA
CTD
PMID:15336504
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo30
F-box protein 30
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA
CTD
PMID:23410634
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FDPS mRNA
CTD
PMID:15336504
NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
G
Fdx1
ferredoxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDX1 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 8:52,268,536...52,287,344
Ensembl chr 8:52,268,536...52,287,414
G
Fdxr
ferredoxin reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDXR mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FEN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fermt2
FERM domain containing kindlin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FERMT2 mRNA
CTD
PMID:15336504
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
G
Fgg
fibrinogen gamma chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FGG mRNA
CTD
PMID:12414654
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
G
Fh
fumarate hydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FH mRNA
CTD
PMID:15336504
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
G
Fhl1
four and a half LIM domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FHL1 mRNA
CTD
PMID:15336504
NCBI chr X:134,555,399...134,614,930
Ensembl chr X:134,555,479...134,614,928
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHL2 mRNA
CTD
PMID:15336504
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
G
Fhod3
formin homology 2 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA
CTD
PMID:15336504
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
G
Fibp
FGF1 intracellular binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIBP mRNA
CTD
PMID:15336504
NCBI chr 1:202,768,065...202,772,405
Ensembl chr 1:202,768,078...202,772,399
G
Fis1
fission, mitochondrial 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIS1 mRNA
CTD
PMID:15336504
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
G
Fjx1
four-jointed box kinase 1
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]
CTD
PMID:20847119
NCBI chr 3:88,774,220...88,776,321
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp1a
FKBP prolyl isomerase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FKBP1A mRNA
CTD
PMID:15336504
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA
CTD
PMID:15336504
NCBI chr16:18,895,608...18,902,648
Ensembl chr16:18,893,576...18,902,612
G
Flnb
filamin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FLNB mRNA
CTD
PMID:15336504
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA
CTD
PMID:12419474
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fn1
fibronectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FN1 mRNA
CTD
PMID:15963989
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Folr1
folate receptor alpha
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOLR1 mRNA tert-Butylhydroperoxide results in decreased expression of FOLR1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:22956110
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions increases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of FOS mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA] tert-Butylhydroperoxide results in increased methylation of FOS gene
CTD
PMID:12419474 PMID:15105052 PMID:27509014
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOSL1 mRNA
CTD
PMID:15336504
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxd1
forkhead box D1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
G
Foxm1
forkhead box M1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Ftl1
ferritin light chain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FTL mRNA
CTD
PMID:12414654 PMID:15963989
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA
CTD
PMID:15336504
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fxyd5
FXYD domain-containing ion transport regulator 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FYCO1 mRNA
CTD
PMID:15336504
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
Fzd1
frizzled class receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA
CTD
PMID:29432895
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzr1
fizzy and cell division cycle 20 related 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZR1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952
G
G0s2
G0/G1switch 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of G0S2 mRNA
CTD
PMID:15336504
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
G6pd
glucose-6-phosphate dehydrogenase
decreases activity increases activity
ISO EXP
tert-Butylhydroperoxide results in decreased activity of G6PD protein tert-Butylhydroperoxide results in increased activity of G6PD protein
CTD
PMID:12628296 PMID:15336504 PMID:16928893
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of GADD45B mRNA tert-Butylhydroperoxide affects the expression of GADD45B mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gak
cyclin G associated kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAK mRNA
CTD
PMID:12419474
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
G
Galm
galactose mutarotase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALM mRNA
CTD
PMID:15003993
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Galns
galactosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GALNS mRNA
CTD
PMID:15336504
NCBI chr19:50,628,639...50,662,477
Ensembl chr19:50,628,552...50,662,246
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT1 mRNA
CTD
PMID:15336504
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
increases methylation decreases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of GALNT3 intron tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron
CTD
PMID:29432895
NCBI chr 3:50,742,500...50,779,266
Ensembl chr 3:50,742,512...50,766,268
G
Galnt6
polypeptide N-acetylgalactosaminyltransferase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT6 mRNA
CTD
PMID:15336504
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
G
Ganab
glucosidase II alpha subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GANAB mRNA
CTD
PMID:15336504
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAPDH protein
CTD
PMID:11295360
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GARS1 mRNA
CTD
PMID:15003993
NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA
CTD
PMID:14729362
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas2l1
growth arrest-specific 2 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAS2L1 mRNA
CTD
PMID:29432895
NCBI chr14:79,955,350...79,961,830
Ensembl chr14:79,950,555...79,961,438
G
Gata6
GATA binding protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GATA6 mRNA
CTD
PMID:15336504
NCBI chr18:2,188,121...2,219,532
Ensembl chr18:2,188,121...2,219,532
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA
CTD
PMID:15336504
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gbp2
guanylate binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp4
guanylate binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gbp6
guanylate binding protein family member 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP6 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gchfr
GTP cyclohydrolase I feedback regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GCHFR mRNA
CTD
PMID:15336504
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions decreases response to substance increases expression decreases expression
ISO EXP
[Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLC mRNA tert-Butylhydroperoxide results in decreased expression of GCLC mRNA
CTD
PMID:12425961 PMID:17092368 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 More...
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions increases expression
EXP ISO
[Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLM mRNA
CTD
PMID:12414654 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:214,718,344...214,755,735
Ensembl chr 1:214,718,293...214,758,776
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA
CTD
PMID:23410634
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GDF15 mRNA
CTD
PMID:12414654
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdpd5
glycerophosphodiester phosphodiesterase domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GDPD5 mRNA
CTD
PMID:23410634
NCBI chr 1:153,679,718...153,761,452
Ensembl chr 1:153,679,718...153,761,446
G
Gem
GTP binding protein overexpressed in skeletal muscle
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA]
CTD
PMID:20847119
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
G
Gemin4
gem (nuclear organelle) associated protein 4
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA]
CTD
PMID:20847119
NCBI chr10:61,062,420...61,073,529
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
G
Gfap
glial fibrillary acidic protein
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GFAP protein tert-Butylhydroperoxide results in increased expression of GFAP protein
CTD
PMID:24394546
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gfer
growth factor, augmenter of liver regeneration
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFER mRNA
CTD
PMID:15336504
NCBI chr10:13,718,489...13,721,782
Ensembl chr10:13,718,489...13,720,869
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA
CTD
PMID:15336504
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gfra1
GDNF family receptor alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
G
Gins2
GINS complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GINS2 mRNA
CTD
PMID:15336504
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
G
Gja1
gap junction protein, alpha 1
decreases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in decreased expression of GJA1 mRNA; tert-Butylhydroperoxide results in decreased expression of GJA1 protein GJA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15336504 PMID:18235030
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
decreases response to substance
ISO
GJB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18235030
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gla
galactosidase, alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLA mRNA
CTD
PMID:14729362
NCBI chr X:97,769,227...97,780,646
Ensembl chr X:97,768,996...97,780,664
G
Glg1
golgi glycoprotein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLG1 mRNA
CTD
PMID:15336504
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA
CTD
PMID:15336504
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
G
Glod4
glyoxalase domain containing 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLOD4 mRNA
CTD
PMID:15003993
NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898
G
Glrx
glutaredoxin
multiple interactions increases expression
EXP ISO
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] tert-Butylhydroperoxide results in increased expression of GLRX mRNA
CTD
PMID:12414654 PMID:12680778
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
G
Glrx3
glutaredoxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA
CTD
PMID:15336504
NCBI chr 1:192,241,707...192,272,012
Ensembl chr 1:192,241,701...192,272,010
G
Glyr1
glyoxylate reductase 1 homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLYR1 mRNA
CTD
PMID:15336504
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
G
Gmpr2
guanosine monophosphate reductase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GMPR2 mRNA
CTD
PMID:15336504
NCBI chr15:29,165,421...29,175,933
Ensembl chr15:29,165,783...29,174,935
G
Gna11
G protein subunit alpha 11
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of GNA11 mRNA tert-Butylhydroperoxide results in decreased expression of GNA11 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,163,520...8,177,863
Ensembl chr 7:8,162,750...8,179,812
G
Gnai1
G protein subunit alpha i1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GNAI1 mRNA
CTD
PMID:23410634
NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417
G
Gnas
GNAS complex locus
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNAS mRNA
CTD
PMID:12419474
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb5
G protein subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNB5 mRNA
CTD
PMID:15336504
NCBI chr 8:76,076,120...76,105,069
Ensembl chr 8:76,073,306...76,105,069
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNPNAT1 mRNA
CTD
PMID:15003993
NCBI chr15:18,596,180...18,608,854
Ensembl chr15:18,596,442...18,608,739
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNS mRNA
CTD
PMID:15336504
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
G
Gosr2
golgi SNAP receptor complex member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GOSR2 mRNA
CTD
PMID:15003993
NCBI chr10:88,585,291...88,605,642
Ensembl chr10:88,586,299...88,605,625
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions increases activity increases expression
EXP
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GOT1 protein]
CTD
PMID:15095147 PMID:15212457 PMID:15645217
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPAT3 mRNA
CTD
PMID:23410634
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
G
Gpc1
glypican 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPC1 mRNA
CTD
PMID:15003993
NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
G
Gper1
G protein-coupled estrogen receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPER1 mRNA
CTD
PMID:15336504
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPI1 mRNA
CTD
PMID:15003993
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
G
Gpnmb
glycoprotein nmb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA
CTD
PMID:15336504
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr107
G protein-coupled receptor 107
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA
CTD
PMID:15336504
NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
G
Gpr161
G protein-coupled receptor 161
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA
CTD
PMID:15336504
NCBI chr13:77,578,257...77,623,661
Ensembl chr13:77,577,739...77,619,613
G
Gpr4
G protein-coupled receptor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPR4 mRNA
CTD
PMID:15336504
NCBI chr 1:78,865,376...78,877,126
Ensembl chr 1:78,865,409...78,876,599
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPRC5B mRNA
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:173,316,904...173,340,933
Ensembl chr 1:173,316,907...173,340,932
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPSM2 mRNA
CTD
PMID:15336504
NCBI chr 2:196,327,149...196,375,322
Ensembl chr 2:196,327,149...196,375,154
G
Gpsm3
G-protein signaling modulator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA
CTD
PMID:15336504
NCBI chr20:4,157,123...4,158,984
Ensembl chr20:4,157,123...4,159,035
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity increases expression
EXP ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GPT protein] rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
CTD
PMID:15015760 PMID:15095147 PMID:15212457 PMID:15645217 PMID:28025122
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
increases reduction decreases response to substance increases response to substance increases expression
ISO EXP
GPX1 protein results in increased reduction of tert-Butylhydroperoxide GPX1 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX1 mRNA
CTD
PMID:8428933 PMID:9741587 PMID:15182862 PMID:19720132
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction decreases expression increases expression
ISO
GPX2 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA tert-Butylhydroperoxide results in increased expression of GPX2 mRNA
CTD
PMID:8428933 PMID:10806356 PMID:12414654 PMID:12419474
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gpx4
glutathione peroxidase 4
multiple interactions decreases response to substance increases response to substance
ISO
GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] GPX4 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX4 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12566075 PMID:15496407
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Grb2
growth factor receptor bound protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRB2 mRNA
CTD
PMID:15336504
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
G
Grem1
gremlin 1, DAN family BMP antagonist
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GREM1 mRNA
CTD
PMID:15336504
NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082
G
Grhpr
glyoxylate and hydroxypyruvate reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRHPR mRNA
CTD
PMID:15003993
NCBI chr 5:59,234,179...59,243,614
Ensembl chr 5:59,234,192...59,243,603
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRIN2C mRNA
CTD
PMID:12414654
NCBI chr10:100,488,430...100,507,083
Ensembl chr10:100,488,431...100,506,427
G
Grpel1
GrpE-like 1, mitochondrial
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRPEL1 mRNA
CTD
PMID:15336504
NCBI chr14:74,292,023...74,298,243
Ensembl chr14:74,292,023...74,298,200
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression multiple interactions decreases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of GSK3B mRNA 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]
CTD
PMID:15336504 PMID:29128606
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSN mRNA
CTD
PMID:15003993
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT1 mRNA
CTD
PMID:15336504
NCBI chr10:4,362,528...4,397,215
Ensembl chr10:4,362,510...4,397,198
G
Gspt2
G1 to S phase transition 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162
G
Gsr
glutathione-disulfide reductase
multiple interactions decreases expression increases activity decreases activity decreases methylation increases expression
ISO EXP
Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GSR protein] tert-Butylhydroperoxide results in decreased expression of GSR mRNA Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of GSR protein] tert-Butylhydroperoxide results in decreased methylation of GSR gene tert-Butylhydroperoxide results in increased expression of GSR mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15212457 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16928893 PMID:17427263 PMID:23410634 PMID:27509014 More...
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases metabolic processing decreases metabolic processing increases expression decreases response to substance
ISO
GSTA2 protein results in increased metabolism of tert-Butylhydroperoxide GSTA2 protein polymorphism results in decreased metabolism of tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTA2 mRNA GSTA2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:3138230 PMID:14729362 PMID:15003993 PMID:15128049
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTA4 mRNA
CTD
PMID:15336504 PMID:31627909
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTK1 mRNA
CTD
PMID:15336504
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Gstm2
glutathione S-transferase mu 2
decreases expression increases expression decreases response to substance
ISO EXP
tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in decreased expression of GSTM2 protein tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:24394546
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTM4 mRNA
CTD
PMID:15336504
NCBI chr 2:195,667,940...195,685,315
Ensembl chr 2:195,680,004...195,685,323
G
Gstp1
glutathione S-transferase pi 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA
CTD
PMID:15336504
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
affects metabolic processing
ISO
GSTT1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9854036
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Gstz1
glutathione S-transferase zeta 1
affects metabolic processing
ISO
GSTZ1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9396740
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Gtf2f1
general transcription factor IIF subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA
CTD
PMID:15336504
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
G
Gtf2i
general transcription factor II I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2I mRNA
CTD
PMID:15336504
NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243
G
Gtf2ird1
GTF2I repeat domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:15336504
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
G
Gtf3a
general transcription factor III A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF3A mRNA
CTD
PMID:15336504
NCBI chr12:8,136,746...8,144,690
Ensembl chr12:8,136,747...8,144,690
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA
CTD
PMID:15336504
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
G
Gusb
glucuronidase, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GUSB mRNA
CTD
PMID:15336504
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Gys1
glycogen synthase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GYS1 mRNA
CTD
PMID:15003993
NCBI chr 1:95,915,443...95,935,292
Ensembl chr 1:95,915,443...95,935,292
G
H1f10
H1.10 linker histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H1-10 mRNA
CTD
PMID:15336504
NCBI chr 4:120,440,515...120,441,578
Ensembl chr 4:120,440,870...120,441,448
G
H2ax
H2A.X variant histone
decreases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in decreased expression of H2AX mRNA tert-Butylhydroperoxide results in increased phosphorylation of H2AX protein
CTD
PMID:15336504 PMID:33207735
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2az2
H2A.Z variant histone 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H2AZ2 mRNA
CTD
PMID:15336504
NCBI chr14:81,293,304...81,312,209
Ensembl chr14:81,293,299...81,312,144
G
H2bc12
H2B clustered histone 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA
CTD
PMID:15336504
NCBI chr17:42,485,699...42,486,162
G
H3f4
H3.4 histone, cluster member
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of H3-4 mRNA tert-Butylhydroperoxide results in increased methylation of H3-4 gene
CTD
PMID:27509014
NCBI chr10:43,740,702...43,741,262
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
increases activity increases expression
ISO
tert-Butylhydroperoxide results in increased activity of H6PD protein tert-Butylhydroperoxide results in increased expression of H6PD mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HADH mRNA
CTD
PMID:15336504
NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353
G
Hamp
hepcidin antimicrobial peptide
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HAMP mRNA
CTD
PMID:23410634
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Has2
hyaluronan synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA
CTD
PMID:15336504
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
G
Haus7
HAUS augmin-like complex, subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HAUS7 mRNA
CTD
PMID:15336504
NCBI chr X:151,154,979...151,174,441
Ensembl chr X:151,154,979...151,180,577
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBEGF mRNA
CTD
PMID:12419474
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hbp1
HMG-box transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBP1 mRNA
CTD
PMID:15336504
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hdac1
histone deacetylase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HDAC1 mRNA
CTD
PMID:12419474
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
Hdac11
histone deacetylase 11
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HDAC11 mRNA
CTD
PMID:23410634
NCBI chr 4:123,645,873...123,667,407
Ensembl chr 4:123,650,157...123,667,405
G
Hdac7
histone deacetylase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HDAC7 mRNA
CTD
PMID:15003993
NCBI chr 7:128,923,918...128,961,926
Ensembl chr 7:128,923,920...128,962,072
G
Heatr1
HEAT repeat containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HEATR1 mRNA
CTD
PMID:15336504
NCBI chr17:58,053,288...58,093,895
Ensembl chr17:58,051,700...58,093,948
G
Heg1
heart development protein with EGF-like domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HEG1 mRNA
CTD
PMID:15336504
NCBI chr11:67,006,954...67,095,020
Ensembl chr11:66,957,190...67,095,051
G
Heph
hephaestin
decreases response to substance decreases expression increases expression
ISO
HEPH protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HEPH mRNA tert-Butylhydroperoxide results in increased expression of HEPH mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HES1 mRNA
CTD
PMID:15336504
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hes6
hes family bHLH transcription factor 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HES6 mRNA
CTD
PMID:23410634
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hgfac
HGF activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HGFAC mRNA
CTD
PMID:12419474
NCBI chr14:75,707,588...75,714,182
Ensembl chr14:75,707,591...75,714,278
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA; [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]
CTD
PMID:15611089 PMID:35690295
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hikeshi
heat shock protein nuclear import factor hikeshi
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HIKESHI mRNA
CTD
PMID:15003993
NCBI chr 1:143,825,399...143,849,361
Ensembl chr 1:143,825,923...143,849,363
G
Hilpda
hypoxia inducible lipid droplet-associated
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC5 mRNA
CTD
PMID:15336504
NCBI chr17:42,792,887...42,793,268
G
Hivep1
HIVEP zinc finger 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA
CTD
PMID:15003993
NCBI chr17:22,585,016...22,714,517
Ensembl chr17:22,585,016...22,711,956
G
Hk1
hexokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HK1 mRNA
CTD
PMID:15336504
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Hmga1
high mobility group AT-hook 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HMGA1 mRNA tert-Butylhydroperoxide results in increased expression of HMGA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA
CTD
PMID:14729362
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HMGB1 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGCR mRNA
CTD
PMID:12414654
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmgn5
high mobility group nucleosome binding domain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGN5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
decreases response to substance multiple interactions increases expression affects expression decreases expression
ISO EXP
HMOX1 protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA] tert-Butylhydroperoxide affects the expression of HMOX1 mRNA [Biological Products results in increased expression of HMOX1 protein] inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; [Biological Products results in increased expression of HMOX1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA] tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in decreased expression of HMOX1 protein tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in increased expression of HMOX1 protein 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]
CTD
PMID:12414654 PMID:15336504 PMID:15589375 PMID:16636651 PMID:17295091 PMID:18812229 PMID:22864849 PMID:22954530 PMID:23266269 PMID:27050144 PMID:27509014 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 PMID:38053484 PMID:38272317 More...
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hmox2
heme oxygenase 2
decreases response to substance decreases expression increases methylation
ISO
HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA tert-Butylhydroperoxide results in increased methylation of HMOX2 gene
CTD
PMID:15589375 PMID:27509014
NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HNRNPA3 mRNA
CTD
PMID:15336504
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] tert-Butylhydroperoxide results in decreased expression of HNRNPDL mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr14:9,557,430...9,563,659
Ensembl chr14:9,557,425...9,562,506
G
Hook2
hook microtubule-tethering protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HOOK2 mRNA
CTD
PMID:15336504
NCBI chr19:23,151,869...23,170,139
Ensembl chr19:23,151,870...23,164,181
G
Hoxd1
homeo box D1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HOXD1 mRNA
CTD
PMID:23410634
NCBI chr 3:59,665,629...59,667,769
Ensembl chr 3:59,665,629...59,667,769
G
Hp1bp3
heterochromatin protein 1, binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HP1BP3 mRNA
CTD
PMID:15336504
NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000
G
Hps1
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HPS1 mRNA
CTD
PMID:15336504
NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268
G
Hs3st3a1
heparan sulfate-glucosamine 3-sulfotransferase 3A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HS3ST3A1 mRNA
CTD
PMID:15336504
NCBI chr10:49,092,850...49,180,676
Ensembl chr10:49,094,026...49,180,676
G
Hsbp1
heat shock factor binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSBP1 mRNA
CTD
PMID:15336504
NCBI chr19:47,401,039...47,405,373
Ensembl chr19:47,400,966...47,435,821
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions decreases expression
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]
CTD
PMID:29935159
NCBI chr13:104,728,539...104,798,884
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HSD11B2 mRNA
CTD
PMID:23410634
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B10 mRNA
CTD
PMID:15003993
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA
CTD
PMID:15336504
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA
CTD
PMID:15003993
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD3B7 mRNA
CTD
PMID:15003993
NCBI chr 1:182,412,216...182,415,447
Ensembl chr 1:182,412,151...182,415,442
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSP90AA1 mRNA
CTD
PMID:15336504
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hspa13
heat shock protein family A (Hsp70) member 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA13 mRNA
CTD
PMID:12419474
NCBI chr11:14,375,669...14,389,853
Ensembl chr11:14,373,275...14,389,895
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1A mRNA
CTD
PMID:12414654
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA
CTD
PMID:12414654
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]
CTD
PMID:20847119
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA4 mRNA
CTD
PMID:15336504
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA
CTD
PMID:12766906
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPA6 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]
CTD
PMID:12414654 PMID:35690295
NCBI chr13:83,273,176...83,274,317
G
Hspb1
heat shock protein family B (small) member 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB1 protein tert-Butylhydroperoxide results in decreased expression of HSPB1 mRNA
CTD
PMID:11295360 PMID:15336504
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Hspb2
heat shock protein family B (small) member 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPB2 mRNA tert-Butylhydroperoxide results in increased expression of HSPB2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA
CTD
PMID:14729362
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPH1 mRNA
CTD
PMID:15336504
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HTATIP2 mRNA
CTD
PMID:15336504
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HTRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]
CTD
PMID:15336504 PMID:28063877
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Icmt
isoprenylcysteine carboxyl methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ICMT mRNA
CTD
PMID:15336504
NCBI chr 5:162,804,368...162,811,129
Ensembl chr 5:162,804,368...162,811,128
G
Id1
inhibitor of DNA binding 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ID1 mRNA tert-Butylhydroperoxide results in increased expression of ID1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:20847119
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ID3 mRNA
CTD
PMID:15003993
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of IDH1 protein
CTD
PMID:16928893
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases activity multiple interactions
ISO
tert-Butylhydroperoxide results in decreased activity of IDH2 protein Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Ier2
immediate early response 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER2 mRNA
CTD
PMID:15336504
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
G
Ier3
immediate early response 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER3 mRNA tert-Butylhydroperoxide results in increased expression of IER3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi27
interferon, alpha-inducible protein 27
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFI27 mRNA tert-Butylhydroperoxide results in decreased expression of IFI27 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA
CTD
PMID:15336504
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifih1
interferon induced with helicase C domain 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFIH1 mRNA tert-Butylhydroperoxide results in increased expression of IFIH1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFIT3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM1 mRNA
CTD
PMID:15336504
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm2
interferon induced transmembrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM2 mRNA
CTD
PMID:15336504
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFITM3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ift122
intraflagellar transport 122
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFT122 mRNA
CTD
PMID:15336504
NCBI chr 4:148,905,031...148,975,458
Ensembl chr 4:148,905,046...148,975,458
G
Igf1
insulin-like growth factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGF1 mRNA
CTD
PMID:22659508
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGF1R mRNA
CTD
PMID:12419474
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGF2BP1 mRNA
CTD
PMID:14729362
NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA
CTD
PMID:15336504
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP3 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP3 mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP4 mRNA
CTD
PMID:15336504
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA
CTD
PMID:12414654
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igfbp6
insulin-like growth factor binding protein 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP6 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP6 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
G
Igsf8
immunoglobulin superfamily, member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGSF8 mRNA
CTD
PMID:14729362
NCBI chr13:84,770,348...84,781,534
Ensembl chr13:84,770,279...84,778,576
G
Il11
interleukin 11
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of IL11 mRNA; tert-Butylhydroperoxide results in increased expression of IL11 protein tert-Butylhydroperoxide affects the expression of IL11 mRNA
CTD
PMID:15336504 PMID:17295091 PMID:23410634
NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129
G
Il15
interleukin 15
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL15 mRNA
CTD
PMID:15336504
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
multiple interactions increases expression increases secretion
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased expression of IL1B mRNA; tert-Butylhydroperoxide results in increased expression of IL1B protein
CTD
PMID:15336504 PMID:15705740 PMID:28063877 PMID:29111459
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il3
interleukin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL3 mRNA
CTD
PMID:12419474
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il4r
interleukin 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IL4R mRNA
CTD
PMID:15336504
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of IL6 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]
CTD
PMID:15336504 PMID:28063877 PMID:29111459
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL6ST mRNA
CTD
PMID:12419474
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Il9
interleukin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL9 mRNA
CTD
PMID:12419474
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILF3 mRNA
CTD
PMID:15336504
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
G
Ilvbl
ilvB acetolactate synthase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILVBL mRNA
CTD
PMID:15336504
NCBI chr 7:11,039,870...11,049,924
Ensembl chr 7:11,039,871...11,049,924
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IMPA2 mRNA
CTD
PMID:15336504
NCBI chr18:60,834,206...60,867,575
Ensembl chr18:60,834,246...60,865,641
G
Ing1
inhibitor of growth family, member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING1 mRNA
CTD
PMID:15336504
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
G
Ing3
inhibitor of growth family, member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING3 mRNA
CTD
PMID:15336504
NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
G
Inhba
inhibin subunit beta A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBA mRNA
CTD
PMID:15336504
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
G
Inhbb
inhibin subunit beta B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBB mRNA
CTD
PMID:12414654
NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
G
Inpp5b
inositol polyphosphate-5-phosphatase B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INPP5B mRNA
CTD
PMID:15336504
NCBI chr 5:136,996,766...137,061,315
Ensembl chr 5:136,996,686...137,061,315
G
Insig1
insulin induced gene 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA
CTD
PMID:15336504
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Ints7
integrator complex subunit 7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of INTS7 gene
CTD
PMID:29432895
NCBI chr13:103,155,123...103,207,953
Ensembl chr13:103,155,090...103,208,592
G
Ipo4
importin 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IPO4 mRNA
CTD
PMID:15336504
NCBI chr15:29,117,365...29,127,382
Ensembl chr15:29,117,365...29,127,285
G
Ipo9
importin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IPO9 mRNA
CTD
PMID:15336504
NCBI chr13:46,810,460...46,862,694
Ensembl chr13:46,813,171...46,862,673
G
Irf1
interferon regulatory factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF1 mRNA
CTD
PMID:15003993
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf7
interferon regulatory factor 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF7 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irf9
interferon regulatory factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Irgm
immunity-related GTPase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRGM mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG15 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG20 mRNA
CTD
PMID:15336504
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itch
itchy E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITCH mRNA
CTD
PMID:15336504
NCBI chr 3:143,642,348...143,733,745
Ensembl chr 3:143,645,637...143,733,543
G
Itga2
integrin subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA2 mRNA
CTD
PMID:12766906
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itga3
integrin subunit alpha 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itga4
integrin subunit alpha 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA4 mRNA
CTD
PMID:15336504
NCBI chr 3:64,162,764...64,235,010
Ensembl chr 3:64,163,085...64,233,715
G
Itga5
integrin subunit alpha 5
decreases expression increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ITGA5 mRNA tert-Butylhydroperoxide results in increased expression of ITGA5 mRNA
CTD
PMID:12419474 PMID:22659508
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itga6
integrin subunit alpha 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA6 mRNA tert-Butylhydroperoxide results in increased expression of ITGA6 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Itga7
integrin subunit alpha 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA7 mRNA
CTD
PMID:15336504
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
G
Itgal
integrin subunit alpha L
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGAL mRNA
CTD
PMID:12419474
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgav
integrin subunit alpha V
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ITGAV mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]
CTD
PMID:20847119
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Itgb3
integrin subunit beta 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB3 mRNA
CTD
PMID:22659508
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB4 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB5 mRNA
CTD
PMID:12419474
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
G
Itgb6
integrin subunit beta 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB6 mRNA
CTD
PMID:12419474
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
G
Itm2b
integral membrane protein 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITM2B mRNA
CTD
PMID:15336504
NCBI chr15:48,545,998...48,568,904
Ensembl chr15:48,546,001...48,568,917
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ITPR3 mRNA
CTD
PMID:23410634
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Itsn1
intersectin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITSN1 mRNA
CTD
PMID:12419474
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
G
Jak2
Janus kinase 2
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein]
CTD
PMID:29128606
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jam3
junctional adhesion molecule 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of JAM3 mRNA
CTD
PMID:14729362
NCBI chr 8:25,508,461...25,569,306
Ensembl chr 8:25,507,057...25,569,355
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
G
Jpt2
Jupiter microtubule associated homolog 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA
CTD
PMID:15336504
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]
CTD
PMID:12414654 PMID:15105052 PMID:15336504 PMID:27509014
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUND mRNA
CTD
PMID:12419474
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Jup
junction plakoglobin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUP mRNA
CTD
PMID:15336504
NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK1 mRNA
CTD
PMID:15336504
NCBI chr 1:222,877,962...223,074,514
Ensembl chr 1:222,877,622...223,074,514
G
Kank2
KN motif and ankyrin repeat domains 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK2 mRNA
CTD
PMID:15336504
NCBI chr 8:20,311,676...20,341,107
Ensembl chr 8:20,311,676...20,340,900
G
Kat2a
lysine acetyltransferase 2A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KAT2A mRNA
CTD
PMID:23410634
NCBI chr10:85,632,216...85,640,561
Ensembl chr10:85,632,216...85,640,166
G
Kcnab2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNAB2 mRNA
CTD
PMID:15003993
NCBI chr 5:162,899,511...162,988,057
Ensembl chr 5:162,901,896...162,988,243
G
Kcnb2
potassium voltage-gated channel subfamily B member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KCNB2 mRNA
CTD
PMID:15336504
NCBI chr 5:3,567,012...4,028,564
Ensembl chr 5:3,569,685...4,028,599
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
decreases response to substance
EXP
KCNJ1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:22811560
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNN4 mRNA
CTD
PMID:15003993
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
G
Kctd21
potassium channel tetramerization domain containing 21
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KCTD21 mRNA
CTD
PMID:23410634
NCBI chr 1:151,650,074...151,669,775
Ensembl chr 1:151,650,104...151,667,645
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KDELR3 mRNA
CTD
PMID:15336504
NCBI chr 7:111,079,236...111,089,463
Ensembl chr 7:111,079,218...111,101,600
G
Kdm3a
lysine demethylase 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KDM3A mRNA
CTD
PMID:23410634
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
G
Kdsr
3-ketodihydrosphingosine reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KDSR mRNA
CTD
PMID:15336504
NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions increases expression
ISO
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]
CTD
PMID:27050144
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Khnyn
KH and NYN domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KHNYN mRNA
CTD
PMID:15336504
NCBI chr15:29,365,399...29,379,650
Ensembl chr15:29,365,260...29,376,967
G
Kif15
kinesin family member 15
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIF15 mRNA tert-Butylhydroperoxide affects the expression of KIF15 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
G
Kif20a
kinesin family member 20A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF20A mRNA
CTD
PMID:15003993
NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
G
Kif23
kinesin family member 23
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KIF23 mRNA
CTD
PMID:23410634
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF2C mRNA
CTD
PMID:15003993
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
G
Kif4a
kinesin family member 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF4 mRNA
CTD
PMID:15003993
NCBI chr X:65,721,746...65,824,277
Ensembl chr X:65,721,779...65,824,139
G
Kif5c
kinesin family member 5C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF5C mRNA
CTD
PMID:15336504
NCBI chr 3:34,032,082...34,185,597
Ensembl chr 3:34,032,105...34,182,413
G
Kifbp
kinesin family binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIFBP mRNA
CTD
PMID:15336504
NCBI chr20:30,512,899...30,532,504
Ensembl chr20:30,512,901...30,532,476
G
Kifc1
kinesin family member C1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIFC1 mRNA
CTD
PMID:15336504
NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
G
Kiss1r
KISS1 receptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KISS1R mRNA
CTD
PMID:23410634
NCBI chr 7:9,785,135...9,790,283
Ensembl chr 7:9,785,135...9,788,793
G
Klf10
KLF transcription factor 10
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KLF10 mRNA
CTD
PMID:23410634
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
G
Klf2
KLF transcription factor 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]
CTD
PMID:20847119
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klf9
KLF transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KLF9 mRNA
CTD
PMID:15336504
NCBI chr 1:220,700,108...220,725,110
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc3
kelch domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KLHDC3 mRNA
CTD
PMID:15336504
NCBI chr 9:14,302,345...14,308,736
Ensembl chr 9:14,302,354...14,308,736
G
Kmt2d
lysine methyltransferase 2D
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of KMT2D gene tert-Butylhydroperoxide results in decreased expression of KMT2D mRNA
CTD
PMID:27509014
NCBI chr 7:129,980,744...130,022,088
Ensembl chr 7:129,962,887...130,020,325
G
Kmt5b
lysine methyltransferase 5B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KMT5B mRNA
CTD
PMID:15336504
NCBI chr 1:201,000,444...201,049,819
Ensembl chr 1:201,000,444...201,049,819
G
Kntc1
kinetochore associated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KNTC1 mRNA
CTD
PMID:15336504
NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561
G
Kpnb1
karyopherin subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KPNB1 mRNA
CTD
PMID:15336504
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Ktn1
kinectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KTN1 mRNA
CTD
PMID:15336504
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
G
Lair1
leukocyte-associated immunoglobulin-like receptor 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LAIR1 intron
CTD
PMID:29432895
NCBI chr 1:70,068,571...70,187,851
Ensembl chr 1:70,157,681...70,185,807
G
Lama5
laminin subunit alpha 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA
CTD
PMID:15336504
NCBI chr 3:167,270,296...167,318,370
Ensembl chr 3:167,270,296...167,318,451
G
Lamb1
laminin subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA
CTD
PMID:15336504
NCBI chr 6:47,835,492...47,902,585
Ensembl chr 6:47,835,525...47,902,585
G
Lamb3
laminin subunit beta 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMB3 mRNA
CTD
PMID:15336504
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMC2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Laptm5
lysosomal protein transmembrane 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAPTM5 mRNA
CTD
PMID:15336504
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lat
linker for activation of T cells
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LAT mRNA
CTD
PMID:22659508
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
G
Lbr
lamin B receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LBR mRNA
CTD
PMID:12414654
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LCAT mRNA
CTD
PMID:12419474
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
decreases secretion
ISO
tert-Butylhydroperoxide results in decreased secretion of LCN2 protein
CTD
PMID:27888128
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lcp1
lymphocyte cytosolic protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LCP1 mRNA
CTD
PMID:14729362
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LDLR mRNA
CTD
PMID:12414654
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lgals3bp
galectin 3 binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS3BP mRNA
CTD
PMID:14729362
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lgals8
galectin 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS8 mRNA
CTD
PMID:15336504
NCBI chr17:58,024,652...58,052,764
Ensembl chr17:58,028,105...58,052,764
G
Lgals9
galectin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LGR5 mRNA
CTD
PMID:23410634
NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
G
Lhx2
LIM homeobox 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LHX2 mRNA
CTD
PMID:15336504
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of LIF mRNA tert-Butylhydroperoxide results in increased methylation of LIF gene
CTD
PMID:12414654 PMID:15336504 PMID:23410634 PMID:27509014
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIFR mRNA
CTD
PMID:15336504
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lig1
DNA ligase 1
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of LIG1 mRNA tert-Butylhydroperoxide results in increased methylation of LIG1 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413
G
Lilrb4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LILRB4B mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:69,805,020...69,810,628
Ensembl chr 1:69,805,250...69,810,660
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMCH1 mRNA
CTD
PMID:15336504
NCBI chr14:41,112,579...41,425,001
Ensembl chr14:41,114,803...41,425,191
G
Limk1
LIM domain kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMK1 mRNA
CTD
PMID:15003993
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMS1 mRNA
CTD
PMID:15336504
NCBI chr20:26,309,833...26,418,511
Ensembl chr20:26,309,895...26,418,500
G
Lipa
lipase A, lysosomal acid type
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LIPA mRNA
CTD
PMID:15336504
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lmbr1
limb development membrane protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LMBR1 mRNA
CTD
PMID:23410634
NCBI chr 4:5,974,687...6,146,348
Ensembl chr 4:5,974,750...6,146,368
G
Lmnb1
lamin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB1 mRNA
CTD
PMID:15336504
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
G
Lmnb2
lamin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
G
Lnx2
ligand of numb-protein X 2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LNX2 intron
CTD
PMID:29432895
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
G
Lox
lysyl oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LOX mRNA
CTD
PMID:23410634
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Loxl2
lysyl oxidase-like 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LOXL2 mRNA
CTD
PMID:15963989
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT1 mRNA
CTD
PMID:15336504
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT3 mRNA
CTD
PMID:15336504
NCBI chr 4:157,468,397...157,509,889
Ensembl chr 4:157,468,290...157,509,880
G
Lpin1
lipin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN1 mRNA
CTD
PMID:14729362
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpin2
lipin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
G
Lpl
lipoprotein lipase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPL mRNA
CTD
PMID:15336504
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lpp
LIM domain containing preferred translocation partner in lipoma
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LPP mRNA
CTD
PMID:15336504
NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597
G
Lrba
LPS responsive beige-like anchor protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRBA mRNA
CTD
PMID:14729362
NCBI chr 2:171,623,668...172,202,576
Ensembl chr 2:171,621,507...172,202,724
G
Lrp1
LDL receptor related protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LRP1 mRNA
CTD
PMID:23410634
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Lrp6
LDL receptor related protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRP6 mRNA
CTD
PMID:12414654
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
G
Lrrc1
leucine rich repeat containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC1 mRNA
CTD
PMID:15336504
NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
G
Lrrc17
leucine rich repeat containing 17
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC17 mRNA
CTD
PMID:15336504
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
G
Lrrc23
leucine rich repeat containing 23
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LRRC23 intron
CTD
PMID:29432895
NCBI chr 4:157,581,285...157,592,188
Ensembl chr 4:157,581,291...157,591,860
G
Lrrc27
leucine rich repeat containing 27
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of LRRC27 promoter
CTD
PMID:29432895
NCBI chr 1:194,004,967...194,035,087
Ensembl chr 1:194,005,182...194,035,084
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSM4 mRNA
CTD
PMID:15336504
NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
G
Lss
lanosterol synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSS mRNA
CTD
PMID:14729362
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
G
Ltbp2
latent transforming growth factor beta binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LTBP2 mRNA
CTD
PMID:15336504
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Ly6a
lymphocyte antigen 6 family member A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LY6A mRNA
CTD
PMID:15003993
NCBI chr 7:107,177,191...107,189,436
Ensembl chr 7:107,183,469...107,189,981
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LYN mRNA
CTD
PMID:12419474
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LYPD1 mRNA
CTD
PMID:15336504
NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
G
Lypla1
lysophospholipase 1
decreases response to substance
ISO
LYPLA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15003993
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
G
Mab21l1
mab-21 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L1 mRNA
CTD
PMID:15336504
NCBI chr 2:139,943,496...139,945,885
Ensembl chr 2:139,943,496...139,945,885
G
Mab21l2
mab-21 like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L2 mRNA
CTD
PMID:15336504
NCBI chr 2:171,946,573...171,949,655
Ensembl chr 2:171,946,573...171,949,655
G
Macroh2a1
macroH2A.1 histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MACROH2A1 mRNA
CTD
PMID:15336504
NCBI chr17:8,479,331...8,542,071
Ensembl chr17:8,479,372...8,542,072
G
Mafb
MAF bZIP transcription factor B
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MAFB mRNA tert-Butylhydroperoxide results in increased methylation of MAFB gene
CTD
PMID:27509014
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAFF mRNA
CTD
PMID:15336504
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of MAFG mRNA tert-Butylhydroperoxide results in increased methylation of MAFG gene
CTD
PMID:12414654 PMID:27509014
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of MAFK gene tert-Butylhydroperoxide results in increased expression of MAFK mRNA
CTD
PMID:27509014
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAL mRNA
CTD
PMID:15336504
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
G
Man2a2
mannosidase, alpha, class 2A, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAN2A2 mRNA
CTD
PMID:15336504
NCBI chr 1:134,304,714...134,327,611
Ensembl chr 1:134,306,236...134,327,315
G
Mansc1
MANSC domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MANSC1 mRNA
CTD
PMID:15336504
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA
CTD
PMID:15336504
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA tert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein
CTD
PMID:15336504 PMID:17003459
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k4
mitogen activated protein kinase kinase 4
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K4 protein
CTD
PMID:17003459
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP2K5 mRNA
CTD
PMID:12419474
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Map2k6
mitogen-activated protein kinase kinase 6
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein
CTD
PMID:17003459
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA
CTD
PMID:15336504
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k6
mitogen-activated protein kinase kinase kinase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA
CTD
PMID:15336504
NCBI chr 5:145,440,126...145,452,213
Ensembl chr 5:145,440,346...145,452,212
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K7 mRNA
CTD
PMID:15336504
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Map4
microtubule-associated protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP4 mRNA
CTD
PMID:15336504
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation multiple interactions decreases expression increases phosphorylation
ISO EXP
tert-Butylhydroperoxide results in decreased phosphorylation of MAPK1 protein [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK1 protein modified form] 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk12
mitogen-activated protein kinase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPK12 mRNA
CTD
PMID:14729362
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
G
Mapk14
mitogen activated protein kinase 14
decreases expression increases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased methylation of MAPK14 gene
CTD
PMID:15336504 PMID:27509014 PMID:29432895
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation decreases expression increases phosphorylation
ISO EXP
[tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK3 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK3 protein modified form] tert-Butylhydroperoxide results in decreased phosphorylation of MAPK3 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK8 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPRE3 mRNA
CTD
PMID:15003993
NCBI chr 6:25,513,800...25,558,876
Ensembl chr 6:25,513,800...25,558,881
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MARCHF2 mRNA tert-Butylhydroperoxide results in increased methylation of MARCHF2 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 7:14,480,605...14,507,821
Ensembl chr 7:14,481,761...14,507,794
G
Mark3
microtubule affinity regulating kinase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MARK3 mRNA
CTD
PMID:12419474
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of MAS1 gene
CTD
PMID:29432895
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Matn2
matrilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA
CTD
PMID:15336504
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Mb21d2
Mab-21 domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MB21D2 mRNA]
CTD
PMID:20847119
NCBI chr11:71,825,748...71,924,770
Ensembl chr11:71,825,748...71,924,769
G
Mbd3
methyl-CpG binding domain protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBD3 mRNA
CTD
PMID:15336504
NCBI chr 7:9,312,961...9,320,166
Ensembl chr 7:9,313,098...9,320,165
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA
CTD
PMID:15336504
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBTPS1 mRNA
CTD
PMID:15336504
NCBI chr19:47,561,598...47,612,769
Ensembl chr19:47,561,598...47,612,791
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCAM mRNA
CTD
PMID:15336504
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCFD2 mRNA
CTD
PMID:15003993
NCBI chr 6:7,274,469...7,285,841
Ensembl chr 6:7,274,469...7,285,841
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases response to substance
ISO
[HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] MCL1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15611089
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA
CTD
PMID:15336504
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA tert-Butylhydroperoxide affects the expression of MCM3 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM4 mRNA
CTD
PMID:12419474
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM5 mRNA tert-Butylhydroperoxide affects the expression of MCM5 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM6 mRNA
CTD
PMID:15336504
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM7 mRNA
CTD
PMID:15336504
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mcrs1
microspherule protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCRS1 mRNA
CTD
PMID:15336504
NCBI chr 7:130,383,853...130,392,667
Ensembl chr 7:130,383,853...130,392,685
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MDM2 mRNA
CTD
PMID:27509014
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ME1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
G
Mecp2
methyl CpG binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MECP2 mRNA
CTD
PMID:15336504
NCBI chr X:151,781,177...151,844,687
Ensembl chr X:151,789,930...151,844,689
G
Med16
mediator complex subunit 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED16 mRNA
CTD
PMID:15336504
NCBI chr 7:9,798,641...9,811,172
Ensembl chr 7:9,798,668...9,811,172
G
Med21
mediator complex subunit 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED21 mRNA
CTD
PMID:15336504
NCBI chr 4:179,560,509...179,583,811
Ensembl chr 4:179,560,579...179,567,548
G
Megf9
multiple EGF-like-domains 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEGF9 mRNA
CTD
PMID:15336504
NCBI chr 5:83,993,565...84,105,622
Ensembl chr 5:83,993,565...84,105,622
G
Mest
mesoderm specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEST mRNA
CTD
PMID:15336504
NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MET mRNA
CTD
PMID:15336504
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd6
major facilitator superfamily domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MFSD6 mRNA
CTD
PMID:15336504
NCBI chr 9:48,773,171...48,858,471
Ensembl chr 9:48,773,414...48,858,465
G
Mgll
monoglyceride lipase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MGLL mRNA
CTD
PMID:15336504
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgp
matrix Gla protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGP mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mgst2
microsomal glutathione S-transferase 2
decreases response to substance increases expression
ISO
MGST2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MGST2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGST3 mRNA tert-Butylhydroperoxide results in increased expression of MGST3 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
G
Mia
MIA SH3 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA mRNA
CTD
PMID:14729362
NCBI chr 1:82,473,677...82,476,378
Ensembl chr 1:82,473,678...82,475,370
G
Mia2
MIA SH3 domain ER export factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA2 mRNA
CTD
PMID:12414654
NCBI chr 6:76,787,508...76,885,246
Ensembl chr 6:76,787,508...76,885,211
G
Mia3
MIA SH3 domain ER export factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIA3 mRNA
CTD
PMID:15003993
NCBI chr13:94,970,421...95,012,071
Ensembl chr13:94,970,424...95,011,972
G
Mid1ip1
MID1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MID1IP1 mRNA
CTD
PMID:15003993
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
G
Mir155
microRNA 155
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]
CTD
PMID:35690295
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mir16
microRNA 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIR16 mRNA
CTD
PMID:15336504
NCBI chr 2:153,245,349...153,245,443
Ensembl chr 2:153,245,349...153,245,443
G
Mir184
microRNA 184
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR184 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]
CTD
PMID:35690295
NCBI chr 8:90,343,134...90,343,210
Ensembl chr 8:90,343,134...90,343,210
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MITF mRNA
CTD
PMID:15336504
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mixl1
Mix paired-like homeobox 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MIXL1 mRNA
CTD
PMID:23410634
NCBI chr13:92,422,031...92,426,065
Ensembl chr13:92,422,031...92,426,065
G
Mkks
MKKS centrosomal shuttling protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKKS mRNA
CTD
PMID:15336504
NCBI chr 3:124,201,877...124,221,142
Ensembl chr 3:124,201,877...124,220,162
G
Mknk2
MAPK interacting serine/threonine kinase 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mkrn1
makorin ring finger protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKRN1 mRNA
CTD
PMID:15336504
NCBI chr 4:68,175,908...68,197,216
Ensembl chr 4:68,175,909...68,197,165
G
Mlh1
mutL homolog 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]
CTD
PMID:12419474 PMID:35690295
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Mme
membrane metallo-endopeptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MME mRNA
CTD
PMID:15336504
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
G
Mmp11
matrix metallopeptidase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MMP11 mRNA
CTD
PMID:12419474
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
G
Mmp3
matrix metallopeptidase 3
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]
CTD
PMID:35690295
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]
CTD
PMID:35690295
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mob1a
MOB kinase activator 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOB1A mRNA
CTD
PMID:15336504
NCBI chr 4:115,831,581...115,848,561
Ensembl chr 4:115,831,551...115,848,561
G
Mok
MOK protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOK mRNA
CTD
PMID:15336504
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mospd1
motile sperm domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOSPD1 mRNA
CTD
PMID:15336504
NCBI chr X:133,100,200...133,127,960
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908
G
Mov10
Mov10 RNA helicase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOV10 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:192,292,041...192,315,142
Ensembl chr 2:192,293,470...192,315,083
G
Moxd1
monooxygenase, DBH-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOXD1 mRNA
CTD
PMID:15336504
NCBI chr 1:21,075,124...21,165,348
Ensembl chr 1:21,075,122...21,161,779
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPG mRNA
CTD
PMID:15336504
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
G
Mphosph8
M-phase phosphoprotein 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA
CTD
PMID:15336504
NCBI chr15:30,800,546...30,828,415
Ensembl chr15:30,686,613...30,828,810
G
Mphosph9
M-phase phosphoprotein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH9 mRNA
CTD
PMID:15336504
NCBI chr12:32,275,449...32,346,097
Ensembl chr12:32,275,558...32,342,392
G
Mpp1
MAGUK p55 scaffold protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPP1 mRNA
CTD
PMID:15003993
G
Mppe1
metallophosphoesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPPE1 mRNA
CTD
PMID:15336504
NCBI chr18:60,763,418...60,781,553
Ensembl chr18:60,763,419...60,781,553
G
Mrpl2
mitochondrial ribosomal protein L2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL2 mRNA
CTD
PMID:15336504
NCBI chr 9:14,333,233...14,337,006
Ensembl chr 9:14,333,234...14,337,040
G
Mrpl23
mitochondrial ribosomal protein L23
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL23 mRNA
CTD
PMID:14729362
NCBI chr 1:197,687,452...197,695,222
Ensembl chr 1:197,687,347...197,695,222
G
Mrpl34
mitochondrial ribosomal protein L34
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPL34 mRNA
CTD
PMID:15336504
NCBI chr16:18,152,470...18,153,205
Ensembl chr16:18,151,342...18,153,208
G
Mrpl48
mitochondrial ribosomal protein L48
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL48 mRNA tert-Butylhydroperoxide results in decreased expression of MRPL48 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:154,896,663...154,939,285
Ensembl chr 1:154,896,663...154,939,281
G
Mrps14
mitochondrial ribosomal protein S14
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPS14 mRNA
CTD
PMID:15336504
NCBI chr13:72,429,168...72,434,915
Ensembl chr13:72,408,558...72,434,915
G
Msh6
mutS homolog 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSH6 mRNA
CTD
PMID:15336504
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
G
Msln
mesothelin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSLN mRNA
CTD
PMID:15336504
NCBI chr10:14,771,946...14,781,382
Ensembl chr10:14,771,961...14,777,643
G
Msn
moesin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MSN mRNA
CTD
PMID:15336504
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Msra
methionine sulfoxide reductase A
decreases response to substance decreases expression multiple interactions
ISO
MSRA protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of MSRA protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRA protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRA protein]
CTD
PMID:15914630 PMID:38272317
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
G
Msrb1
methionine sulfoxide reductase B1
decreases response to substance increases expression
ISO
MSRB1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MSRB1 mRNA
CTD
PMID:15003993 PMID:15914630
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Msrb2
methionine sulfoxide reductase B2
decreases response to substance decreases expression multiple interactions
ISO
MSRB2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of MSRB2 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRB2 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRB2 protein]
CTD
PMID:15914630 PMID:38272317
NCBI chr17:81,974,378...82,000,044
Ensembl chr17:81,974,196...82,000,043
G
Msrb3
methionine sulfoxide reductase B3
decreases response to substance
ISO
MSRB3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr 7:56,260,985...56,426,004
Ensembl chr 7:56,303,308...56,425,496
G
Mt1
metallothionein 1
affects response to substance decreases response to substance
ISO
MT1 protein affects the susceptibility to tert-Butylhydroperoxide MT1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:16150881
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions decreases response to substance increases expression affects response to substance
ISO
MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA] MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MT2A mRNA MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide MT2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:12414654 PMID:16150881 PMID:16402917 PMID:16636651
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MTARC1 mRNA
CTD
PMID:23410634
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
G
Mtf1
metal-regulatory transcription factor 1
increases response to substance
ISO
MTF1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15378601
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
G
Mtg1
mitochondrial ribosome-associated GTPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTG1 mRNA
CTD
PMID:15336504
NCBI chr 1:194,931,543...194,944,278
Ensembl chr 1:194,931,531...194,944,277
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]
CTD
PMID:35690295
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MTR mRNA
CTD
PMID:27509014
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Mtx1
Metaxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTX1 mRNA
CTD
PMID:14729362
NCBI chr 2:174,615,460...174,621,383
Ensembl chr 2:174,615,461...174,620,982
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MUC1 mRNA
CTD
PMID:15336504
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Mx1
MX dynamin like GTPase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MX1 mRNA tert-Butylhydroperoxide results in increased expression of MX1 mRNA; tert-Butylhydroperoxide results in increased expression of MX2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mxd1
max dimerization protein 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYC mRNA
CTD
PMID:27509014
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mydgf
myeloid-derived growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYDGF mRNA
CTD
PMID:15336504
NCBI chr 9:999,659...1,008,804
Ensembl chr 9:1,000,722...1,008,822
G
Mylk
myosin light chain kinase
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYLK mRNA tert-Butylhydroperoxide affects the expression of MYLK mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Myo10
myosin X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO10 mRNA
CTD
PMID:15336504
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
G
Myo5a
myosin VA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO5A mRNA
CTD
PMID:15336504
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
G
Myo5c
myosin VC
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYO5C mRNA
CTD
PMID:15336504
NCBI chr 8:75,989,497...76,066,485
Ensembl chr 8:75,989,528...76,066,483
G
Myo7a
myosin VIIA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO7A mRNA
CTD
PMID:14729362
NCBI chr 1:152,342,611...152,414,171
Ensembl chr 1:152,344,448...152,414,157
G
N4bp1
Nedd4 binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP1 mRNA
CTD
PMID:15336504
NCBI chr19:20,222,811...20,273,570
Ensembl chr19:20,222,776...20,273,570
G
N4bp2l2
NEDD4 binding protein 2-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP2L2 mRNA
CTD
PMID:15336504
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAA15 mRNA
CTD
PMID:15336504
NCBI chr 2:135,458,018...135,520,756
Ensembl chr 2:135,457,948...135,520,756
G
Nap1l1
nucleosome assembly protein 1-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAP1L1 mRNA
CTD
PMID:15336504
NCBI chr 7:46,933,278...46,957,853
Ensembl chr 7:46,933,356...46,956,593
G
Napsa
napsin A aspartic peptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAPSA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094
G
Nav3
neuron navigator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAV3 mRNA
CTD
PMID:15336504
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Naxd
NAD(P)HX dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAXD mRNA
CTD
PMID:15336504
NCBI chr16:77,986,148...78,004,200
Ensembl chr16:77,987,726...78,004,192
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAM1 mRNA
CTD
PMID:15336504
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPD2 mRNA
CTD
PMID:15336504
NCBI chr 4:157,968,814...157,992,314
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPG2 mRNA
CTD
PMID:15336504
NCBI chr 6:137,342,449...137,418,083
Ensembl chr 6:137,342,943...137,415,159
G
Ncf1
neutrophil cytosolic factor 1
increases expression multiple interactions affects localization
EXP ISO
tert-Butylhydroperoxide results in increased expression of NCF1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide affects the localization of NCF1 protein]
CTD
PMID:22659508 PMID:29111459
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
G
Ncf4
neutrophil cytosolic factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCF4 mRNA
CTD
PMID:14729362
NCBI chr 7:109,825,420...109,843,389
Ensembl chr 7:109,826,020...109,843,389
G
Ncor2
nuclear receptor co-repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCOR2 mRNA
CTD
PMID:15336504
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ndc80
NDC80 kinetochore complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NDC80 mRNA
CTD
PMID:23410634
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Ndrg1
N-myc downstream regulated 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NDRG1 mRNA]
CTD
PMID:20847119
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg3
NDRG family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG3 mRNA
CTD
PMID:15336504
NCBI chr 3:145,587,505...145,650,896
Ensembl chr 3:145,548,041...145,650,873
G
Ndrg4
NDRG family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG4 mRNA
CTD
PMID:15336504
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NDUFA3 mRNA
CTD
PMID:15003993
NCBI chr 1:65,597,567...65,600,197
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA
CTD
PMID:15336504
NCBI chr 7:14,609,283...14,622,064
Ensembl chr 7:14,609,146...14,631,976
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB2 mRNA
CTD
PMID:15336504
NCBI chr 4:68,367,526...68,374,609
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
G
Ndufb7
NADH:ubiquinone oxidoreductase subunit B7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB7 mRNA
CTD
PMID:15336504
NCBI chr19:24,568,241...24,572,579
Ensembl chr19:24,568,241...24,572,579
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFS7 mRNA
CTD
PMID:15336504
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
G
Necap1
NECAP endocytosis associated 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NECAP1 mRNA
CTD
PMID:23410634
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NEDD4L mRNA
CTD
PMID:15336504
NCBI chr18:58,393,759...58,726,709
Ensembl chr18:58,393,509...58,723,137
G
Nelfcd
negative elongation factor complex member C/D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NELFCD mRNA
CTD
PMID:15336504
NCBI chr 3:163,213,765...163,224,886
Ensembl chr 3:163,213,762...163,224,884
G
Nes
nestin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NES mRNA
CTD
PMID:15003993
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NF2 mRNA
CTD
PMID:12419474
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfatc1
nuclear factor of activated T-cells 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA
CTD
PMID:12419474
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC2IP mRNA
CTD
PMID:15336504
NCBI chr 1:180,954,834...180,971,847
Ensembl chr 1:180,955,043...180,971,747
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions decreases response to substance decreases expression increases expression affects localization
ISO
NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide]; NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein]; NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide]; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA; tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA
CTD
PMID:19647727 PMID:20028456 PMID:20100471 PMID:20932822 PMID:24211276 PMID:27050144 PMID:27509014 PMID:27511913 PMID:28025122 PMID:30273691 PMID:38272317 More...
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfic
nuclear factor I/C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFIC mRNA
CTD
PMID:15003993
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
G
Nfix
nuclear factor I X
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFIX mRNA
CTD
PMID:12419474
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of NFKB1 mRNA tert-Butylhydroperoxide results in increased expression of NFKB1 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]
CTD
PMID:12419474 PMID:16704919 PMID:24394546
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases expression increases phosphorylation multiple interactions affects expression
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIA mRNA tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein] tert-Butylhydroperoxide affects the expression of NFKBIA mRNA
CTD
PMID:15336504 PMID:15879681 PMID:23410634
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIE mRNA
CTD
PMID:15336504
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfyb
nuclear transcription factor Y subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFYB mRNA
CTD
PMID:15336504
NCBI chr 7:20,964,988...20,980,569
Ensembl chr 7:20,964,993...20,980,565
G
Ngf
nerve growth factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NGF mRNA
CTD
PMID:15003993
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
G
Nip7
nucleolar pre-rRNA processing protein NIP7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIP7 mRNA
CTD
PMID:15336504
NCBI chr19:34,962,557...34,964,700
Ensembl chr19:34,962,557...34,964,711
G
Nisch
nischarin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NISCH mRNA
CTD
PMID:15336504
NCBI chr16:6,364,370...6,400,675
Ensembl chr16:6,364,374...6,400,668
G
Nit1
nitrilase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIT1 mRNA
CTD
PMID:14729362
NCBI chr13:83,769,888...83,773,324
Ensembl chr13:83,765,941...83,773,332
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKAIN1 mRNA
CTD
PMID:15003993
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NKD1 mRNA
CTD
PMID:23410634
NCBI chr19:18,476,344...18,549,380
Ensembl chr19:18,476,344...18,549,380
G
Nkiras1
NFKB inhibitor interacting Ras-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKIRAS1 mRNA
CTD
PMID:15003993
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
G
Nktr
natural killer cell triggering receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NKTR mRNA
CTD
PMID:15336504
NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314
G
Nkx3-1
NK3 homeobox 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA
CTD
PMID:15336504
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nmd3
NMD3 ribosome export adaptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NMD3 mRNA
CTD
PMID:23410634
NCBI chr 2:154,012,973...154,038,466
Ensembl chr 2:154,013,020...154,039,259
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NME2 mRNA
CTD
PMID:12419474
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18463239
NCBI chr 8:98,892,168...99,003,912
Ensembl chr 8:98,873,398...99,020,645
G
Nmrk1
nicotinamide riboside kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NMRK1 mRNA
CTD
PMID:15336504
NCBI chr 1:216,049,350...216,076,792
Ensembl chr 1:216,049,437...216,076,791
G
Nmt1
N-myristoyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NMT1 mRNA
CTD
PMID:15336504
NCBI chr10:87,988,826...88,025,405
Ensembl chr10:87,988,826...88,022,648
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NNT mRNA
CTD
PMID:15336504
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Noc4l
nucleolar complex associated 4 homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NOC4L mRNA
CTD
PMID:15336504
NCBI chr12:46,016,077...46,020,615
Ensembl chr12:46,016,069...46,020,614
G
Nono
non-POU domain containing, octamer-binding
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of NONO mRNA; tert-Butylhydroperoxide results in decreased expression of NONO protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO protein]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO protein]
CTD
PMID:15336504 PMID:38272317
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
EXP
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:10231168 PMID:18812229
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nox4
NADPH oxidase 4
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of NOX4 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:29111459
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npc1
NPC intracellular cholesterol transporter 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPC1 mRNA
CTD
PMID:15336504
NCBI chr18:3,379,482...3,425,100
Ensembl chr18:3,379,482...3,425,049
G
Nphp4
nephrocystin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NPHP4 mRNA
CTD
PMID:15336504
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
G
Nppb
natriuretic peptide B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPPB mRNA
CTD
PMID:15336504
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of NQO1 mRNA tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA; tert-Butylhydroperoxide results in decreased expression of NQO1 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]
CTD
PMID:12414654 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 PMID:38272317 More...
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA
CTD
PMID:15336504
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR0B2 mRNA
CTD
PMID:23410634
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR1H4 mRNA tert-Butylhydroperoxide affects the expression of NR1H4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR2F6 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR3C1 mRNA
CTD
PMID:23410634
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA
CTD
PMID:12414654
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrbf2
nuclear receptor binding factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NRBF2 mRNA
CTD
PMID:15336504
NCBI chr20:21,308,555...21,326,881
Ensembl chr20:21,308,576...21,326,818
G
Nsd2
nuclear receptor binding SET domain protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NSD2 mRNA
CTD
PMID:15336504
NCBI chr14:76,833,179...76,911,304
Ensembl chr14:76,835,637...76,913,641
G
Nsmaf
neutral sphingomyelinase activation associated factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NSMAF mRNA
CTD
PMID:15336504
NCBI chr 5:19,517,795...19,578,773
Ensembl chr 5:19,518,348...19,577,627
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NTRK2 mRNA
CTD
PMID:15336504
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
G
Nucb1
nucleobindin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUCB1 mRNA
CTD
PMID:15336504
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
G
Nudt11
nudix hydrolase 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUDT11 mRNA
CTD
PMID:15336504
NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145
G
Nudt21
nudix hydrolase 21
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA
CTD
PMID:15336504
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
G
Nudt6
nudix hydrolase 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NUDT6 mRNA
CTD
PMID:23410634
NCBI chr 2:120,289,908...120,306,197
Ensembl chr 2:120,290,847...120,306,230
G
Nup188
nucleoporin 188
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP188 mRNA
CTD
PMID:15336504
NCBI chr 3:13,559,917...13,616,313
Ensembl chr 3:13,559,990...13,616,307
G
Nup205
nucleoporin 205
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP205 mRNA
CTD
PMID:15336504
NCBI chr 4:63,854,934...63,920,852
Ensembl chr 4:63,854,783...63,920,844
G
Nup37
nucleoporin 37
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUP37 mRNA
CTD
PMID:15336504
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
G
Nup58
nucleoporin 58
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of NUP58 gene tert-Butylhydroperoxide results in increased expression of NUP58 mRNA
CTD
PMID:27509014
NCBI chr15:34,358,170...34,407,160
Ensembl chr15:34,358,277...34,407,060
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Oas1a
2'-5' oligoadenylate synthetase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS1 mRNA
CTD
PMID:15336504
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oas3
2'-5'-oligoadenylate synthetase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS3 mRNA
CTD
PMID:15336504
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Oaz1
ornithine decarboxylase antizyme 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAZ1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,883,855...8,886,315
Ensembl chr 7:8,883,851...8,886,310
G
Obsl1
obscurin like cytoskeletal adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OBSL1 mRNA
CTD
PMID:15336504
NCBI chr 9:76,967,802...76,993,771
Ensembl chr 9:76,974,253...76,993,560
G
Ocel1
occludin/ELL domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OCEL1 mRNA
CTD
PMID:15336504
NCBI chr16:18,042,037...18,045,080
Ensembl chr16:18,043,309...18,045,078
G
Ocln
occludin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OCLN protein
CTD
PMID:34303734
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of ODC1 protein
CTD
PMID:2013121
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
G
Ogdh
oxoglutarate dehydrogenase
multiple interactions decreases activity
EXP
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]
CTD
PMID:12680778
NCBI chr14:81,150,021...81,217,479
Ensembl chr14:81,150,091...81,217,479
G
Ogfod3
2-oxoglutarate and iron-dependent oxygenase domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGFOD3 mRNA
CTD
PMID:15336504
NCBI chr10:106,452,334...106,480,632
Ensembl chr10:106,452,329...106,480,134
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGT mRNA
CTD
PMID:15336504
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
G
Ola1
Obg-like ATPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of OLA1 mRNA
CTD
PMID:15336504
NCBI chr 3:57,966,896...58,085,955
Ensembl chr 3:57,966,896...58,084,480
G
Opn3
opsin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OPN3 mRNA
CTD
PMID:15336504
NCBI chr13:87,589,333...87,619,847
Ensembl chr13:87,589,333...87,619,847
G
Os9
OS9, endoplasmic reticulum lectin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OS9 mRNA
CTD
PMID:15336504
NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:62,915,515...62,943,745
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSBPL1A mRNA
CTD
PMID:15336504
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Oser1
oxidative stress responsive serine-rich 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSER1 mRNA
CTD
PMID:15336504
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of OSGIN1 mRNA tert-Butylhydroperoxide affects the expression of OSGIN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Osr2
odd-skipped related transciption factor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSR2 mRNA
CTD
PMID:15336504
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HA1 mRNA
CTD
PMID:15336504
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
P4htm
prolyl 4-hydroxylase, transmembrane
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HTM mRNA
CTD
PMID:15336504
NCBI chr 8:109,274,629...109,292,802
Ensembl chr 8:109,274,626...109,292,473
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:15336504
NCBI chr10:59,533,042...59,591,808
Ensembl chr10:59,534,117...59,591,808
G
Pafah2
platelet-activating factor acetylhydrolase 2
multiple interactions decreases response to substance affects localization affects response to substance
ISO
PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] PAFAH2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide affects the localization of PAFAH2 protein PAFAH2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:12406338 PMID:18024956
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
G
Palb2
partner and localizer of BRCA2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of PALB2 intron
CTD
PMID:29432895
NCBI chr 1:176,665,076...176,689,053
Ensembl chr 1:176,665,076...176,688,990
G
Palld
palladin, cytoskeletal associated protein
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PALLD mRNA
CTD
PMID:23410634
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAM mRNA
CTD
PMID:15336504
NCBI chr 9:97,998,581...98,271,966
Ensembl chr 9:98,122,916...98,271,965
G
Pan2
poly(A) specific ribonuclease subunit PAN2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAN2 mRNA
CTD
PMID:15336504
NCBI chr 7:729,146...747,744
Ensembl chr 7:729,562...747,744
G
Papola
poly (A) polymerase alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPOLA mRNA
CTD
PMID:15336504
NCBI chr 6:124,682,015...124,734,706
Ensembl chr 6:124,682,105...124,734,468
G
Papss1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAPSS1 mRNA
CTD
PMID:15336504
NCBI chr 2:220,040,343...220,114,399
Ensembl chr 2:220,040,312...220,114,395
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPSS2 mRNA
CTD
PMID:15336504
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PARD3 mRNA
CTD
PMID:15336504
NCBI chr19:55,080,282...55,630,111
Ensembl chr19:55,080,282...55,629,778
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage decreases expression
ISO EXP
6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]
CTD
PMID:15569404 PMID:16753784 PMID:27050144 PMID:27511913 PMID:28733231 PMID:29111459 PMID:38053484 More...
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PASK mRNA
CTD
PMID:15336504
NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111
G
Pawr
pro-apoptotic WT1 regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PAWR mRNA
CTD
PMID:23410634
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAX6 mRNA
CTD
PMID:15336504
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
G
Paxip1
PAX interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAXIP1 mRNA
CTD
PMID:15336504
NCBI chr 4:7,525,132...7,576,659
Ensembl chr 4:7,525,004...7,576,548
G
Pbx1
PBX homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX1 mRNA
CTD
PMID:15336504
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
G
Pbx2
PBX homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PBX2 mRNA
CTD
PMID:15336504
NCBI chr20:4,151,500...4,156,425
Ensembl chr20:4,151,500...4,156,425
G
Pbx3
PBX homeobox 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX3 mRNA
CTD
PMID:15336504
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
G
Pcdh9
protocadherin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCDH9 mRNA
CTD
PMID:15336504
NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538
G
Pcid2
PCI domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCID2 mRNA
CTD
PMID:15336504
NCBI chr16:76,423,245...76,448,712
Ensembl chr16:76,423,245...76,448,712
G
Pcmtd2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA
CTD
PMID:15336504
NCBI chr 3:168,960,312...168,979,504
Ensembl chr 3:168,960,305...168,979,497
G
Pcolce
procollagen C-endopeptidase enhancer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCOLCE mRNA
CTD
PMID:15336504
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PCOLCE2 mRNA
CTD
PMID:15336504
NCBI chr 8:96,193,461...96,251,116
Ensembl chr 8:96,193,461...96,251,114
G
Pcyox1
prenylcysteine oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1 mRNA
CTD
PMID:15336504
NCBI chr 4:118,832,114...118,842,951
Ensembl chr 4:118,830,638...118,842,951
G
Pcyox1l
prenylcysteine oxidase 1 like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1L mRNA
CTD
PMID:15336504
NCBI chr18:55,150,637...55,161,334
Ensembl chr18:55,150,650...55,161,327
G
Pdap1
PDGFA associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDAP1 mRNA
CTD
PMID:15336504
NCBI chr12:9,470,652...9,480,880
Ensembl chr12:9,470,574...9,535,374
G
Pdcd4
programmed cell death 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDCD4 mRNA
CTD
PMID:15336504
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd5
programmed cell death 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDCD5 mRNA
CTD
PMID:14729362
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
G
Pde4dip
phosphodiesterase 4D interacting protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA
CTD
PMID:15336504
NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDGFA mRNA
CTD
PMID:15336504
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdhx
pyruvate dehydrogenase complex, component X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDHX mRNA
CTD
PMID:15336504
NCBI chr 3:89,372,248...89,431,779
Ensembl chr 3:89,371,497...89,431,773
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA4 mRNA
CTD
PMID:15003993
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA5 mRNA
CTD
PMID:15003993
NCBI chr11:65,272,152...65,359,087
Ensembl chr11:65,272,155...65,359,084
G
Pdia6
protein disulfide isomerase family A, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA6 mRNA
CTD
PMID:15003993
NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:40,062,926...40,080,613
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDLIM3 mRNA
CTD
PMID:15336504
NCBI chr16:46,352,460...46,383,680
Ensembl chr16:46,352,467...46,383,657
G
Pdlim4
PDZ and LIM domain 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM4 mRNA
CTD
PMID:15336504
NCBI chr10:38,198,686...38,212,935
Ensembl chr10:38,198,689...38,212,938
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM7 mRNA
CTD
PMID:15336504
NCBI chr17:9,124,565...9,139,814
Ensembl chr17:9,124,649...9,139,811
G
Pdp1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDP1 mRNA
CTD
PMID:15336504
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
G
Pdzd2
PDZ domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA
CTD
PMID:15336504
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
G
Peg10
paternally expressed 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PEG10 mRNA
CTD
PMID:15336504
NCBI chr 4:32,842,441...32,855,639
Ensembl chr 4:32,848,493...32,852,621
G
Perp
p53 apoptosis effector related to PMP22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PERP mRNA
CTD
PMID:21382384
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
G
Pfdn6
prefoldin subunit 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFDN6 mRNA
CTD
PMID:15336504
NCBI chr20:4,945,959...4,947,433
Ensembl chr20:4,945,959...4,947,433
G
Pfkl
phosphofructokinase, liver type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKL mRNA
CTD
PMID:15003993
NCBI chr20:10,664,285...10,686,324
Ensembl chr20:10,664,272...10,686,315
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKP mRNA
CTD
PMID:15003993
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
G
Pfn2
profilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PFN2 mRNA
CTD
PMID:14729362
NCBI chr 2:142,067,102...142,072,938
Ensembl chr 2:142,067,104...142,072,938
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGGT1B mRNA
CTD
PMID:12414654
NCBI chr18:38,952,147...38,995,656
Ensembl chr18:38,952,914...38,995,503
G
Pgls
6-phosphogluconolactonase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PGLS mRNA
CTD
PMID:15336504
NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,300,317...18,305,803
G
Pgm2
phosphoglucomutase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGM2 mRNA
CTD
PMID:15003993
NCBI chr14:44,166,314...44,199,828
Ensembl chr14:44,164,425...44,199,967
G
Phf2
PHD finger protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA
CTD
PMID:15336504
NCBI chr17:15,783,221...15,851,209
Ensembl chr17:15,781,864...15,851,208
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHKA2 mRNA
CTD
PMID:15003993
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHKB mRNA
CTD
PMID:15336504
NCBI chr19:21,013,719...21,210,671
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA1 mRNA
CTD
PMID:15336504
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
G
Pi4ka
phosphatidylinositol 4-kinase alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PI4KA mRNA
CTD
PMID:15336504
NCBI chr11:83,609,148...83,726,876
Ensembl chr11:83,609,069...83,724,080
G
Pias1
protein inhibitor of activated STAT, 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIAS1 mRNA
CTD
PMID:15336504
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PID1 mRNA
CTD
PMID:15336504
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pidd1
p53-induced death domain protein 1
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of PIDD1 mRNA tert-Butylhydroperoxide results in increased methylation of PIDD1 gene
CTD
PMID:27509014
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIGN mRNA
CTD
PMID:15336504
NCBI chr13:21,659,092...21,812,932
Ensembl chr13:21,662,455...21,806,790
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R2 mRNA
CTD
PMID:12419474
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R3 mRNA
CTD
PMID:15336504
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Pilrb1
paired immunoglobin-like type 2 receptor beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PILRB mRNA
CTD
PMID:15336504
NCBI chr12:18,516,161...18,525,375
Ensembl chr12:18,516,156...18,525,346
G
Pkp4
plakophilin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PKP4 mRNA
CTD
PMID:15336504
NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
G
Pla2g4a
phospholipase A2 group 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA
CTD
PMID:15336504
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Pla2g5
phospholipase A2, group V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Pla2g7
phospholipase A2 group VII
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Pla2r1
phospholipase A2 receptor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2R1 mRNA
CTD
PMID:12414654
NCBI chr 3:44,883,943...45,013,793
Ensembl chr 3:44,883,943...45,013,660
G
Plaa
phospholipase A2, activating protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLAA mRNA
CTD
PMID:15336504
NCBI chr 5:109,428,600...109,460,373
Ensembl chr 5:109,428,265...109,460,282
G
Plagl1
PLAG1 like zinc finger 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAGL1 mRNA
CTD
PMID:15336504
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAUR mRNA
CTD
PMID:15336504
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plbd1
phospholipase B domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLBD1 mRNA
CTD
PMID:15336504
NCBI chr 4:169,472,983...169,529,277
Ensembl chr 4:169,472,983...169,529,277
G
Plcd1
phospholipase C, delta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLCD1 mRNA
CTD
PMID:15003993
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
G
Plce1
phospholipase C, epsilon 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLCE1 mRNA
CTD
PMID:15336504
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
G
Plek2
pleckstrin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA
CTD
PMID:15336504
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plekho1
pleckstrin homology domain containing O1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLEKHO1 mRNA
CTD
PMID:23410634
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plin3
perilipin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLIN3 mRNA
CTD
PMID:15336504
NCBI chr 9:1,111,178...1,123,057
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLK1 mRNA tert-Butylhydroperoxide results in increased expression of PLK1 mRNA
CTD
PMID:12414654 PMID:15003993
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk3
polo-like kinase 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLK3 mRNA
CTD
PMID:23410634
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plscr4
phospholipid scramblase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLSCR4 mRNA
CTD
PMID:15336504
NCBI chr 8:92,987,290...93,026,056
Ensembl chr 8:92,987,381...93,026,049
G
Plxna2
plexin A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA
CTD
PMID:15336504
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Plxnb2
plexin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:120,232,276...120,258,385
Ensembl chr 7:120,232,331...120,258,330
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PMAIP1 mRNA
CTD
PMID:23410634
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pnp
purine nucleoside phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PNP mRNA
CTD
PMID:15336504
NCBI chr15:24,170,607...24,178,269
Ensembl chr15:24,170,602...24,203,986
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PNPLA6 mRNA
CTD
PMID:15336504
NCBI chr12:1,574,387...1,603,735
Ensembl chr12:1,560,363...1,603,734
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA
CTD
PMID:15336504
NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLD1 mRNA
CTD
PMID:12419474
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of POLD4 mRNA tert-Butylhydroperoxide affects the expression of POLD4 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr 1:201,526,591...201,528,406
Ensembl chr 1:201,526,665...201,528,401
G
Pole2
DNA polymerase epsilon 2, accessory subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLE2 mRNA
CTD
PMID:12414654
NCBI chr 6:87,674,702...87,712,723
Ensembl chr 6:87,674,702...87,699,305
G
Polr2e
RNA polymerase II, I and III subunit E
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2E mRNA
CTD
PMID:15336504
NCBI chr 7:9,666,695...9,670,638
Ensembl chr 7:9,666,716...9,670,643
G
Polr2j
RNA polymerase II subunit J
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2J mRNA
CTD
PMID:15336504
NCBI chr12:20,543,038...20,548,590
Ensembl chr12:20,543,038...20,548,594
G
Pon2
paraoxonase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PON2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Popdc3
popeye domain cAMP effector 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of POPDC3 mRNA
CTD
PMID:15336504
NCBI chr20:48,772,397...48,800,677
Ensembl chr20:48,772,462...48,800,593
G
Pot1
protection of telomeres 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POT1 mRNA
CTD
PMID:15336504
NCBI chr 4:54,205,330...54,263,137
Ensembl chr 4:54,205,332...54,263,042
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein] tert-Butylhydroperoxide results in decreased expression of PPARA mRNA; tert-Butylhydroperoxide results in decreased expression of PPARA protein
CTD
PMID:26989860
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPARD mRNA
CTD
PMID:15336504
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases activity
ISO
tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]] tert-Butylhydroperoxide results in increased activity of PPARG protein
CTD
PMID:16417216 PMID:20847119
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
decreases response to substance multiple interactions decreases expression
ISO
PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]]; dorsomorphin promotes the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]
CTD
PMID:17460188 PMID:25522270
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppip5k1
diphosphoinositol pentakisphosphate kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPIP5K1 mRNA
CTD
PMID:15336504
NCBI chr 3:108,284,120...108,327,683
Ensembl chr 3:108,284,120...108,323,428
G
Ppl
periplakin
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPL mRNA tert-Butylhydroperoxide results in decreased expression of PPL mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPM1D mRNA
CTD
PMID:12414654
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CA mRNA
CTD
PMID:12419474
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CB mRNA
CTD
PMID:15336504
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP1R15A mRNA
CTD
PMID:15336504
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R3C mRNA tert-Butylhydroperoxide affects the expression of PPP1R3C mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r7
protein phosphatase 1, regulatory subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R7 mRNA
CTD
PMID:15336504
NCBI chr 9:93,886,068...93,911,198
Ensembl chr 9:93,886,143...93,914,850
G
Ppp1r8
protein phosphatase 1, regulatory subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA
CTD
PMID:12419474
NCBI chr 5:145,031,632...145,048,753
Ensembl chr 5:145,031,498...145,048,752
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP2CB mRNA
CTD
PMID:12414654
NCBI chr16:58,558,119...58,579,325
Ensembl chr16:58,558,122...58,579,576
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA
CTD
PMID:12419474
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PPP3CC mRNA
CTD
PMID:23410634
NCBI chr15:45,289,917...45,362,012
Ensembl chr15:45,290,373...45,361,832
G
Pprc1
PPARG related coactivator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPRC1 mRNA
CTD
PMID:15336504
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
G
Prdx1
peroxiredoxin 1
increases expression increases activity multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX1 protein tert-Butylhydroperoxide results in increased activity of PRDX1 protein Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PRDX1 protein]
CTD
PMID:11295360 PMID:16880205 PMID:20100471
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRDX2 mRNA tert-Butylhydroperoxide results in increased expression of PRDX2 protein
CTD
PMID:11295360 PMID:14729362 PMID:15336504
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prdx3
peroxiredoxin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRDX3 protein
CTD
PMID:24394546
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
G
Prdx5
peroxiredoxin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX5 mRNA
CTD
PMID:14729362
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
G
Prdx6
peroxiredoxin 6
increases expression decreases response to substance increases response to substance affects response to substance
ISO
tert-Butylhydroperoxide results in increased expression of PRDX6 protein PRDX6 protein results in decreased susceptibility to tert-Butylhydroperoxide PRDX6 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide PRDX6 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:11295360 PMID:12732627 PMID:14741336 PMID:20627125
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
G
Prepl
prolyl endopeptidase-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PREPL mRNA
CTD
PMID:15336504
NCBI chr 6:9,580,367...9,609,957
Ensembl chr 6:9,580,217...9,607,772
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKAR1A mRNA
CTD
PMID:15336504
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkca
protein kinase C, alpha
decreases expression affects localization increases activity
ISO EXP
tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA tert-Butylhydroperoxide affects the localization of PRKCA protein tert-Butylhydroperoxide results in increased activity of PRKCA protein
CTD
PMID:15336504 PMID:16716901
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCE mRNA
CTD
PMID:27509014
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkch
protein kinase C, eta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRKCH mRNA
CTD
PMID:15336504
NCBI chr 6:92,292,000...92,490,663
Ensembl chr 6:92,292,000...92,490,654
G
Prkcq
protein kinase C, theta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCQ mRNA tert-Butylhydroperoxide results in increased methylation of PRKCQ gene
CTD
PMID:27509014
NCBI chr17:67,246,394...67,379,049
Ensembl chr17:67,246,394...67,378,704
G
Prmt3
protein arginine methyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRMT3 mRNA
CTD
PMID:15336504
NCBI chr 1:99,492,712...99,581,774
Ensembl chr 1:99,492,724...99,579,435
G
Prnp
prion protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRNP mRNA
CTD
PMID:15336504
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
Pros1
protein S
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA
CTD
PMID:15336504
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Prr13
proline rich 13
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRR13 mRNA
CTD
PMID:15003993
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
G
Prrg2
proline rich and Gla domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA
CTD
PMID:14729362
NCBI chr 1:95,534,276...95,543,364
Ensembl chr 1:95,534,290...95,543,425
G
Prune1
prune exopolyphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
G
Prune2
prune homolog 2 with BCH domain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE2 mRNA
CTD
PMID:15336504
NCBI chr 1:214,352,586...214,624,848
Ensembl chr 1:214,352,955...214,622,650
G
Psca
prostate stem cell antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSCA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSD3 mRNA
CTD
PMID:15336504
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psip1
PC4 and SRSF1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSIP1 mRNA
CTD
PMID:15336504
NCBI chr 5:97,847,010...97,879,280
Ensembl chr 5:97,847,015...97,879,257
G
Psma6
proteasome 20S subunit alpha 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMA6 mRNA
CTD
PMID:15336504
NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
G
Psmb9
proteasome 20S subunit beta 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA
CTD
PMID:15003993
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psmd11
proteasome 26S subunit, non-ATPase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSMD11 mRNA
CTD
PMID:15336504
NCBI chr10:65,433,853...65,479,774
Ensembl chr10:65,433,853...65,479,766
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMD12 mRNA
CTD
PMID:12414654
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Psrc1
proline and serine rich coiled-coil 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSRC1 mRNA
CTD
PMID:15336504
NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTBP2 mRNA
CTD
PMID:15336504
NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
G
Pten
phosphatase and tensin homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTEN mRNA
CTD
PMID:15336504
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGES mRNA
CTD
PMID:15336504
NCBI chr 3:14,177,892...14,189,236
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGR1 mRNA
CTD
PMID:14729362 PMID:23410634
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of PTGS1 protein
CTD
PMID:15604817
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression increases activity
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased activity of PTGS2 protein
CTD
PMID:14729362 PMID:15604817 PMID:15705740 PMID:16417216 PMID:28063877
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTK2 mRNA
CTD
PMID:15336504
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptma
prothymosin alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTMA mRNA
CTD
PMID:12419474
NCBI chr 9:87,176,251...87,180,333
Ensembl chr 9:87,176,230...87,180,333
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A1 mRNA
CTD
PMID:15336504
NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
G
Ptp4a2
protein tyrosine phosphatase 4A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A2 mRNA
CTD
PMID:15336504
NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:142,165,700...142,191,899
G
Ptprr
protein tyrosine phosphatase, receptor type, R
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTPRR mRNA
CTD
PMID:15336504
NCBI chr 7:51,662,595...51,929,605
Ensembl chr 7:51,662,595...51,929,603
G
Ptrh2
peptidyl-tRNA hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTRH2 mRNA
CTD
PMID:15336504
NCBI chr10:71,505,113...71,515,297
Ensembl chr10:71,504,956...71,515,398
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTTG1 mRNA
CTD
PMID:15003993
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Pum2
pumilio RNA-binding family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PUM2 mRNA
CTD
PMID:15336504
NCBI chr 6:31,462,879...31,542,976
Ensembl chr 6:31,462,872...31,542,976
G
Pvr
PVR cell adhesion molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PVR mRNA
CTD
PMID:15336504
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PXMP2 mRNA
CTD
PMID:15336504
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pygl
glycogen phosphorylase L
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PYGL mRNA
CTD
PMID:15336504
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Qsox1
quiescin sulfhydryl oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of QSOX1 mRNA
CTD
PMID:12419474
NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459
G
R3hdm2
R3H domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of R3HDM2 mRNA
CTD
PMID:15336504
NCBI chr 7:63,212,519...63,340,574
Ensembl chr 7:63,232,346...63,340,540
G
Rab22a
RAB22A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB22A mRNA
CTD
PMID:15336504
NCBI chr 3:162,459,727...162,506,129
Ensembl chr 3:162,459,726...162,506,137
G
Rab27a
RAB27A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB27A mRNA
CTD
PMID:15336504
NCBI chr 8:73,782,730...73,836,630
Ensembl chr 8:73,782,694...73,847,829
G
Rab29
RAB29, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB29 mRNA
CTD
PMID:15336504
NCBI chr13:43,307,757...43,313,420
Ensembl chr13:43,307,775...43,313,417
G
Rab4a
RAB4A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB4A mRNA
CTD
PMID:15336504
NCBI chr19:51,795,613...51,822,706
Ensembl chr19:51,795,613...51,822,703
G
Rab5c
RAB5C, member RAS oncogene family
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of RAB5C intron
CTD
PMID:29432895
NCBI chr10:85,642,553...85,666,142
Ensembl chr10:85,642,809...85,666,103
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB7 mRNA
CTD
PMID:12419474
NCBI chr 4:120,461,966...120,510,756
Ensembl chr 4:120,461,963...120,506,889
G
Rab8a
RAB8A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB8A mRNA
CTD
PMID:15336504
NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABEP2 mRNA
CTD
PMID:15336504
NCBI chr 1:181,010,305...181,026,651
Ensembl chr 1:181,010,305...181,026,648
G
Rabgap1
RAB GTPase activating protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:21,208,012...21,326,013
Ensembl chr 3:21,208,055...21,326,013
G
Rabgap1l
RAB GTPase activating protein 1-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1L mRNA
CTD
PMID:15336504
NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984
G
Rac2
Rac family small GTPase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAC2 mRNA
CTD
PMID:22659508
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAD23A mRNA
CTD
PMID:15336504
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Raet1e
retinoic acid early transcript 1E
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAET1G mRNA
CTD
PMID:14729362
NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755
G
Rala
RAS like proto-oncogene A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RALA mRNA
CTD
PMID:15336504
NCBI chr17:47,092,163...47,145,192
Ensembl chr17:47,092,207...47,144,063
G
Ranbp2
RAN binding protein 2
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr20:26,442,156...26,493,481
Ensembl chr20:26,442,217...26,493,481
G
Ranbp9
RAN binding protein 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RANBP9 mRNA
CTD
PMID:23410634
NCBI chr17:21,220,807...21,303,009
Ensembl chr17:21,220,618...21,303,004
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GAP mRNA
CTD
PMID:23410634
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rap1gds1
Rap1 GTPase-GDP dissociation stimulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GDS1 mRNA
CTD
PMID:15336504
NCBI chr 2:227,500,366...227,645,213
Ensembl chr 2:227,500,367...227,645,169
G
Rap2a
RAP2A, member of RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAP2A mRNA
CTD
PMID:15336504
NCBI chr15:97,596,848...97,597,338
Ensembl chr15:97,596,020...97,624,138
G
Rapgef2
Rap guanine nucleotide exchange factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAPGEF2 mRNA
CTD
PMID:15336504
NCBI chr 2:164,207,513...164,322,157
Ensembl chr 2:164,207,513...164,244,247
G
Rarb
retinoic acid receptor, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RARB mRNA
CTD
PMID:12419474
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rasa4
RAS p21 protein activator 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RASA4 mRNA
CTD
PMID:15003993
NCBI chr12:20,552,805...20,580,177
Ensembl chr12:20,552,806...20,580,147
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRF1 mRNA
CTD
PMID:15336504
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
G
Rasgrp3
RAS guanyl releasing protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA
CTD
PMID:15336504
NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RB1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBBP8 mRNA
CTD
PMID:15336504
NCBI chr18:2,922,985...2,988,851
Ensembl chr18:2,921,286...2,988,846
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBL2 mRNA
CTD
PMID:12419474
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBM12 mRNA
CTD
PMID:15336504
NCBI chr 3:144,609,661...144,629,911
Ensembl chr 3:144,611,623...144,629,915 Ensembl chr 3:144,611,623...144,629,915
G
Rcn1
reticulocalbin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RCN1 mRNA
CTD
PMID:14729362
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcn3
reticulocalbin 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RCN3 mRNA tert-Butylhydroperoxide results in increased expression of RCN3 mRNA
CTD
PMID:15336504
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:95,564,380...95,573,725
G
Rcor3
REST corepressor 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RCOR3 mRNA
CTD
PMID:23410634
NCBI chr13:103,624,966...103,665,565
Ensembl chr13:103,624,971...103,665,565
G
Rdh14
retinol dehydrogenase 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RDH14 mRNA
CTD
PMID:15336504
NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712
G
Recql
RecQ like helicase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RECQL mRNA
CTD
PMID:15336504
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
G
Reep3
receptor accessory protein 3
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr20:21,493,868...21,578,698
Ensembl chr20:21,493,954...21,578,697
G
Reep4
receptor accessory protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of REEP4 mRNA
CTD
PMID:23410634
NCBI chr15:45,620,317...45,623,524
Ensembl chr15:45,619,941...45,623,526
G
Reep5
receptor accessory protein 5
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REEP5 mRNA tert-Butylhydroperoxide results in increased expression of REEP5 mRNA
CTD
PMID:15336504
NCBI chr18:25,945,375...25,983,271
Ensembl chr18:25,945,381...25,976,509
G
Rel
REL proto-oncogene, NF-kB subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REL mRNA
CTD
PMID:12419474
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression affects localization
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide affects the localization of RELA protein] tert-Butylhydroperoxide results in increased expression of RELA mRNA
CTD
PMID:15879681 PMID:16704919
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RELB mRNA
CTD
PMID:15336504
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Renbp
renin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RENBP mRNA
CTD
PMID:14729362
NCBI chr X:151,661,463...151,670,538
Ensembl chr X:151,661,458...151,670,516
G
Rer1
retention in endoplasmic reticulum sorting receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RER1 mRNA
CTD
PMID:15336504
NCBI chr 5:165,634,567...165,646,643
Ensembl chr 5:165,634,300...165,646,750
G
Retsat
retinol saturase
increases response to substance
ISO
RETSAT protein results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:17664141
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
G
Rfc3
replication factor C subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFC3 mRNA
CTD
PMID:15336504
NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778
G
Rfxank
regulatory factor X-associated ankyrin-containing protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFXANK mRNA
CTD
PMID:15336504
NCBI chr16:19,280,857...19,288,886
Ensembl chr16:19,281,475...19,460,255
G
Rgn
regucalcin
multiple interactions decreases expression
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RGN protein]
CTD
PMID:16677110 PMID:24394546
NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450
G
Rgs10
regulator of G-protein signaling 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS10 mRNA
CTD
PMID:15003993
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS2 mRNA
CTD
PMID:15336504
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rgs3
regulator of G-protein signaling 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RGS3 mRNA
CTD
PMID:23410634
NCBI chr 5:76,022,038...76,161,895
Ensembl chr 5:76,022,001...76,161,894
G
Rhd
Rh blood group, D antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHD mRNA
CTD
PMID:15003993
NCBI chr 5:147,087,479...147,121,716
Ensembl chr 5:147,087,518...147,121,715
G
Rheb
Ras homolog, mTORC1 binding
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHEB mRNA
CTD
PMID:15336504
NCBI chr 4:10,278,970...10,320,160
Ensembl chr 4:10,279,370...10,320,160
G
Rhod
ras homolog family member D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHOD mRNA
CTD
PMID:15336504
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHPN2 mRNA
CTD
PMID:14729362
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rictor
RPTOR independent companion of MTOR, complex 2
multiple interactions increases expression affects expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RICTOR mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA] tert-Butylhydroperoxide affects the expression of RICTOR mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
G
Riox1
ribosomal oxygenase 1
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]
CTD
PMID:20847119
NCBI chr 6:103,579,642...103,582,260
Ensembl chr 6:103,579,642...103,582,250
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA
CTD
PMID:15336504
NCBI chr 5:29,630,806...29,662,804
Ensembl chr 5:29,631,570...29,662,657
G
Rmnd5b
required for meiotic nuclear division 5 homolog B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RMND5B mRNA
CTD
PMID:15336504
NCBI chr10:35,881,250...35,892,322
Ensembl chr10:35,881,268...35,892,265
G
Rnaseh2c
ribonuclease H2, subunit C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RNASEH2C mRNA
CTD
PMID:15003993
NCBI chr 1:202,894,626...202,895,675
Ensembl chr 1:202,894,643...202,897,516
G
Rnd3
Rho family GTPase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RND3 mRNA
CTD
PMID:15336504
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
G
Rnf103
ring finger protein 103
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF103 mRNA
CTD
PMID:15003993
NCBI chr 4:103,526,456...103,542,529
Ensembl chr 4:103,526,502...103,555,919
G
Rnf13
ring finger protein 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF13 mRNA
CTD
PMID:15336504
NCBI chr 2:141,927,887...142,061,801
Ensembl chr 2:141,927,909...142,061,801
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNFT2 mRNA
CTD
PMID:15336504
NCBI chr12:38,329,217...38,387,303
Ensembl chr12:38,329,269...38,387,290
G
Rnh1
ribonuclease/angiogenin inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNH1 mRNA
CTD
PMID:12419474
NCBI chr 1:196,269,293...196,281,763
Ensembl chr 1:196,269,293...196,281,910
G
Rora
RAR-related orphan receptor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RORA mRNA
CTD
PMID:15336504
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rpa1
replication protein A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,148,793...60,199,949
G
Rpgr
retinitis pigmentosa GTPase regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPGR mRNA
CTD
PMID:23410634
NCBI chr X:12,566,447...12,628,171
Ensembl chr X:12,566,645...12,747,882
G
Rpl13a
ribosomal protein L13A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPL13A mRNA
CTD
PMID:12419474
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
G
Rpl27a
ribosomal protein L27A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPL27A mRNA
CTD
PMID:23410634
NCBI chr 1:163,539,732...163,542,771
G
Rpl5
ribosomal protein L5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPL5 mRNA
CTD
PMID:15336504
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
G
Rps19
ribosomal protein S19
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPS19 mRNA
CTD
PMID:12419474
NCBI chr 1:80,480,718...80,486,511
Ensembl chr 1:80,480,951...80,486,508
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPS27L mRNA
CTD
PMID:15336504
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rps6ka1
ribosomal protein S6 kinase A1
increases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein]
CTD
PMID:17003459
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
G
Rpusd2
RNA pseudouridine synthase domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RPUSD2 mRNA]
CTD
PMID:20847119
NCBI chr 3:106,017,759...106,023,010
Ensembl chr 3:106,017,864...106,023,251
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAD mRNA
CTD
PMID:15336504
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rragd
Ras-related GTP binding D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAGD mRNA
CTD
PMID:15336504
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Rras2
RAS related 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAS2 mRNA
CTD
PMID:23410634
NCBI chr 1:168,233,693...168,303,111
Ensembl chr 1:168,233,693...168,303,111
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of RRM1 mRNA tert-Butylhydroperoxide affects the expression of RRM1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
Rrn3
RRN3 homolog, RNA polymerase I transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRN3 mRNA
CTD
PMID:29432895
NCBI chr10:2,129,949...2,165,381
Ensembl chr10:2,129,978...2,165,663
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSAD2 mRNA tert-Butylhydroperoxide results in decreased expression of RSAD2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
Rsl1d1
ribosomal L1 domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSL1D1 mRNA
CTD
PMID:29432895
NCBI chr10:4,424,868...4,436,753
Ensembl chr10:4,397,821...4,439,593
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HLA-E mRNA
CTD
PMID:15336504
NCBI chr20:4,870,939...4,910,183
G
RT1-DMb
RT1 class II, locus DMb
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2-DMB1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
RT1-Ha
RT1 class II, locus Ha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPA1 mRNA
CTD
PMID:15336504
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPB1 mRNA
CTD
PMID:15336504
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
Rtn3
reticulon 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RTN3 mRNA
CTD
PMID:15336504
NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:204,612,675...204,669,275
G
Rtn4r
reticulon 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RTN4R mRNA
CTD
PMID:29432895
NCBI chr11:82,844,309...82,869,251
Ensembl chr11:82,844,309...82,869,466
G
Rxra
retinoid X receptor alpha
decreases response to substance
ISO
RXRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14978233
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Rxrb
retinoid X receptor beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RXRB mRNA
CTD
PMID:12419474
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
G
Rybp
RING1 and YY1 binding protein
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of RYBP gene tert-Butylhydroperoxide results in increased expression of RYBP mRNA
CTD
PMID:27509014
NCBI chr 4:132,876,260...132,928,328
Ensembl chr 4:132,876,361...132,928,316
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of S100A3 mRNA
CTD
PMID:15336504
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100A4 mRNA
CTD
PMID:15336504
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100pbp
S100P binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100PBP mRNA
CTD
PMID:15336504
NCBI chr 5:141,494,352...141,535,752
Ensembl chr 5:141,494,353...141,535,525
G
Samd4a
sterile alpha motif domain containing 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAMD4A mRNA
CTD
PMID:15336504
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
G
Sap18
Sin3A associated protein 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP18 mRNA
CTD
PMID:15336504
NCBI chr15:31,943,228...31,947,534
Ensembl chr15:31,943,230...31,950,038 Ensembl chr10:31,943,230...31,950,038
G
Sap30
Sin3A associated protein 30
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP30 mRNA
CTD
PMID:15336504
NCBI chr16:32,747,777...32,753,114
Ensembl chr16:32,747,734...32,753,112
G
Sapcd2
suppressor APC domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SAPCD2 mRNA
CTD
PMID:23410634
NCBI chr 3:8,186,089...8,195,119
Ensembl chr 3:8,187,266...8,192,546
G
Sar1a
secretion associated, Ras related GTPase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1A mRNA
CTD
PMID:15336504
NCBI chr20:29,623,529...29,635,935
Ensembl chr20:29,623,553...29,635,935
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1B mRNA
CTD
PMID:15336504
NCBI chr10:36,024,415...36,054,069
Ensembl chr10:36,024,382...36,054,066
G
Saraf
store-operated calcium entry-associated regulatory factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SARAF mRNA
CTD
PMID:15003993
NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAT1 mRNA
CTD
PMID:15336504
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Satb1
SATB homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA
CTD
PMID:15336504
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Scarb2
scavenger receptor class B, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCARB2 mRNA
CTD
PMID:15336504
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCD mRNA
CTD
PMID:15336504
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scg5
secretogranin V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCG5 mRNA
CTD
PMID:15336504
NCBI chr 3:100,544,101...100,588,558
Ensembl chr 3:100,544,099...100,588,463
G
Scml1
Scm polycomb group protein like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCML1 mRNA
CTD
PMID:15336504
NCBI chr X:32,893,100...32,912,686
Ensembl chr X:32,894,327...32,911,366
G
Scp2
sterol carrier protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCP2 mRNA
CTD
PMID:15336504
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Sdc2
syndecan 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SDC2 mRNA
CTD
PMID:15336504
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
G
Sec14l1
SEC14-like lipid binding 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEC14L1 mRNA
CTD
PMID:15336504
NCBI chr10:102,319,920...102,367,070
Ensembl chr10:102,319,920...102,367,068
G
Sec24b
SEC24 homolog B, COPII coat complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SEC24B mRNA
CTD
PMID:23410634
NCBI chr 2:218,562,670...218,632,753
Ensembl chr 2:218,562,676...218,632,699
G
Sectm1b
secreted and transmembrane 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SECTM1 mRNA
CTD
PMID:15336504
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Sel1l3
SEL1L family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEL1L3 mRNA
CTD
PMID:15336504
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
G
Selenbp1
selenium binding protein 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENBP1 mRNA tert-Butylhydroperoxide results in increased expression of SELENBP1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Selenok
selenoprotein K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENOK mRNA
CTD
PMID:15003993
NCBI chr16:5,152,066...5,160,648
Ensembl chr16:5,152,066...5,159,188
G
Selenop
selenoprotein P
multiple interactions decreases response to substance
ISO
dimethyl mercaptosuccinate inhibits the reaction [SELENOP protein results in decreased susceptibility to tert-Butylhydroperoxide]
CTD
PMID:16632112
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sephs1
selenophosphate synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPHS1 mRNA
CTD
PMID:15336504
NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593
G
Septin2
septin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPTIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:94,018,141...94,051,386
Ensembl chr 9:94,018,208...94,051,386
G
Septin9
septin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEPTIN9 mRNA
CTD
PMID:15003993
NCBI chr10:102,409,798...102,579,056
Ensembl chr10:102,409,711...102,579,055
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA
CTD
PMID:15336504
NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,590,677...31,599,102
G
Serpinb2
serpin family B member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB2 mRNA
CTD
PMID:15336504
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Serpinb5
serpin family B member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB5 mRNA
CTD
PMID:12414654
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpinb8
serpin family B member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB8 mRNA
CTD
PMID:15336504
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE1 mRNA
CTD
PMID:15336504
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpine2
serpin family E member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE2 mRNA
CTD
PMID:15336504
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Serpinh1
serpin family H member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINH1 mRNA
CTD
PMID:12766906
NCBI chr 1:153,643,500...153,650,853
Ensembl chr 1:153,643,510...153,650,801
G
Serpini1
serpin family I member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINI1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sesn2
sestrin 2
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SESN2 protein
CTD
PMID:32740777
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Setd2
SET domain containing 2, histone lysine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETD2 mRNA
CTD
PMID:15336504
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
G
Setd3
SET domain containing 3, actin N3(tau)-histidine methyltransferase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SETD3 mRNA
CTD
PMID:15336504
NCBI chr 6:127,023,058...127,090,020
Ensembl chr 6:127,023,058...127,090,008
G
Setdb1
SET domain bifurcated histone lysine methyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETDB1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,898,738...182,930,283
Ensembl chr 2:182,898,738...182,930,506
G
Sf1
splicing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SF1 mRNA
CTD
PMID:12419474
NCBI chr 1:203,670,016...203,683,432
Ensembl chr 1:203,670,018...203,684,330
G
Sfpq
splicing factor proline and glutamine rich
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SFPQ intron
CTD
PMID:29432895
NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
G
Sgce
sarcoglycan, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SGCE mRNA
CTD
PMID:15336504
NCBI chr 4:32,771,477...32,842,238
Ensembl chr 4:32,771,477...32,842,254
G
Sgk2
serum/glucocorticoid regulated kinase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SGK2 mRNA
CTD
PMID:23410634
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sh2b3
SH2B adaptor protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SH2B3 mRNA
CTD
PMID:15336504
NCBI chr12:34,731,934...34,753,617
Ensembl chr12:34,731,911...34,753,616
G
Sh2d4a
SH2 domain containing 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH2D4A mRNA
CTD
PMID:15336504
NCBI chr16:21,339,010...21,409,360
Ensembl chr16:21,340,015...21,409,260
G
Sh2d5
SH2 domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SH2D5 mRNA
CTD
PMID:23410634
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA
CTD
PMID:15336504
NCBI chr 2:233,750,838...233,784,817
Ensembl chr 2:233,750,838...233,784,784
G
Shisa5
shisa family member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SHISA5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 8:109,691,504...109,706,411
Ensembl chr 8:109,691,522...109,706,408
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SHMT1 mRNA
CTD
PMID:15336504 PMID:27509014
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SIAH1A mRNA tert-Butylhydroperoxide affects the expression of SIAH1 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr19:20,378,908...20,402,512
Ensembl chr19:20,378,439...20,403,808
G
Sik1
salt-inducible kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIK1 mRNA
CTD
PMID:15336504
NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,396...9,958,991
G
Sin3a
SIN3 transcription regulator family member A
increases localization
EXP
Tert-butyl hydroperoxide increases localization of Sin3a protein at Ar promoter in hepatoma cells
RGD
PMID:18945670
RGD:2306468
NCBI chr 8:57,481,539...57,536,195
Ensembl chr 8:57,481,573...57,536,192
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIPA1L1 mRNA
CTD
PMID:15336504
NCBI chr 6:101,839,351...102,118,408
Ensembl chr 6:101,839,404...102,116,950
G
Sirt1
sirtuin 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of SIRT1 protein hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein]
CTD
PMID:18552516
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
multiple interactions
ISO
SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Ska3
spindle and kinetochore associated complex subunit 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SKA3 mRNA
CTD
PMID:23410634
NCBI chr15:31,951,812...31,971,010
Ensembl chr15:31,951,825...31,971,010
G
Skp2
S-phase kinase associated protein 2
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA tert-Butylhydroperoxide results in decreased methylation of SKP2 intron
CTD
PMID:15336504 PMID:29432895
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLAMF1 mRNA
CTD
PMID:12414654
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
G
Slc11a2
solute carrier family 11 member 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC11A2 mRNA tert-Butylhydroperoxide results in decreased expression of SLC11A2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SLC13A3 intron
CTD
PMID:29432895
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc16a2
solute carrier family 16 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC16A2 mRNA
CTD
PMID:15336504
NCBI chr X:68,725,365...68,848,572
Ensembl chr X:68,723,261...68,848,771
G
Slc17a2
solute carrier family 17, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC17A2 mRNA
CTD
PMID:23410634
NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
G
Slc19a2
solute carrier family 19 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA
CTD
PMID:15336504
NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
G
Slc1a1
solute carrier family 1 member 1
decreases expression multiple interactions decreases activity
ISO EXP
tert-Butylhydroperoxide results in decreased expression of SLC1A1 mRNA [Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein]
CTD
PMID:15336504 PMID:17382927
NCBI chr 1:226,549,932...226,631,925
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a4
solute carrier family 1 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC1A4 mRNA
CTD
PMID:15336504
NCBI chr14:94,530,801...94,560,190
Ensembl chr14:94,529,084...94,560,418
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC20A1 mRNA
CTD
PMID:15003993
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a18
solute carrier family 22, member 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC22A18 mRNA
CTD
PMID:15336504
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
G
Slc22a3
solute carrier family 22 member 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC22A3 mRNA
CTD
PMID:23410634
NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
G
Slc25a10
solute carrier family 25 member 10
multiple interactions increases expression
EXP ISO
[SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of SLC25A10 mRNA
CTD
PMID:12388626 PMID:15003993
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a16
solute carrier family 25 member 16
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC25A16 mRNA
CTD
PMID:15336504
NCBI chr20:25,691,474...25,717,558
Ensembl chr20:25,662,055...25,716,319
G
Slc27a2
solute carrier family 27 member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC27A2 mRNA
CTD
PMID:23410634
NCBI chr 3:113,804,728...113,842,208
Ensembl chr 3:113,804,728...113,842,208
G
Slc2a3
solute carrier family 2 member 3
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]
CTD
PMID:20847119
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc31a1
solute carrier family 31 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA
CTD
PMID:14729362
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc35f2
solute carrier family 35, member F2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35F2 mRNA
CTD
PMID:15336504
NCBI chr 8:54,159,970...54,203,614
Ensembl chr 8:54,159,970...54,203,612
G
Slc35g2
solute carrier family 35, member G2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA
CTD
PMID:15336504
NCBI chr 8:101,085,579...101,113,339
Ensembl chr 8:101,085,545...101,113,349
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC37A4 mRNA
CTD
PMID:15336504
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc39a14
solute carrier family 39 member 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC39A14 mRNA
CTD
PMID:15336504
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc44a4
solute carrier family 44, member 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC44A4 mRNA
CTD
PMID:23410634
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc46a1
solute carrier family 46 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA
CTD
PMID:22956110
NCBI chr10:63,361,504...63,367,940
Ensembl chr10:63,361,486...63,368,848
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of SLC4A1 protein
CTD
PMID:15040847
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC4A11 mRNA
CTD
PMID:29432895
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
G
Slc6a14
solute carrier family 6 member 14
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC6A14 mRNA
CTD
PMID:23410634
NCBI chr X:112,314,643...112,375,412
Ensembl chr X:112,314,691...112,375,096
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC7A11 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC7A5 mRNA
CTD
PMID:12419474
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of SLPI mRNA SLPI protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Sltm
SAFB-like, transcription modulator
multiple interactions increases expression
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr 8:71,215,995...71,261,821
Ensembl chr 8:71,216,612...71,261,825
G
Smad1
SMAD family member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:12419474
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SMAD3 mRNA tert-Butylhydroperoxide results in increased methylation of SMAD3 gene
CTD
PMID:27509014
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Smad5
SMAD family member 5
decreases methylation increases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of SMAD5 gene tert-Butylhydroperoxide results in increased expression of SMAD5 mRNA
CTD
PMID:27509014
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
G
Smad7
SMAD family member 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMAD7 mRNA
CTD
PMID:15336504
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smad9
SMAD family member 9
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD9 mRNA tert-Butylhydroperoxide results in decreased methylation of SMAD9 gene
CTD
PMID:27509014
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
G
Smarca2
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA
CTD
PMID:15336504
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA
CTD
PMID:15336504
NCBI chr 8:110,111,097...110,214,734
Ensembl chr 8:110,111,122...110,214,720
G
Smarcc2
SWI/SNF related BAF chromatin remodeling complex subunit C2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC2 mRNA
CTD
PMID:15336504
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc4
structural maintenance of chromosomes 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMC4 mRNA tert-Butylhydroperoxide affects the expression of SMC4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smim19
small integral membrane protein 19
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SMIM19 mRNA
CTD
PMID:23410634
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Smim7
small integral membrane protein 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMIM7 mRNA
CTD
PMID:15336504
NCBI chr16:17,274,417...17,278,336
Ensembl chr16:17,273,258...17,278,336
G
Smndc1
survival motor neuron domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMNDC1 mRNA
CTD
PMID:15336504
NCBI chr 1:252,389,675...252,400,749
Ensembl chr 1:252,389,673...252,401,616
G
Smox
spermine oxidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMOX mRNA
CTD
PMID:15336504
NCBI chr 3:118,731,814...118,767,242
Ensembl chr 3:118,731,900...118,765,710
G
Smtn
smoothelin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMTN mRNA
CTD
PMID:15336504
NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SNAI2 mRNA
CTD
PMID:15336504
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snap23
synaptosome associated protein 23
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNAP23 mRNA
CTD
PMID:15336504
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
G
Snn
stannin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNN mRNA
CTD
PMID:15336504
NCBI chr10:4,572,933...4,581,606
Ensembl chr10:4,572,376...4,584,021
G
Snx1
sorting nexin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX1 mRNA
CTD
PMID:15336504
NCBI chr 8:66,630,086...66,670,418
Ensembl chr 8:66,630,086...66,670,360
G
Snx4
sorting nexin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX4 mRNA
CTD
PMID:15336504
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
G
Soat1
sterol O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOAT1 mRNA
CTD
PMID:15336504
NCBI chr13:68,552,274...68,597,529
Ensembl chr13:68,552,317...68,597,494
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SOBP mRNA
CTD
PMID:15336504
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS1 mRNA
CTD
PMID:15003993
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs6
suppressor of cytokine signaling 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA
CTD
PMID:15336504
NCBI chr18:82,111,866...82,139,193
Ensembl chr18:82,111,827...82,139,219
G
Sod1
superoxide dismutase 1
decreases response to substance increases activity increases expression multiple interactions
ISO
SOD1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD1 protein tert-Butylhydroperoxide results in increased expression of SOD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:15849717 PMID:31627909 PMID:35690295 More...
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases response to substance increases activity increases expression affects response to substance multiple interactions decreases expression
ISO
SOD2 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD2 protein tert-Butylhydroperoxide results in increased expression of SOD2 mRNA SOD2 protein affects the susceptibility to tert-Butylhydroperoxide 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD2 mRNA; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein
CTD
PMID:15182862 PMID:15336504 PMID:16636651 PMID:16704919 PMID:17003459 PMID:20107204 PMID:25522270 PMID:27050144 PMID:27509014 PMID:29128606 PMID:31627909 PMID:35690295 More...
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
increases expression increases activity decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SORD mRNA tert-Butylhydroperoxide results in increased activity of SORD protein tert-Butylhydroperoxide results in decreased expression of SORD protein
CTD
PMID:15336504 PMID:16928893 PMID:24394546
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOX9 mRNA
CTD
PMID:15336504
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp100
SP100 nuclear antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SP100 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
G
Sp2
Sp2 transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SP2 mRNA
CTD
PMID:12419474
NCBI chr10:81,940,580...81,970,040
Ensembl chr10:81,940,587...81,970,548
G
Spag5
sperm associated antigen 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPAG5 mRNA
CTD
PMID:23410634
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Sparc
secreted protein acidic and cysteine rich
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPARC mRNA tert-Butylhydroperoxide results in increased expression of SPARC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Spata20
spermatogenesis associated 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPATA20 mRNA
CTD
PMID:15336504
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
G
Spdl1
spindle apparatus coiled-coil protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPDL1 mRNA
CTD
PMID:23410634
NCBI chr10:19,269,125...19,294,213
Ensembl chr10:19,269,127...19,294,127
G
Sphk1
sphingosine kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPHK1 mRNA
CTD
PMID:15336504
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPINT2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616
G
Spred2
sprouty-related, EVH1 domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRED2 mRNA
CTD
PMID:15336504
NCBI chr14:94,149,210...94,250,787
Ensembl chr14:94,148,837...94,249,162
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRR1A mRNA
CTD
PMID:15003993
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Spry4
sprouty RTK signaling antagonist 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPRY4 mRNA
CTD
PMID:23410634
NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004
G
Spta1
spectrin, alpha, erythrocytic 1
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr13:86,203,504...86,279,371
Ensembl chr13:86,203,504...86,279,371
G
Sptan1
spectrin, alpha, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTAN1 mRNA
CTD
PMID:15336504
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sptb
spectrin, beta, erythrocytic
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn1
spectrin, beta, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTBN1 mRNA
CTD
PMID:15336504
NCBI chr14:103,841,713...104,016,900
Ensembl chr14:103,842,684...104,008,507
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTLC1 mRNA
CTD
PMID:15336504
NCBI chr17:11,877,249...11,916,295
Ensembl chr17:11,877,249...11,916,295
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA
CTD
PMID:15336504
NCBI chr 6:106,948,682...107,031,532
Ensembl chr 6:106,950,949...107,031,542
G
Sptssa
serine palmitoyltransferase, small subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTSSA mRNA
CTD
PMID:15336504
NCBI chr 6:72,144,714...72,156,130
Ensembl chr 6:72,144,714...72,156,214
G
Sqle
squalene epoxidase
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SQLE mRNA tert-Butylhydroperoxide results in increased expression of SQLE mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqor
sulfide quinone oxidoreductase
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of SQOR mRNA tert-Butylhydroperoxide affects the expression of SQOR mRNA
CTD
PMID:14729362 PMID:15336504 PMID:23410634
NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:109,841,250...109,960,778
G
Sqstm1
sequestosome 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SQSTM1 mRNA
CTD
PMID:23410634
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srf
serum response factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRF mRNA
CTD
PMID:12419474
NCBI chr 9:14,426,453...14,435,734
Ensembl chr 9:14,426,472...14,435,733
G
Srgn
serglycin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRGN mRNA
CTD
PMID:15336504
NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
G
Srpk2
SRSF protein kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA
CTD
PMID:15336504
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPRA mRNA
CTD
PMID:15336504
NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470
G
Srpx
sushi-repeat-containing protein, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRPX mRNA
CTD
PMID:15336504
NCBI chr X:12,676,984...12,751,296
Ensembl chr X:12,566,645...12,747,882
G
Srrd
SRR1 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRRD mRNA
CTD
PMID:15336504
NCBI chr12:44,294,675...44,300,287
Ensembl chr12:44,294,271...44,300,287
G
Srrt
serrate, RNA effector molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRRT mRNA
CTD
PMID:15336504
NCBI chr12:19,392,578...19,406,098
Ensembl chr12:19,392,625...19,406,095
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRSF3 mRNA
CTD
PMID:15336504
NCBI chr20:7,091,928...7,101,860
Ensembl chr20:7,091,910...7,101,078
G
Srxn1
sulfiredoxin 1
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA tert-Butylhydroperoxide results in decreased methylation of SRXN1 gene
CTD
PMID:22003191 PMID:23410634 PMID:27509014
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ss18l1
SS18L1 subunit of BAF chromatin remodeling complex
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SS18L1 mRNA
CTD
PMID:15336504
NCBI chr 3:167,143,730...167,165,253
Ensembl chr 3:167,143,994...167,165,253
G
Sst
somatostatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SST mRNA
CTD
PMID:12414654
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SSX2IP mRNA
CTD
PMID:15336504
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ST6GALNAC4 mRNA
CTD
PMID:15003993
NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:15,872,532...15,885,243
G
ST7
suppression of tumorigenicity 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ST7 mRNA
CTD
PMID:15336504
NCBI chr 4:46,041,655...46,289,745
Ensembl chr 4:46,042,236...46,289,740
G
Stag1
STAG1 cohesin complex component
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAG1 mRNA
CTD
PMID:15336504
NCBI chr 8:101,179,039...101,564,684
Ensembl chr 8:101,179,039...101,564,677
G
Stat1
signal transducer and activator of transcription 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT1 mRNA tert-Butylhydroperoxide results in increased expression of STAT1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation
ISO
3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of STAT3 protein]
CTD
PMID:29128606
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT5A mRNA
CTD
PMID:12766906
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT6 mRNA
CTD
PMID:12419474
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stc1
stanniocalcin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC1 mRNA
CTD
PMID:15336504
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC2 mRNA
CTD
PMID:15336504
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stk10
serine/threonine kinase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STK10 mRNA
CTD
PMID:15336504
NCBI chr10:17,117,860...17,212,065
Ensembl chr10:17,117,878...17,212,061
G
Stk24
serine/threonine kinase 24
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STK24 mRNA
CTD
PMID:15336504
NCBI chr15:98,363,707...98,458,940
Ensembl chr15:98,365,791...98,460,553
G
Stmn1
stathmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STMN1 mRNA
CTD
PMID:15336504
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stx7
syntaxin 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STX7 mRNA
CTD
PMID:15336504
NCBI chr 1:21,197,075...21,237,320
Ensembl chr 1:21,197,075...21,237,279
G
Sugp2
SURP and G patch domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUGP2 mRNA
CTD
PMID:15336504
NCBI chr16:19,159,951...19,191,412
Ensembl chr16:19,164,767...19,191,340
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUMO3 mRNA
CTD
PMID:29432895
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
G
Suox
sulfite oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SUOX mRNA
CTD
PMID:23410634
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Susd6
sushi domain containing 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SUSD6 mRNA
CTD
PMID:15336504
NCBI chr 6:100,437,834...100,531,621
Ensembl chr 6:100,437,642...100,531,606
G
Synj2
synaptojanin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SYNJ2 mRNA
CTD
PMID:15336504
NCBI chr 1:46,518,594...46,621,919
Ensembl chr 1:46,518,709...46,633,687
G
Syt1
synaptotagmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SYT1 mRNA
CTD
PMID:15336504
NCBI chr 7:43,813,204...44,358,020
Ensembl chr 7:43,815,785...44,357,803
G
Tada3
transcriptional adaptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TADA3 mRNA
CTD
PMID:12419474
NCBI chr 4:146,510,213...146,521,975
Ensembl chr 4:146,510,246...146,521,590
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TAP1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tapbpl
TAP binding protein-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TAPBPL mRNA
CTD
PMID:15336504
NCBI chr 4:158,021,454...158,028,905
G
Tasor
transcription activation suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TASOR mRNA
CTD
PMID:15336504
NCBI chr16:2,606,807...2,669,902
Ensembl chr16:2,603,936...2,667,292
G
Tbc1d22a
TBC1 domain family, member 22a
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TBC1D22A mRNA
CTD
PMID:15336504
NCBI chr 7:117,292,481...117,577,473
Ensembl chr 7:117,292,631...117,577,483
G
Tbl1xr1
TBL1X/Y related 1
affects expression decreases methylation
ISO
tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA tert-Butylhydroperoxide results in decreased methylation of TBL1XR1 intron
CTD
PMID:23410634 PMID:29432895
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tbrg1
transforming growth factor beta regulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA
CTD
PMID:14729362
NCBI chr 8:37,355,274...37,362,933
Ensembl chr 8:37,354,658...37,362,930
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCAF1 mRNA
CTD
PMID:15336504
NCBI chr 4:71,589,674...71,639,274
Ensembl chr 4:71,591,200...71,613,309
G
Tcea1
transcription elongation factor A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCEA1 mRNA
CTD
PMID:12419474
NCBI chr 5:14,631,454...14,668,769
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
G
Tcf3
transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
G
Tcf4
transcription factor 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF4 mRNA
CTD
PMID:15336504
NCBI chr18:62,941,739...63,288,126
Ensembl chr18:62,943,782...63,284,425
G
Tcfl5
transcription factor like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCFL5 mRNA
CTD
PMID:15336504
NCBI chr 3:167,734,471...167,754,174
Ensembl chr 3:167,734,473...167,754,282
G
Tead4
TEA domain transcription factor 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of TEAD4 mRNA tert-Butylhydroperoxide affects the expression of TEAD4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:161,474,122...161,572,837
Ensembl chr 4:161,497,851...161,572,323
G
Tenm4
teneurin transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA
CTD
PMID:15336504
NCBI chr 1:149,895,097...151,263,315
Ensembl chr 1:150,780,381...151,259,144
G
Tent2
terminal nucleotidyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TENT2 mRNA
CTD
PMID:23410634
NCBI chr 2:24,380,135...24,432,099
Ensembl chr 2:24,380,225...24,432,099
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TERF1 mRNA
CTD
PMID:12419474
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Tet1
tet methylcytosine dioxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TET1 mRNA
CTD
PMID:27509014
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
G
Tex10
testis expressed 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TEX10 mRNA
CTD
PMID:15336504
NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373
G
Tfcp2
transcription factor CP2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFCP2 mRNA
CTD
PMID:15336504
NCBI chr 7:131,616,777...131,658,995
Ensembl chr 7:131,616,785...131,658,939
G
Tfdp1
transcription factor Dp-1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFDP1 mRNA
CTD
PMID:15336504
NCBI chr16:76,162,040...76,200,871
Ensembl chr16:76,162,043...76,200,817
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA
CTD
PMID:15336504
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tfrc
transferrin receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFRC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tgfa
transforming growth factor alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFA mRNA
CTD
PMID:15336504
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1 mRNA; tert-Butylhydroperoxide results in increased expression of TGFB1 protein
CTD
PMID:15147944 PMID:15336504 PMID:15963989
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA tert-Butylhydroperoxide affects the expression of TGFB1I1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgm2
transglutaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGM2 mRNA
CTD
PMID:15336504
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Tgoln2
trans-golgi network protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TGOLN2 mRNA
CTD
PMID:15336504
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Thap1
THAP domain containing 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of THAP1 mRNA
CTD
PMID:23410634
NCBI chr16:65,905,348...65,909,942
Ensembl chr16:65,904,230...65,909,942
G
Thbd
thrombomodulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBD mRNA
CTD
PMID:15336504
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS1 mRNA
CTD
PMID:29432895
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thbs3
thrombospondin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS3 mRNA
CTD
PMID:14729362
NCBI chr 2:174,621,788...174,633,594
Ensembl chr 2:174,621,812...174,633,594
G
Them6
thioesterase superfamily member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THEM6 mRNA
CTD
PMID:15336504
NCBI chr 7:106,606,570...106,609,747
Ensembl chr 7:106,606,570...106,609,746
G
Thoc6
THO complex subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THOC6 mRNA
CTD
PMID:15336504
NCBI chr10:12,700,051...12,705,411
Ensembl chr10:12,700,051...12,706,925
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA
CTD
PMID:15336504
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIAL1 mRNA
CTD
PMID:15336504
NCBI chr 1:183,008,358...183,045,092
Ensembl chr 1:183,009,253...183,031,637
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIE1 mRNA
CTD
PMID:15336504
NCBI chr 5:132,000,013...132,019,658
Ensembl chr 5:132,000,015...132,019,592
G
Timm22
translocase of inner mitochondrial membrane 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM22 mRNA
CTD
PMID:15003993
NCBI chr10:61,253,459...61,261,217
Ensembl chr10:61,253,450...61,261,755
G
Timm9
translocase of inner mitochondrial membrane 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM9 mRNA
CTD
PMID:15336504
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMP3 mRNA
CTD
PMID:15336504
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TINAGL1 mRNA
CTD
PMID:15003993
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIPARP mRNA
CTD
PMID:15336504
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tjp1
tight junction protein 1
multiple interactions affects localization
EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]
CTD
PMID:16716901
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TK1 mRNA
CTD
PMID:12414654
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TKFC mRNA
CTD
PMID:15336504
NCBI chr 1:207,238,230...207,253,035
Ensembl chr 1:207,236,557...207,252,737
G
Tle3
TLE family member 3, transcriptional corepressor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TLE3 mRNA
CTD
PMID:15336504
NCBI chr 8:61,857,791...61,903,505
Ensembl chr 8:61,858,200...61,903,493
G
Tle4
TLE family member 4, transcriptional corepressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE4 mRNA
CTD
PMID:15336504
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tle5
TLE family member 5, transcriptional modulator
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE5 mRNA tert-Butylhydroperoxide results in increased expression of TLE5 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,143,357...8,150,295
Ensembl chr 7:8,143,357...8,150,113
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 2:141,456,950...141,466,146
Ensembl chr 2:141,453,310...141,466,146
G
Tm7sf2
transmembrane 7 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM7SF2 mRNA
CTD
PMID:15336504
NCBI chr 1:203,355,930...203,360,287
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf2
transmembrane 9 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM9SF2 mRNA
CTD
PMID:15336504
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tm9sf3
transmembrane 9 superfamily member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM9SF3 mRNA
CTD
PMID:15336504
NCBI chr 1:240,032,060...240,085,125
Ensembl chr 1:240,035,003...240,084,776
G
Tmco3
transmembrane and coiled-coil domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMCO3 mRNA
CTD
PMID:15336504
NCBI chr16:76,217,146...76,254,309
Ensembl chr16:76,217,201...76,254,107
G
Tmem106c
transmembrane protein 106C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM106C mRNA
CTD
PMID:15336504
NCBI chr 7:129,088,468...129,094,128
Ensembl chr 7:129,088,498...129,094,130
G
Tmem132a
transmembrane protein 132A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM132A mRNA
CTD
PMID:15336504
NCBI chr 1:207,507,074...207,518,756
Ensembl chr 1:207,507,077...207,518,758
G
Tmem158
transmembrane protein 158
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM158 mRNA
CTD
PMID:15336504
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem177
transmembrane protein 177
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of TMEM177 mRNA] tert-Butylhydroperoxide results in increased expression of TMEM177 mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem205
transmembrane protein 205
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM205 mRNA
CTD
PMID:14729362
NCBI chr 8:20,452,092...20,458,011
Ensembl chr 8:20,452,092...20,457,828
G
Tmem248
transmembrane protein 248
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM248 mRNA
CTD
PMID:15336504
NCBI chr12:26,430,775...26,457,105
Ensembl chr12:26,432,953...26,457,105
G
Tmem80
transmembrane protein 80
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM80 mRNA
CTD
PMID:15336504
NCBI chr 1:196,435,999...196,444,368
Ensembl chr 1:196,436,003...196,444,367 Ensembl chr 1:196,436,003...196,444,367
G
Tmpo
thymopoietin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMPO mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 7:25,642,752...25,667,756
Ensembl chr 7:25,586,725...25,667,727
G
Tmsb10
thymosin, beta 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMSB10 mRNA
CTD
PMID:15003993
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmsb15b2
thymosin beta 15B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMSB15A mRNA
CTD
PMID:15336504
NCBI chr X:100,298,705...100,300,820
Ensembl chr X:100,298,514...100,300,886
G
Tmt1a
thiol methyltransferase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMT1A mRNA
CTD
PMID:15336504
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
G
Tmx4
thioredoxin-related transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMX4 mRNA
CTD
PMID:15336504
NCBI chr 3:121,856,237...121,899,680
Ensembl chr 3:121,856,261...121,899,641
G
Tnc
tenascin C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNC mRNA
CTD
PMID:15336504
NCBI chr 5:77,375,851...77,460,712
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions increases secretion increases expression
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 8-methoxymethyl-3-isobutyl-1-methylxanthine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] tert-Butylhydroperoxide results in increased expression of TNF mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNF mRNA; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]
CTD
PMID:10231168 PMID:17129690 PMID:17369293 PMID:29111459 PMID:29935159 PMID:35690295 More...
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFAIP3 mRNA
CTD
PMID:15336504
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNFRSF1A mRNA
CTD
PMID:12419474
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA
CTD
PMID:15003993
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tnnc1
troponin C1, slow skeletal and cardiac type
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNNC1 mRNA tert-Butylhydroperoxide results in increased expression of TNNC1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr16:6,400,801...6,405,634
Ensembl chr16:6,402,171...6,405,634
G
Tnnt1
troponin T1, slow skeletal type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:69,306,362...69,316,721
Ensembl chr 1:69,306,362...69,316,721
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT2 mRNA
CTD
PMID:14729362
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
G
Tnpo1
transportin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNPO1 mRNA
CTD
PMID:15336504
NCBI chr 2:30,207,529...30,300,162
Ensembl chr 2:30,211,510...30,300,375
G
Tnpo2
transportin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNPO2 mRNA
CTD
PMID:15336504
NCBI chr19:23,099,398...23,119,696
Ensembl chr19:23,099,401...23,119,596
G
Tom1
target of myb1 membrane trafficking protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TOM1 mRNA
CTD
PMID:12414654
NCBI chr19:13,405,482...13,440,384
Ensembl chr19:13,405,501...13,440,384
G
Top6bl
TOP6B like initiator of meiotic double strand breaks
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TOP6BL mRNA
CTD
PMID:15336504
NCBI chr 1:201,902,564...201,989,945
G
Tp53
tumor protein p53
multiple interactions decreases expression increases expression increases glutathionylation increases phosphorylation
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein]; S-ethyl glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein modified form] tert-Butylhydroperoxide results in decreased expression of TP53 mRNA tert-Butylhydroperoxide results in increased glutathionylation of TP53 protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] tert-Butylhydroperoxide results in increased expression of TRP53 mRNA; tert-Butylhydroperoxide results in increased expression of TRP53 protein
CTD
PMID:12419474 PMID:12782109 PMID:15879681 PMID:17555331 PMID:18619952 PMID:35690295 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP53BP1 mRNA tert-Butylhydroperoxide results in decreased methylation of TP53BP1 gene
CTD
PMID:27509014
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TP53I3 mRNA
CTD
PMID:15336504
NCBI chr 6:27,818,327...27,825,753
G
Tp73
tumor protein p73
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP73 mRNA tert-Butylhydroperoxide results in increased methylation of TP73 gene
CTD
PMID:27509014
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tpd52l1
TPD52 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPD52L1 mRNA
CTD
PMID:15336504
NCBI chr 1:26,172,038...26,290,704
Ensembl chr 1:26,172,170...26,291,109
G
Tpgs2
tubulin polyglutamylase complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPGS2 mRNA
CTD
PMID:15336504
NCBI chr18:16,432,628...16,489,604
Ensembl chr18:16,422,238...16,489,570
G
Tpm2
tropomyosin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPM2 mRNA
CTD
PMID:15336504
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
G
Tpp1
tripeptidyl peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPP1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
G
Tpsab1
tryptase alpha/beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPSAB1 mRNA
CTD
PMID:15003993
NCBI chr10:14,360,396...14,362,811
Ensembl chr10:14,360,396...14,362,811
G
Tpst2
tyrosylprotein sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPST2 mRNA
CTD
PMID:15336504
NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAF1 mRNA
CTD
PMID:15003993
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
Traf2
Tnf receptor-associated factor 2
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Traf4
Tnf receptor associated factor 4
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of TRAF4 mRNA tert-Butylhydroperoxide results in increased methylation of TRAF4 gene
CTD
PMID:27509014
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
G
Trak1
trafficking kinesin protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAK1 mRNA
CTD
PMID:15336504
NCBI chr 8:120,984,445...121,139,357
Ensembl chr 8:120,984,431...121,139,367
G
Tram1
translocation associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAM1 mRNA
CTD
PMID:15336504
NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971
G
Trappc1
trafficking protein particle complex subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAPPC1 mRNA
CTD
PMID:15003993
NCBI chr10:54,045,598...54,047,184
Ensembl chr10:54,045,537...54,047,331
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIAP1 mRNA
CTD
PMID:15336504
NCBI chr12:41,267,534...41,270,053
Ensembl chr12:41,267,549...41,270,042
G
Trib1
tribbles pseudokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIB1 mRNA
CTD
PMID:15336504
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trib2
tribbles pseudokinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIB2 mRNA
CTD
PMID:15336504
NCBI chr 6:38,545,971...38,570,349
Ensembl chr 6:38,545,975...38,569,370
G
Trim21
tripartite motif-containing 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM21 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:156,964,896...156,987,504
Ensembl chr 1:156,964,913...156,987,440
G
Trim25
tripartite motif-containing 25
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM25 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:73,812,818...73,831,271
Ensembl chr10:73,812,818...73,831,257
G
Trio
trio Rho guanine nucleotide exchange factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIO mRNA
CTD
PMID:15336504
NCBI chr 2:78,505,069...78,801,384
Ensembl chr 2:78,505,070...78,803,135
G
Triobp
TRIO and F-actin binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIOBP mRNA
CTD
PMID:15336504
NCBI chr 7:110,505,916...110,569,301
Ensembl chr 7:110,506,248...110,562,474
G
Trip6
thyroid hormone receptor interactor 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIP6 mRNA
CTD
PMID:15336504
NCBI chr12:19,386,212...19,390,619
Ensembl chr12:19,386,014...19,390,618
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRPV2 mRNA
CTD
PMID:15336504
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Trrap
transformation/transcription domain-associated protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA
CTD
PMID:15336504
NCBI chr12:9,738,006...9,827,708
Ensembl chr12:9,738,006...9,827,674
G
Tsc22d2
TSC22 domain family, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TSC22D2 mRNA
CTD
PMID:23410634
NCBI chr 2:142,646,778...142,697,977
Ensembl chr 2:142,644,744...142,693,606
G
Tsg101
tumor susceptibility 101
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSG101 mRNA
CTD
PMID:12419474
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tshb
thyroid stimulating hormone subunit beta
decreases activity increases oxidation
ISO
tert-Butylhydroperoxide results in decreased activity of TSHB protein tert-Butylhydroperoxide results in increased oxidation of TSHB protein
CTD
PMID:14751029
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tspan14
tetraspanin 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN14 mRNA
CTD
PMID:15336504
NCBI chr16:16,784,242...16,841,368
Ensembl chr16:16,783,234...16,841,400
G
Tspan3
tetraspanin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN3 mRNA
CTD
PMID:15336504
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Tspan31
tetraspanin 31
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN31 mRNA
CTD
PMID:12419474
NCBI chr 7:62,889,552...62,892,428
Ensembl chr 7:62,889,552...62,898,388
G
Tspan5
tetraspanin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN5 mRNA
CTD
PMID:15336504
NCBI chr 2:227,294,180...227,469,361
Ensembl chr 2:227,294,217...227,465,664
G
Tspan9
tetraspanin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN9 mRNA
CTD
PMID:15003993
NCBI chr 4:160,813,879...160,995,574
Ensembl chr 4:160,813,879...160,995,501
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TTC3 mRNA
CTD
PMID:15336504
NCBI chr11:33,689,119...33,788,976
Ensembl chr11:33,688,952...33,788,975
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1A mRNA
CTD
PMID:12414654
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1B mRNA; tert-Butylhydroperoxide results in decreased expression of TUBA1B protein
CTD
PMID:12419474 PMID:15050405
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2A mRNA
CTD
PMID:14729362
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb2b
tubulin, beta 2B class IIb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2B mRNA
CTD
PMID:15336504
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tubgcp3
tubulin gamma complex component 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA
CTD
PMID:15336504
NCBI chr16:76,851,859...76,912,499
Ensembl chr16:76,851,810...76,912,499
G
Tulp3
TUB like protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TULP3 mRNA
CTD
PMID:15336504
NCBI chr 4:161,590,478...161,632,244
Ensembl chr 4:161,590,479...161,632,149
G
Tusc3
tumor suppressor candidate 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUSC3 mRNA
CTD
PMID:15336504
NCBI chr16:53,196,195...53,345,241
Ensembl chr16:53,196,195...53,344,781
G
Txn1
thioredoxin 1
decreases response to substance
ISO
TXN protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:10754530
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
increases oxidation decreases response to substance
ISO
tert-Butylhydroperoxide results in increased oxidation of TXN2 protein TXN2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16797630 PMID:18550601
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
G
Txnip
thioredoxin interacting protein
decreases expression decreases response to substance increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TXNIP mRNA TXNIP protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of TXNIP mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Txnl1
thioredoxin-like 1
multiple interactions increases expression
ISO
LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNL1 mRNA]
CTD
PMID:31627909
NCBI chr18:57,125,362...57,155,167
Ensembl chr18:57,125,369...57,165,266
G
Txnrd1
thioredoxin reductase 1
multiple interactions increases expression
ISO
MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA]
CTD
PMID:12414654 PMID:16636651
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TXNRD2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
G
Tymp
thymidine phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TYMP mRNA
CTD
PMID:14729362
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Uba7
ubiquitin-like modifier activating enzyme 7
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of UBA7 mRNA; tert-Butylhydroperoxide results in decreased expression of UBA7 protein tert-Butylhydroperoxide results in increased expression of UBA7 mRNA Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UBA7 protein]
CTD
PMID:15003993 PMID:15336504 PMID:25649257
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBAP2 mRNA
CTD
PMID:14729362
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA
CTD
PMID:12414654
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2E1 mRNA
CTD
PMID:15336504
NCBI chr15:7,439,751...7,493,410
Ensembl chr15:7,439,759...7,493,400
G
Ube2k
ubiquitin-conjugating enzyme E2K
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2K mRNA
CTD
PMID:15336504
NCBI chr14:42,658,016...42,718,899
Ensembl chr14:42,658,016...42,718,630
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2L6 mRNA
CTD
PMID:15003993
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ube3c
ubiquitin protein ligase E3C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE3C mRNA
CTD
PMID:15336504
NCBI chr 4:5,648,932...5,749,922
Ensembl chr 4:5,648,690...5,750,011
G
Ubl5
ubiquitin-like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBL5 mRNA
CTD
PMID:15336504
NCBI chr 8:19,181,504...19,185,224
Ensembl chr 8:19,181,615...19,185,217
G
Ubxn7
UBX domain protein 7
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBXN7 mRNA tert-Butylhydroperoxide results in increased expression of UBXN7 mRNA
CTD
PMID:15336504
NCBI chr11:68,427,896...68,460,100
G
Uck2
uridine-cytidine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UCK2 mRNA
CTD
PMID:15336504
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
G
Umps
uridine monophosphate synthetase
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UMPS mRNA]
CTD
PMID:20847119
NCBI chr11:66,806,107...66,816,520
Ensembl chr11:66,806,045...66,821,903
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UNG mRNA
CTD
PMID:12414654
NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPB1 mRNA
CTD
PMID:29432895
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Upf3a
UPF3A, regulator of nonsense mediated mRNA decay
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPF3A mRNA
CTD
PMID:15336504
NCBI chr16:75,757,442...75,768,478
Ensembl chr16:75,757,441...75,769,345
G
Upp1
uridine phosphorylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UPP1 mRNA
CTD
PMID:15336504
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
EXP
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein; Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein]
CTD
PMID:16023995
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Usp17la
ubiquitin specific peptidase 17-like A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP17LA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:159,165,961...159,169,738
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP18 mRNA
CTD
PMID:15003993
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp21
ubiquitin specific peptidase 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of USP21 mRNA
CTD
PMID:15336504
NCBI chr13:83,702,672...83,709,215
Ensembl chr13:83,702,631...83,708,717
G
Usp22
ubiquitin specific peptidase 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP22 mRNA
CTD
PMID:15003993
NCBI chr10:45,828,619...45,855,468
Ensembl chr10:45,828,622...45,855,497
G
Usp9x
ubiquitin specific peptidase 9, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP9X mRNA
CTD
PMID:15336504
NCBI chr X:9,588,825...9,726,993
Ensembl chr X:9,588,825...9,696,711
G
Utp14a
UTP14A small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP14A mRNA
CTD
PMID:15336504
NCBI chr X:127,439,282...127,464,634
Ensembl chr X:127,439,268...127,464,633
G
Utp25
UTP25 small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP25 mRNA
CTD
PMID:15336504
NCBI chr13:104,630,390...104,651,681
Ensembl chr13:104,630,391...104,651,662
G
Vamp1
vesicle-associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VAMP1 mRNA
CTD
PMID:15336504
NCBI chr 4:158,012,634...158,019,350
Ensembl chr 4:158,012,663...158,019,349
G
Vasn
vasorin
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vcam1
vascular cell adhesion molecule 1
decreases expression multiple interactions increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VCAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]
CTD
PMID:12419474 PMID:28063877
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VCAN mRNA
CTD
PMID:15336504
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
G
Vdac2
voltage-dependent anion channel 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of VDAC2 mRNA
CTD
PMID:15336504
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
G
Vegfa
vascular endothelial growth factor A
multiple interactions increases secretion increases expression
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA] tert-Butylhydroperoxide results in increased secretion of VEGFA protein tert-Butylhydroperoxide results in increased expression of VEGFA mRNA; tert-Butylhydroperoxide results in increased expression of VEGFA protein
CTD
PMID:15336504 PMID:17200665 PMID:20847119 PMID:35690295
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases secretion increases expression
ISO
tert-Butylhydroperoxide results in increased secretion of VEGFC protein tert-Butylhydroperoxide results in increased expression of VEGFC mRNA; tert-Butylhydroperoxide results in increased expression of VEGFC protein
CTD
PMID:15336504 PMID:17200665
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VGLL4 mRNA
CTD
PMID:15336504
NCBI chr 4:147,925,630...148,038,519
Ensembl chr 4:147,927,034...148,038,471
G
Vim
vimentin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VIM protein
CTD
PMID:15050405
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vsnl1
visinin-like 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of VSNL1 mRNA
CTD
PMID:23410634
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Wbp11
WW domain binding protein 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WBP11 mRNA
CTD
PMID:15336504
NCBI chr 4:169,680,984...169,694,431
Ensembl chr 4:169,680,983...169,694,443
G
Wdr1
WD repeat domain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR1 mRNA
CTD
PMID:15336504
NCBI chr14:72,258,032...72,291,768
Ensembl chr14:72,257,956...72,291,766
G
Wdr26
WD repeat domain 26
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR26 mRNA
CTD
PMID:15336504
NCBI chr13:92,930,282...92,972,061
Ensembl chr13:92,930,285...92,977,295
G
Wdr43
WD repeat domain 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR43 mRNA
CTD
PMID:15336504
NCBI chr 6:23,845,499...23,884,846
Ensembl chr 6:23,845,499...23,884,846
G
Wdr77
WD repeat domain 77
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR77 mRNA
CTD
PMID:15336504
NCBI chr 2:193,435,465...193,445,534
Ensembl chr 2:193,435,468...193,445,520
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WEE1 mRNA
CTD
PMID:15336504
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WIPI1 mRNA
CTD
PMID:15336504
NCBI chr10:94,542,946...94,580,174
Ensembl chr10:94,542,946...94,579,846
G
Wnt4
Wnt family member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WNT4 mRNA
CTD
PMID:15003993
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Xcr1
X-C motif chemokine receptor 1
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of XCR1 exon
CTD
PMID:29432895
NCBI chr 8:123,479,454...123,516,168
Ensembl chr 8:123,479,590...123,487,226
G
Xist
X inactive specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of XIST mRNA
CTD
PMID:15336504
NCBI chr X:68,474,987...68,492,500
G
Xpnpep1
X-prolyl aminopeptidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP1 mRNA
CTD
PMID:15336504
NCBI chr 1:252,001,366...252,052,077
Ensembl chr 1:252,001,367...252,051,479
G
Xpnpep3
X-prolyl aminopeptidase 3
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP3 mRNA tert-Butylhydroperoxide results in decreased methylation of XPNPEP3 gene
CTD
PMID:29432895
NCBI chr 7:112,926,154...112,978,793
Ensembl chr 7:112,926,248...112,974,878
G
Ybx3
Y box binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YBX3 mRNA
CTD
PMID:12419474
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YIPF2 mRNA
CTD
PMID:15336504
NCBI chr 8:20,141,148...20,145,349
Ensembl chr 8:20,141,155...20,145,339
G
Ypel1
yippee-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YPEL1 mRNA
CTD
PMID:15336504
NCBI chr11:83,921,799...83,936,409
G
Ythdf1
YTH N6-methyladenosine RNA binding protein F1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YTHDF1 mRNA
CTD
PMID:15003993
NCBI chr 3:168,024,660...168,040,172
Ensembl chr 3:168,024,663...168,040,172
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YWHAH mRNA
CTD
PMID:12419474
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZAP70 mRNA
CTD
PMID:22659508
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Zbtb5
zinc finger and BTB domain containing 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZBTB5 mRNA
CTD
PMID:15336504
NCBI chr 5:59,244,132...59,265,461
Ensembl chr 5:59,243,307...59,265,426
G
Zc3h11a
zinc finger CCCH-type containing 11A
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]
CTD
PMID:20847119
NCBI chr13:45,073,422...45,113,901
Ensembl chr13:45,071,718...45,114,009
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZC3H12A mRNA
CTD
PMID:15336504
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zdhhc4
zinc finger DHHC-type palmitoyltransferase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC4 mRNA
CTD
PMID:15336504
NCBI chr12:11,230,864...11,244,898
Ensembl chr12:11,230,902...11,244,898
G
Zdhhc6
zinc finger DHHC-type palmitoyltransferase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA
CTD
PMID:15003993
NCBI chr 1:254,335,472...254,356,141
Ensembl chr 1:254,335,113...254,356,108
G
Zfp217
zinc finger protein 217
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ZNF217 mRNA
CTD
PMID:23410634
NCBI chr 3:158,890,464...158,931,148
Ensembl chr 3:158,892,265...158,913,040
G
Zfp36
zinc finger protein 36
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA]
CTD
PMID:20847119
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp395
zinc finger protein 395
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZNF395 mRNA
CTD
PMID:15336504
NCBI chr15:39,581,603...39,621,911
Ensembl chr15:39,608,080...39,619,950
G
Zfp593
zinc finger protein 593
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNF593 mRNA
CTD
PMID:15336504
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zfyve16
zinc finger FYVE-type containing 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZFYVE16 mRNA
CTD
PMID:15336504
NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:23,713,766...23,756,990
G
Zmiz1
zinc finger, MIZ-type containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA
CTD
PMID:15336504
NCBI chr16:1,027,083...1,232,616
Ensembl chr16:1,027,325...1,232,597
G
Zmynd19
zinc finger, MYND-type containing 19
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of ZMYND19 gene
CTD
PMID:29432895
NCBI chr 3:7,758,133...7,769,722
Ensembl chr 3:7,758,133...7,767,514
G
Znhit1
zinc finger, HIT-type containing 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNHIT1 mRNA tert-Butylhydroperoxide results in decreased expression of ZNHIT1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr12:19,686,606...19,692,880
Ensembl chr12:19,686,148...19,692,880
G
Zpr1
ZPR1 zinc finger
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZPR1 mRNA
CTD
PMID:15336504
NCBI chr 8:46,564,898...46,574,719
Ensembl chr 8:46,565,146...46,574,719
G
Zswim7
zinc finger, SWIM-type containing 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZSWIM7 mRNA
CTD
PMID:15003993
NCBI chr10:46,953,311...46,969,800
Ensembl chr10:46,957,525...46,969,671
G
Zyx
zyxin
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZYX mRNA tert-Butylhydroperoxide affects the expression of ZYX mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all